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SUMMARY
Clostridium perfringens type A was isolated from 27 of 60 
natural cases of diarrhoea and enteritis in pigs. In 14 cases 
C.perfringens type A was recovered in profuse culture and no other 
potential pathogens were isolated. Its presence was associated 
with enteritis in young piglets but accurate description of 
associated lesions was prevented by post-mortem change.
An isolate of C.perfringens type A was used to infect 8 day 
old hysterectomy-derived, colostrum-deprived (HDCD) piglets and 
found to produce diarrhoea and enteritis similar to that found in 
the field. The same isolate caused fatal infections in 5 out of 6 
newborn HDCD piglets in a second experiment.
Deaths and diarrhoea could be prevented by the oral and 
parenteral administration of serum and the oral administration of 
milk and colostrum from sows immunised with a crude toxoid, a 
bacterin and a combination of these prepared from the challenge 
isolate. It was not clear from this study whether antitoxin or 
antibody to somatic antigens were responsible.
38 out of 42 isolates of C.perfringens type A isolated from 
cases of porcine enteritis were found to produce alpha toxin at 
levels varying from 4 haemolytic units to 256 haemolytic units. 
Alpha toxin was purified from the pathogenic isolate and found to 
produce no fluid* accumulation but some inflammation in piglet gut 
loops. This change could be neutralised by antibody raised to the 
toxin. Antibody to alpha toxin was demonstrated by counterimmuno­
electrophoresis in the sera of 45 out of 106 sows in a survey 
indicating that exposure to alpha toxin was widespread.
Spores of C.perfringens type A were detected in pig faeces and 
intestinal contents in 20 out of 23 cases of enteritis at levels of 
up to 5xlO*Vgram. Lower numbers of spores up to 2xloVgram were 
present in 5 out of 10 samples from normal pigs. Enterotoxin was 
demonstrated by Vero cell assay in 5 of the 23 samples from 
diarrhoeic pigs but in none of the 10 from normal pigs. An
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enterotoxin-producing isolate was used to prepare pure enterotoxin 
and antibody to it. Antibody to enterotoxin was demonstrated by 
counterimmunoelectrophoresis in 98 out of 106 sow sera from 4 
herds.
The enterotoxin was found to produce fluid accumulation in 
piglet gut loops and a transient watery diarrhoea when given 
intraluminally to HDCD piglets. The enterotoxin-producing strain 
was used to infect neonatal HDCD piglets and both vegetative and 
sporulated cells caused a transient, non fatal diarrhoea. 
Sporulated cells and enterotoxin were demonstrated in their 
faeces. No protection was found when pig serum containing antibody 
to enterotoxin was given orally or parenterally.
These studies showed that both alpha toxin and enterotoxin- 
producing strains of C.perfringens type A of porcine origin could 
produce diarrhoea in neonatal HDCD piglets and that both the 
organisms and antibody to their toxin occurred widely in the pig 
population.
xxxii
CHAPTER 1
INTRODUCTION AND REVIEW OF THE LITERATURE
1. INTRODUCTION
Infectious enteric disease is a major problem in the pig and 
outbreaks of enteric disease are a significant cause of morbidity, 
mortality and economic loss on pig farms. A number of microbial 
agents, Escherichia coli, Salmonella spp., Clostridium perfringens 
type C, Treponema hyodysenteriae, Transmissible Gastroenteritis 
virus and, Isospora suis have been considered major causes of 
enteric disease for many years. Recently agents such as
Campylobacter spp., Rotavirus, Cryptosporidia and the coronavirus 
of Porcine Epidemic Diarrhoea have also been incriminated.
C.perfringens type A has been largely ignored as a cause of 
enteritis in the pig. It has been recovered regularly from the
intestinal tract of both diseased and normal animals, but few
attempts have been made to correlate the presence of the bacterium 
with disease and it has been regarded generally as part of the 
normal intestinal flora. Recently C.perfringens type A has been 
associated with enteritis in calves, chickens, pigs and in food 
poisoning and some other enteric syndromes in man.
The literature on Clostridium perfringens in general and 
C.perfringens type A in particular is voluminous. Much of it 
relates to C.perfringens in animals other than the pig or to 
infections outside the gastrointestinal tract. The material 
selected for presentation in this review comprises work on the 
general properties of the organism, its biochemical and antigenic 
features and its relationship to enteric disease in the pig and was 
selected in 1985. More recent papers have been included, where 
relevant in the general discussion (Chapter 7).
The literature on the relationship between C.perfringens and 
the intestine has been reviewed separately with particular emphasis 
on the immune response of the gut to antigens and to C.perfringens 
in particular. This section concludes with a review of immune 
protection against enteric pathogens in the pig and other animals 
and C.perfringens in particular.
A final section gives an outline of the experimental approach 
adopted.
2. CLOSTRIDIUM PERFRINGENS
(a) General characteristics of the organism
Clostridium perfringens was discovered at the end of the last 
century. It was shown to be an important cause of gas gangrene in 
the First World War (Ispolatovskaya, 1971).
C.perfringens is a Gram-positive rod, about 4 x 1.5 pm, 
straight with parallel sides and rounded ends. Spores of
C.perfringens are seldom seen in cultures grown on the usual 
laboratory media and their absence is one of the characteristic 
features of C.perfringens (Willis, 1977). When they do occur, they 
are oval in shape and usually subterminal in position, although 
terminal spores are sometimes seen (Smith, 1975a). Occasionally 
strains of C.perfringens are encountered which sporulate readily on 
ordinary media, ,and sporulating mutant strains have been induced by 
treatment with acridine orange or nitrosoguanidine (Duncan et al.,
1972).
C.perfringens is not a strict anaerobe, growing readily in the 
presence of small amounts of oxygen. It is one of the most rapidly 
growing anaerobes, surface growth often being detectable after only 
4-6 hours of incubation; growth in deep broth may be evident after 
only 2 hours (Willis, 1977). Colonial morphology is of value in 
identification. Colonies on the surface of blood agar after 
overnight incubation are 1 to 3 mm in diameter, low convex,
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semi-opaque, glossy, with entire margins. On further incubation, 
the colonies are 3 to 8 mm in diameter, sometimes with a raised 
centre and a flattened periphery, or of comparatively even 
thickness except for the thinner periphery. Often, this periphery 
does not extend uniformly around the colony, but is much wider on 
one side than another, as if swarming were about to start, however, 
swarming is not observed with C.perfringens (Smith, 1975a).
Aberrant colony forms are sometimes encountered. Mucoid 
colonies are hemispherical, opaque, glistening, with sharp, regular 
margins. The organisms in mucoid colonies are encapsulated, 
particularly in young cultures and at the edge of the colonies. 
Rough cultures are 3 to 5 mm in diameter, slightly raised with a 
flat, rough surface, semi-translucent, with lobate margins. The 
cells are not encapsulated and tend to adhere to one another in the 
fashion of cells in rough colonies of other species. Pure cultures
of C.perfringens frequently give rise to two or more colony forms
1 “
(Smith, 1975a).
On horse blood agar many strains of C.perfringens produce 
zones of complete haemolysis due to the production of theta toxin 
(Willis, 1977). Partial haemolysis is frequently seen among type A 
strains, and absence of haemolysis is characteristic of some 
heat-resistant food poisoning type A strains, and of some type C 
strains, since they do not produce any theta toxin (Hobbs, 1965). 
Partial haemolysis on horse blood agar is due to the alpha toxin, 
which is relatively inactive against the red cells of the horse 
(Willis, 1977). On egg yolk agar C.perfringens produces diffuse 
opalescence, which is inhibited by C.perfringens anti-alpha toxin, 
no pearly layer is produced. In cooked meat medium growth is 
evident in a few hours, a fair amount of gas is produced and the 
meat particles are turned pink, there is no meat digestion. In 
ordinary milk medium rapid fermentation of the lactose occurs, with 
the subsequent development of a characteristic stormy clot reaction 
(Willis, 1977).
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About three-fourths of the strains of C.perfringens have 
capsules demonstrable by negative staining with India ink. Some 
strains, produce capsules of appreciable size especially those 
forming mucoid colonies on nutrient agar containing 5 per cent 
glucose. Some strains do not seem to form capsules under any 
circumstances. Most strains, however, form demonstrable capsules 
if grown slightly above neutrality in the presence of fermentable 
carbohydrate and serum or milk (Smith, 1975a). Both species 
specific and strain-specific capsular antigens appear to exist. 
Cells of C.perfringens can sometimes be induced to lose the 
capsular antigen by cultivation in the presence of homologous 
antibody. When this happens the organisms become agglutinable by 
antisera to all C.perfringens strains, indicating that a somatic 
antigen underlying the capsule is common to all strains (Smith, 
1975a).
C.perfringens ferments fructose, galactose, glucose, inositol, 
lactose, maltose, mannose, starch, and sucrose. A minority of the 
strains will ferment cellobiose, glycerol, insulin, raffinose, or 
salicin. It does not ferment adonitol, amygdalin, arabinose, 
cellulose, dulcitol, erythritol, esculin, mannitol, melezitose, 
meliziose, rhammose, ribose, sorbitol, sorbose, trehalose, or 
xylose. The fermentation products include acetic and butyric 
acids, with or without butanol (Willis, 1977).
Gelatin is hydrolysed, sometimes slowly. A few strains will 
hydrolyse casein,,. Urease is produced by some strains, particularly 
those of type B and E (Smith, 1975a). Type C strains isolated from 
animals do not produce this enzyme but two-thirds of the strains 
isolated from enteritis necroticans in man do so (Prevot et al. ,
1967). Nitrate is reduced by almost all strains, although this 
characteristic is dependent upon the medium that is used. Hydrogen 
sulphide and indol are not produced. Acetyl-methy1-carbinol is 
rarely produced (Smith, 1975a).
The optimum temperature for rapid growth of strains of types 
A, D and E is about 45°C, this is not, however, the optimum
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temperature for the production of the various enzymes of this 
species, in every case the optimum temperature for the production 
of the enzymes is lower (Smith, 1972). The pH range over which 
growth most readily takes place is from 5.5 to 8.0 and the optimum 
pH value for maximum growth is about the same for all strains, 
being about 6.5 (Smith, 1972).
The highest redox potential at which growth of C.perfringens 
will take place is about +200 millivolts in a medium at pH 7.0. 
After the organism starts growing, the redox potential will drop 
sharply to a value near that of the hydrogen electrode, about -400. 
millivolts at pH 7.0 (Tabatabai and Walker, 1970).
C.perfringens produces at least 12 different toxins that may 
be involved in pathogenesis (McDonel, 1980; Table 1). Whether or 
not all these toxins are directly involved in the production of 
lesions or contribute to the pathogenesis of infections in animals 
or man is unclear (McDonel, 1980). At least eight of the toxins 
are believed to be lethal. The role in pathogenesis of eta, gamma, 
kappa, lambda, mu and nu toxins is uncertain (McDonel, 1980). Four 
of the lethal toxins, alpha, beta, epsilon and iota, are considered 
to be the major toxins and are used to group the species into five 
toxigenic types of A, B, C, D and E. Type A strains produce
predominantly alpha toxin; type B, beta and epsilon toxins; type 
C, beta and delta toxins; type D, epsilon toxin; and type E, iota 
toxin (Stern and Warrack, 1964). A strain once classed as type F 
(Zeissler and Rossfeld-Sternberg, 1949) has been abandoned because 
of its essential similarity to type C (Stern and Warrack, 1964). 
Typing of the organism is accomplished with type-specific
antisera. Type A antiserum neutralises only type A strains. Type 
B antiserum neutralises types A, B, C and D. Type C antiserum 
neutralises types A and C. Type D antiserum neutralises types A 
and D and type E antiserum neutralises types A and E (Carter, 
1979). Treatment with trypsin usually inactivates, or reduces the 
potency of alpha and beta toxins, consequently, culture fluids of 
type C strains are often without toxic activity after trypsin
treatment. Type B strains often yield culture filtrates that
5
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before trypsin treatment are neutralisable only by type B antiserum 
because they contain both beta and epsilon toxin; however, after 
trypsin treatment only epsilon toxin is left in active form and the 
culture fluids can then be neutralised by both types B and D 
antisera. Strains of B and D that are poor producers of epsilon 
toxin may require trypsin treatment before epsilon toxin can be 
demonstrated (Smith, 1975a).
(b) Distribution of the organism
C.perfringens is more widely spread than any other pathogenic 
bacterium (Prevot et al., 1967). Its principal habitats are the 
soil and the intestinal contents of man and animals. Only type A 
strains are found as part of the microflora of both soil and
intestinal tracts; B, C, D and E strains seem to be obligate
parasites, mostly of animals, although they may occasionally be 
found in man (Smith, 1975a).
Almost every sample of soil that has ever been examined, has 
been found to contain C.perfringens (Prevot et al., 1967). The 
number of cells of this organism vary considerably from one
specimen to another, but any fertile soil can be expected to 
contain several thousand per gram, and may contain as many as fifty 
thousand per gram (Smith, 1975a). The existence of, these strains 
of C.perfringens in the soil primarily as vegetative cells
indicates that they are actively multiplying there and that the 
soil is a true ,habitat (Prevot et al., 1967). If cultures of 
C.perfringens types B, C, D and E are added to soil, they die 
within a few months, apparently being unable to compete with the 
type A strains that are native to soil (Smith, 1975a). It is 
reported (Beerens and Delcourte, 1958) that soil strains of type A 
differ from intestinal strains of type A in being more resistant to 
the toxic effect of sodium chloride.
C.perfringens has been found, in varying numbers, in the 
intestinal contents of almost every animal that has ever been 
investigated (Prevot et al., 1967). C.perfringens forms a part of
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the normal intestinal flora of man and animals (Niilo, 1980) but is 
also associated with a number of disease syndromes' in both man and 
animals. These may be extra intestinal e.g. Gas Gangrene in man 
and other species associated with C.perfringens type A or 
intestinal in origin (the enterotoxaemias) with clinical signs and 
lesions in a number of different organs systems as a result of 
C.perfringens infection in the gut of non-immune animals. These 
diseases are associated with the individual types of C.perfringens 
shown in Table 2.
(c) Clostridium perfringens in pigs
(i) Clostridium perfringens type A
C.perfringens type A is part of the normal intestinal flora of 
the pig, reaching levels of 10^  cells per gram of faeces within 
72 hours of birth and subsequently declining to levels of 10  ^cells
*r
per gram by 2 weeks of age (Mansson and Smith, 1962).
Both extra-intestinal infections and intestinal disease have 
been associated with C.perfringens type A. C.perfringens type A 
has been involved in cases of gas gangrene in pigs. Jaartsveld et 
al. (1962) reported the occurrence of C.perfringens infection in 
two herds following intramuscular injection of an iron 
preparation. Twelve of 25 piglets in one herd died hours after the 
injection. It was suggested that alpha toxin was responsible for 
the production of the lesions (Jaartsveld et al., 1962). When 
Mansson and Smith (1962) placed 8 week-old pigs on a diet high in 
protein, there was an increase in the number of C.perfringens type 
A from about 250 per gram of faeces on a normal diet to about 
1,000,000 per gram in pigs on the high-protein diet. Another study 
(Mansson and Olhagen, 1967) demonstrated that when pigs were fed on 
a high-protein diet, the number of C.perfringens type A was 
dramatically increased in the faeces. In association with this 
increase, the animals showed skin lesions typical of parakeratosis 
and developed an arthritis involving mainly the phalangeal joints. 
They related the development of these joint and skin lesions to a
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TABLE 2
The association of C.perfringens types with enteric disease
V.
Disease
Type A Enterotoxin food poisoning and neonatal necrotic 
enteritis. Enteritis in cattle, chickens, dogs, goats, 
horses, rabbits, monkeys, pigs and necrotic enteritis in 
sheep.
Type B Lamb dysentery, enterotoxaemia in goats and guinea pigs.
Type C ’Pig Bel' in man, 'Struck' in sheep, enterotoxaemia in 
cattle, pigs and chickens. **
Type D Pulpy kidney in sheep, enterotoxaemia in goats, cattle 
and guinea pigs.
Type E Enterotoxaemia in sheep, calves, guinea pigs and 
rabbits.
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rise in serum antibody to alpha toxin. On histological examination 
the lesions were found to consist of a highly vascularised 
granulation tissue. In the synovial membrane of the phalangeal 
joints, there was a slight accumulation of mononuclear cells. 
There was also distinct villous hypertrophy with a proliferation of 
the vascular tissue in particular. Bacteriological examinations of 
the synovia were negative. Mansson et al. (1971) later confirmed 
these results and in addition demonstrated a delayed 
hypersensitivity against intestinal C.perfringens type A in the 
experimental animals. Control pigs were negative but the 
hypersensitivity could be transferred to them by lymphocytes from 
an experimental pig. It was suggested that circulating soluble 
alpha toxin-anti alpha toxin complexes formed in antigen excess 
were responsible for the lesions produced (Mansson et al., 1971).
C.perfringens type A has been incriminated in enteric lesions 
in pigs from which no other pathogen could be demonstrated 
(Amtsberg et al., 1976). Another study (Ramisse et al., 1979) 
reported the isolation of C.perfringens type A from newborn piglets 
which died of diarrhoea. C.perfringens type A enteric disease was 
experimentally reproduced by Olubunmi (1982) in hysterectomy- 
derived, colostrum-deprived piglets. Profuse diarrhoea containing 
flecks of blood was noted in the inoculated piglets from the second 
day following infection. Two out of three inoculated animals died 
within 3 days of inoculation. Conventional weaned pigs were 
infected with the organism (Olubunmi, 1982). Loose faeces with 
varying amounts. of mucus and blood were noticed. Poor bodily 
condition developed in the inoculated animals. The disease 
produced in this study was not fatal. Gross pathological changes 
attributable to C.perfringens type A infection were demonstrated in 
both experiments, the mucosa of the small intestine, particularly 
that of the jejunum was found to contain congestion and necrotic 
areas and villous atrophy was seen in all cases. Histological 
changes were found to be more severe in the hysterectomy-derived 
colostrum-deprived piglets than in the conventional weaned pigs. 
In the former animals the lesions included congestion, destruction 
of the villi and necrosis at small intestinal level. Epithelial
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cell shedding and presence of inflammatory and red cells in the 
lumen was recorded. Necrosis of the epithelium and large areas of 
congestion were present in the large intestine. In conventional 
weaned pigs, histological changes were restricted to the small 
intestine with a mild congestion, oedema of the mucosa and villous 
atrophy. C.perfringens type A was recovered from the mucosa of the 
duodenum, jejunum and ileum, less frequently from stomach, caecum 
and colon. It was concluded that C.perfringens type A was capable 
of producing an enteric disease in inoculated pigs (Olubunmi, 
1982). Another study (Nabuurs et al., 1983) on the aetiology of 
diarrhoea in piglets of one to three weeks of age revealed high 
numbers of C.perfringens type A in intestinal contents of severely 
affected animals. Experimental infections with hysterectomy- 
derived, colostrum-deprived piglets resulted in a clinical picture 
indistinguishable from the clinical signs observed under field 
conditions. The clinical signs were creamy diarrhoea, emaciation, 
abundant gas in the gut. Mortality was low. The predominant post­
mortem findings were the presence of gas in the intestinal ltimen, 
and superficial necrosis and villus atrophy in the mucosa.
A study in neonatal diarrhoea of piglets (Secasiu, 1984) 
associated an increase of the number of C.perfringens type A in 
intestinal contents of diseased piglets with the onset of 
diarrhoea. Most of the isolates were found to be strong alpha 
toxin producers and when tested in rabbit intestinal loops, 39 out 
of 178 were found to be toxigenic.
More recently, studies of enterotoxin have been carried out in 
pigs. Purified enterotoxin from a C.perfringens type A reference 
strain was found to induce fluid accumulation in the ileal loops of 
hysterectomy-derived piglets (Popoff and Jestin, 1985) suggesting 
that enterotoxin could be involved in diarrhoeas occurring 
naturally in young pigs. Jestin et al. (1985) reported a 
diarrhoeic syndrome in fattening pigs associated with C.perfringens 
type A enterotoxin in their faeces. A correlation was observed 
between the intensity of the diarrhoea and the level of 
C.perfringens type A enterotoxin in faeces. It was concluded that
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C.perfringens type A enterotoxin was an important contributing
factor of diarrhoea in fattening pigs.
(ii) Clostridium perfringens type C
C.perfringens type C is recognised as the cause of a highly 
fatal necrotic enteritis of young, pigs. Young piglets less than 
one week of age are usually affected although sucking pigs up to a 
month old are occasionally affected (Bergeland, 1981).
C.perfringens type C has been shown to attach to and invade the 
epithelium of the small intestinal villi, and to proliferate along 
the basement membrane. Attachment first occurs at the apices of 
jejunal villi (Arbuckle, 1972). This is accompanied by 
desquamation of the epithelium and complete necrosis of the lamina 
propria of the villi. In peracute cases, massive haemorrhage 
accompanies the necrosis. The majority of the bacteria remain 
attached to the necrotic villi and the villi, together with the 
adherent bacteria, are sloughed into the intestinal lumen 
(Bergeland, 1981). Beta toxin produced by the organism in the 
intestine is probably responsible for the inflammation of the
intestine and the whole loss of mucosa (Meszaros et al., 1967). 
The disease may be associated with the inhibition of the
proteolytic action of trypsin in the small intestine of neonates by 
a factor in the colostrum. Both trypsin and chymotrypsin have a 
notable inactivating effect on beta toxin of C.perfringens type C. 
The disease seems to be associated with low tryptic activity in the 
small intestine ' (Meszaros et al., 1967). It has been reported 
(Bergeland, 1972) that characteristic intestinal necrosis appears 
to result from active invasion of the mucosa by type C organisms 
rather than simply from the presence of toxin in the intestinal 
lumen. Intestinal necrosis was not observed in ligated intestinal 
loops injected with bacteria-free toxin, whereas focal areas of 
bacterial invasion and necrosis were seen in loops injected with 
whole broth culture of C.perfringens type C (Bergeland, 1972). 
Toxaemia may be a contributing factor in peracute cases in which 
the pigs collapse and die suddenly. Beta toxin is present in high 
concentration in the haemorrhagic intestinal content as well as the
peritoneal fluid of some of these pigs, and it is probable that 
some toxin is absorbed. Experimental intravenous infusion of type 
C toxin in high doses causes sudden death in young pigs (Bergeland, 
1981). The mortality rate of pigs with clinical signs is usually 
very high, and complete recovery is rare. In the peracute form, 
sudden death occurs in piglets with little or no evidence of 
diarrhoea; others may have haemorrhagic diarrhoea and there may be 
perineal staining with bloody fluid, in these cases death usually 
occurs on the first or second day after birth. In the acute 
syndrome, affected animals may survive for two days after the onset 
of clinical signs, and commonly die within three days; throughout 
the course of the disease they have reddish brown liquid faeces 
that contain shreds of grey necrotic debris. In the subacute form, 
the affected animals have a persistent, non-haemorrhagic diarrhoea 
and usually die when 5-7 days old, their faeces tend to be soft and 
yellow at first and then change to a clear liquid containing flecks 
of grey necrotic debris. Chronic cases may have an intermittent or 
persistent diarrhoea for one or more weeks, faeces are yellowish- 
grey and mucoid, and the perineum and the tail may be coated with 
dried faeces. These pigs may eventually die after several weeks 
and the survivors fail to gain weight (Bergeland, 1981). The most 
consistent pathological feature in infected pigs is varying degrees 
of necrosis and desquamation of the epithelial layer of the mucous 
membrane of the jejunum, and sometimes of the ileum. In peracute 
cases, the jejunum is dark red and the lumen is filled with blood­
stained fluid; the rest of the small and large intestine also 
contains bloody fluid. Microscopically, the villi in the jejunum 
are necrotic and are covered by large bacilli; the epithelium of 
the crypts may be necrotic. Profuse haemorrhages are present in 
the mucosal and submucosal layers. The jejunum may be emphy­
sematous and there may be fibrinous peritonitis. Most of the villi 
are sloughed, leaving a necrotic membrane overlying the submucosa. 
Submucosal vessels are necrotic and may contain thrombi. The 
affected portion of the jejunum and ileum in piglets with subacute 
disease is thickened with a tightly adherent necrotic membrane in 
place of the mucosa. The intestine of pigs with chronic disease 
may appear normal from the serosal surface. Microscopically, there
13
is replacement of the mucosa by a necrotic membrane, with numerous 
bacteria on its underside. The submucosa and tunica muscularis are 
infiltrated by chronic inflammatory cells (Bergeland, 1981).
(d ) Pathogenic mechanisms in Clostridium perfringens
The above review of the literature about clostridial 
infections in pigs has associated the adhesion of C.perfringens 
type C to the villi and the production of toxins to the damage 
caused. The mechanisms by which adhesion to epithelial cells occur 
have not been studied, it has merely been reported to occur in both 
human (Walker et al., 1980) and porcine (Arbuckle, 1972) infections 
with C.perfringens type C. In view of this scarcity of information 
this section of the review deals almost entirely with the exotoxins 
of C.perfringens.
(i) Alpha toxin
Alpha toxin (Lecithinase, Phospholipase C) is produced by all 
five types of C.perfringens, however type A strains usually produce 
the largest quantities (Ispolatovskaya, 1971). The majority of 
type A strains of C.perfringens produce amounts of alpha toxin 
detectable on horse blood agar or egg yolk agar but some isolates 
do not appear to do so. These isolates have the biochemical 
characters of C.perfringens but do not produce other toxins and 
were considered by Ispolatovskaya (1971) to be C.perfringens type 
A. The production of alpha toxin also varies considerably from one 
medium to another; alpha toxin production and the amount of growth 
are not necessarily correlated (Smith, 1975a). A study (Mollby et 
al., 1976) showed that the yields of alpha toxin produced by type A 
strains isolated from cases of gas gangrene and abdominal wounds 
were indistinguishable from those isolated from faecal samples from 
healthy persons. It was found in another study (Forget et al., 
1969) that toxicity for mice and yield of alpha toxin production in 
culture supernatant fluids correlated with virulence of 
C.perfringens type A strains.
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The genetic control of alpha toxin production is virtually 
unknowni one reported attempt to link its production to a plasmid 
was unsuccessful (Kramer and Schallehn, 1978).
The composition of the nutrient medium strongly influences 
growth and alpha toxin production of C.perfringens A. It has been 
shown that the cultivation of the organism on medium containing 
pieces of meat or meat extract promoted production of alpha toxin 
but not theta toxin (Takahashi et al. , 1981).
Yields of alpha toxin production are influenced by the 
presence of aminoacids, carbohydrates, salts, vitamins and metal 
ions in the culture medium (Ispolatovskaya, 1971).
Production of alpha toxin is possible in most synthetic media 
only if peptides are present. However, a synthetic medium was 
devised (Murata et al., 1968) that supported some alpha toxin
production, even though this was considerably less than tothat 
produced in a medium containing peptone. It has been shown 
(Ispolatovskaya, 1971) that cystine, tyrosine, glycine and arginine 
accelerate the growth of C.perfringens, but that alpha toxin 
production was stimulated by arginine exclusively and was further 
increased by histidine and tryptophan.
Nakamura et al. (1968) did not find alpha toxin produced in 
detectable amounts using a synthetic medium containing amino acids 
as a nitrogen source. The addition of some peptides, such as 
glycyl-DL-valine, glycyl-DL-norvaline, or D-leUcyl glycyl glycine 
resulted in the production of alpha toxin. The addition of
corresponding amounts of the individual acids composing these 
peptides did not result in alpha toxin production, nor did the
addition of a number of other peptides. The importance of peptides
for the formation of alpha toxin was also indicated in a study
(Nekvasilova et al., 1970) which demonstrated that the substances 
which stimulated most active alpha toxin production in casein 
digest were tyrosine-containing peptides of low molecular weight. 
Starch, dextrin or fructose are the carbohydrates which produce the 
greatest increases in the yield of the toxin (Smith, 1975a).
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The addition of a combination of vitamins, zinc and magnesium 
to the medium stimulates alpha toxin production (Ispolatovskaya, 
1971). Murata et al. (1965) reported the production of alpha toxin 
by C.perfringens on a synthetic medium consisting of 19 amino 
acids, vitamins, and trace elements. Fructose was used as a 
carbohydrate source in this medium. It was observed that toxin 
production increased by the addition to the nutrient medium of 
arginine and was decreased in the presence of cystine. Zinc and 
magnesium had no influence on the growth of the bacteria but 
increased toxin production. An excess of manganese or of iron had 
a suppressive effect on toxin production. It was reported (Sato et 
al., 1978) that C.perfringens type A produces several distinct
proteases that destroy alpha toxin produced in a zinc deficient 
medium. Alpha toxin without zinc is highly sensitive to proteases 
but resistant when combined with zinc.
The production of toxin components of C.perfringens depends 
upon the conditions of cultivation of the bacteria and the 
constituents of the nutrient medium (Ispolatovskaya, 1971). 
Quantitatively, alpha toxin production by C.perfringens is 
dependent upon the strain, the medium, the culture conditions, pH, 
temperature of incubation, and the length of incubation (Nakamura 
et al., 1969).
Roberts (1957) showed that there was less alpha toxin produced 
when the cultures were incubated at 43°C compared to 37°C.
It was reported (Weiss and Strong, 1967) that the alpha toxin 
activity of some strains decreased rapidly after reaching a maximum 
at 4-6 hours of incubation. However, Nakamura et al. (1969) 
reported that alpha toxin activity in older cultures (30-60 hours) 
was greater than the lecithinase activity in young actively growing 
cultures. It is possible that the composition of the medium used 
for the growth and production of alpha toxin plays an important 
role in the stability of the lecithinase after it is produced; in 
culture media deficient in nutrients alpha toxin may be broken down 
and metabolized (Ispolatovskaya, 1971).
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Alpha toxin is readily inactivated by acid pH, being more 
resistant to alkaline pH values (Nakamura et al., 1969). The 
optimum pH of the culture medium for alpha toxin production has 
been reported to be between 7.6- 7.8 (Takahashi et al., 1981).
The alpha toxin activity of culture fluids may be assayed in
several ways. The ability of the culture fluid to cause an
increase in the turbidity of an egg yolk suspension may be used;
the products of the reaction between the enzyme and lecithin can be
titrated (Hanahan and Vercamer, 1954). Agar diffusion procedures
can be used with egg yolk or blood agar as indicator, the toxin
being placed either in holes cut in the agar with a cork-borer or
on paper discs (Holdeman and Moore, 1973). The haemolytic activity
can be titrated, or intraperitoneal inoculation of mice or
intracutaneous injection of guinea pigs may be used to determine
the action of the toxin in vivo (Smith, 1975a). The amount of
alpha toxin antigen may be determined, rather than the enzyme or
«*
toxic activity, by combining tests with antiserum whose antitoxin 
value in international units is known, using egg yolk suspension or 
red blood cell suspensions as indicator of unneutralised alpha 
toxin (Smith, 1975a).
Alpha toxin has been demonstrated to have phospholipase C, 
lecithinase, lethal, necrotizing, haemolytic and cytolytic 
activities (Willis, 1977). It was the first bacterial toxin to be 
identified as an enzyme (a phospholipase C that catalyzes the 
hydrolysis of the phosphodiester bond in position 3 of the lecithin 
molecule to produce phosphorylcholine and water-insoluble 1, 
2-diacylglyceride) (MacFarlane and Knight, 1941).
The molecular weight of alpha toxin has been variously 
determined as 106,000 (Meduski and Volkova, 1958); 31,000
(Bernheimer and Grushoff, 1967); 51,200 (Shemanova et al., 1968); 
90,000 (Casu et al., 1971); 43,000 (Yamakawa and Ohsaka, 1977). 
The most reproducible value appears to be about 30,000 obtained by 
gel filtration chromatography (Mollby, 1978). The isoelectric 
point of alpha toxin has been reported to be at 5.0 (Bangham and
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Dawson, 1961); 5.2 (Ispolatovskaya, 1971; 4.75 (Bird et al.,
1974); 5.6 (Smyth and Arbuthnott, 1974). Using the technique of 
isoelectric focusing (Sugahara and Ohsaka, 1970) showed the 
existence of two forms of alpha toxin differing in charge with 
isoelectric points of 5.2 and 5.5 and 5.3 and 5.6 respectively.
Variations in published data on alpha toxin may result from 
the fact that many authors have used preparations of the enzyme 
from commercial or other sources with insufficient or no regard for 
the fact that these preparations may contain as many as 10 contam­
inating active substances. These may include theta haemolysin, 
mu and nu toxins, protease, alpha-glucosidase, N-acetyl- 
glucosamine, sulphatase, and p-glucuronidase (Mollby et al.,
1973). Several of these contaminating substances have marked
activity with respect to biological membranes (Smyth et al., 1975).
Alpha toxin is resistant to inactivation by heat. It can
retain 45 per cent of its activity when exposed to f00°C 
(MacFarlane and Knight, 1941). It has been found (Smith and 
Gardner, 1950) that alpha toxin is greatly inactivated at 65°C, but 
can be partially reactivated by further heating to 100°C. It was
suggested (Smith and Gardner, 1950) that enzymatically inactive
complexes linked by calcium ions were formed at 65°C, however, at 
100°C these complexes dissociated with the liberation of active 
toxin.
The activity of alpha toxin is calcium dependent (Bangham and 
Dawson, 1961), although the role of calcium appears to be limited 
to its effect on the substrate, not the enzyme (Dawson et al.,
1976). Divalent cations and positively charged detergents are 
believed to activate the phospholipase action by giving the 
substrate a positive charge which optimizes attachment of the 
negatively charged enzyme (Dawson et al., 1976).
Alpha toxin is markedly haemolytic, although there is 
considerable variation from one species to another in erythrocyte 
susceptibility. Erythrocytes of cattle and mice seem most
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susceptible, those of rabbit, sheep and men moderately susceptible, 
while those of horses and goats are comparatively resistant (Smith, 
1975a), Apparently, either the type of phospholipid, lecithin, 
sphingomyelin, or other, or its position in the cell membrane 
determines the susceptibility or resistance of erythrocytes to 
lysis by alpha toxin (Smith, 1975a). The damage to the cell 
membrane may result directly in haemoglobin release but other 
factors may be involved. After exposure to low concentrations of 
alpha toxin at 37°C erythrocytes of many species of animals do not 
undergo lysis until they have been cooled to 4°C, a phenomenon 
called Jtiot-cold haemolysis (Smith, 1975a). It was reported 
(Mollby, 1978) that only a slight hot-cold haemolytic phenomenon is 
detectable using highly purified alpha toxin from C.perfringens.
Aside from its effects upon red cells, alpha toxin also lyses 
platelets and leucocytes (Mihancea et al., 1970), stimulates
histamine release from cells in vivo and in vitro (Strandberg et 
al., 1974) and damages membranes in fibroblasts (Mollby et ..al., 
1974) and intact muscle cells (Boethius et al., 1973).
Furthermore, it causes aggregation of platelets in vitro and in 
vivo (Ohsaka et al. , 1978); this last study demonstrates that
within one minute of topical application of alpha toxin to rat 
mesentery, pavementation of leucocytes occurred in venules but not 
arterioles. Thrombi then formed in venules, capillaries and 
eventually, in arterioles. This study concluded that thrombosis 
must be involved as an early important step in the pathogenesis of 
necrosis caused by alpha toxin and that these alpha toxin induced 
thrombi may be one of the factors involved in the causation of 
toxaemia often manifested in the late stage of gas gangrene (Ohsaka 
et al., 1978). It has also been shown (Ohsaka et al., 1978) that 
alpha toxin causes an increase in vascular permeability in 
guinea-pig skin due possibly, to release of some mediators from 
aggregating platelets. Wilkinson (1975) demonstrated that the 
locomotor response of human monocytes is inhibited by the toxin.
The systemic effects of alpha toxin are affected by the route 
of administration (Smith, 1975a). When injected intravenously a 5
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to 20 per cent drop in the red cell count occurs within a few hours 
followed shortly thereafter by death. Other effects are 
destruction of platelets, a drop in clotting time, and widespread 
capillary damage (Smith, 1975a). Under experimental conditions 90 
per cent of the toxin injected disappears from circulating blood 
within 5 minutes of injection (Ellner, 1961). The toxin that 
disappears from the blood appears in the following organs: liver,
72 per cent; lungs, 15 per cent; kidneys, 8 per cent; and spleen, 5 
per cent. Toxin does not appear to bind to skeletal muscle. There 
is little or no intravascular haemolysis after intramuscular 
administration of alpha toxin, and there are no systemic toxic 
effects unless massive doses are administered (Smith, 1979).
A disease in which alpha toxin alone appears to be the lethal 
factor is the post-abortion septicaemia caused by C.perfringens 
that occasionaly follows induced abortion (Willis, 1969). The 
organisms are introduced by unsterile instruments, and fragments of
i
blood clot and necrotic tissue of foetal, placental, or maternal 
origin provide conditions suitable for the initiation of the 
infection. This type of septicaemia is usually marked by massive 
haemolysis with haemoglobinemia, haemoglobinuria, leukopenia, and 
renal involvement, all the result of the action of alpha toxin on 
the lipids of the cell membrane (Willis, 1969).
Rheumatoid arthritis and other collagen diseases have been 
associated with alpha toxin of C.perfringens (Olhagen and Mansson, 
1968). Patients* suffering from these diseases may show a higher 
C.perfringens faecal count than normal, as well as a higher than 
normal amount of antibody to C.perfringens alpha toxin in the serum 
(Olhagen and Mansson, 1968). Not all investigators have been able 
to demonstrate this association between increased levels of 
C.perfringens in the faeces of patients with rheumatoid arthritis 
(Sapico et al., 1973). Necrotic enteritis of chickens was
reproduced by feeding C.perfringens type A (Al-Sheikhly and 
Truscott, 1977) and they considered that it was caused in large 
part by alpha toxin from Ce pg't'fringens type A. This was partly 
confirmed by ^1110,(1978) who associated necrotic enteritis with
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the isolation of strains of C.perfringens type A which were strong 
alpha toxin-producers. A different view was held by Smith (1975b) 
who reported the isolation of C.perfringens type C from necrotic 
enteritis but did not reproduce the disease.
Alpha toxin, purified and in concentrated culture supernatant 
fraction, failed to produce a response when inoculated in rabbit 
ileal loops (Duncan et al., 1968).
Inoculation of large amounts of alpha toxin in intestinal 
loops in lambs caused accumulation of fluid (Hauschild et al.,
1968), however, the authors concluded that despite the demonstrated 
effect of alpha toxin on the sheep intestine, the toxin had no 
major role in C.perfringens type A enteritis in lambs.
Intravenous injections of crude alpha toxin in calves were 
fatal if large amounts were given in a short time; when slowly
administered, the toxin was even less effective, probably due to 
its rapid catabolism and excretion (Niilo et al., 1963). The
association between C.perfringens type A alpha toxin, high levels 
of dietary protein, arthritis and. parakeratosis described by 
Mansson and Olhagen (1967) and Mansson et al. (1971) has already 
been reported above. In addition they reported an association 
between alpha toxin and proliferative glomerulonephritis and 
considered that all the changes were due to delayed ' hyper­
sensitivity to alpha toxin, a somewhat surprising conclusion.
♦
(ii) Beta toxin
Beta toxin is produced exclusively by C.perfringens types B 
and C (Sakurai and Duncan, 1978), which are the organisms most
likely responsible for necrotic enteritis in man and animals.
Beta toxin can be demonstrated in the laboratory by growing a 
strain of type B or type C in cooked meat medium containing 2 per 
cent peptone, 0.5 per cent sodium phosphate, and 1 per cent 
glucose, adjusted to pH 7.2. The culture should be harvested at
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the end of the log phase of growth, usually 4 to 5 hours after 
inoculation. If cultures are allowed to incubate overnight, the 
yield of beta toxin may be much reduced. Toxin synthesis is not 
related to growth yield of the organism (Sakurai and Duncan, 1979).
Sakurai and Duncan (1978) reported the purification of beta 
toxin from type C organisms by ammonium sulphate fractionation, gel 
filtration through sephadex G-100, isoelectric focusing on a pH 3 
to 6 gradient, and immunoaffinity chromatography. The resultant 
purified toxin gave a single band with polyacrylamide gel 
electrophoresis. This study reported that the toxin appears to be 
a single polypeptide chain protein with a molecular weight of 
approximately 30,000 and a major component with an isoelectric 
point of 5.53 and a minor peak with an isoelectric point of 5.06. 
The toxin was found to be heat labile with 75 per cent loss of 
biological activity after 5 minutes at 50°C and destroyed by 
trypsin after 30 minutes at 37°C.
Necrotic enteritis caused by type C occurs in calves, lambs, 
pigs, and possibly feeder cattle (Kennedy et al., 1977); it is 
generally believed that beta toxin is the one primarily responsible 
for the symptoms noted in necrotic enteritis (Willis, 1977).
Beta toxin has also been incriminated as the cause of 
necrotising jejunitis in man (Lawrence and Walker, 1976). Parnas 
(1976) reported that beta toxin administered into the rabbit 
jejunum and ileum produces paralysis of the motor activity of the 
intestine which is believed to be similar to the paralyzing 
activity in the intestine noted in piglet dysentery (Parnas, 1976).
(iii) Epsilon toxin
C.perfringens types B and D do not produce epsilon toxin as 
such, instead they produce an only slightly toxic prototoxin that 
can be made highly toxic by treatment with certain proteolytic 
enzymes, such as trypsin (Smith, 1975a).
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Worthington and Mulders (1977) reported a molecular weight of 
32,700 for the prototoxin and 31,200 for the activated epsilon
toxin. The isoelectric point for the major peak of prototoxin was
8.02. The activated toxin had two major peaks with isoelectric
points of 5.36 and 5.74. The significant change in isoelectric
point and the small change in molecular weight that resulted upon 
activation of the prototoxin suggested that a small highly basic 
peptide was being removed (Worthington and Mulders, 1977).
While activation is usually affected by the enzymatic activity 
of trypsin, some activation can occur spontaneously in growing 
cultures, presumably due to the activities of proteolytic enzymes 
such as kappa and lambda toxins produced by the bacteria (Smith, 
1975a).
Epsilon toxin is responsible for acute enterotoxaemia in 
animals, most commonly in sheep but found also in goats and cattle 
(Hauschild, 1971). A contributing factor in enterotoxaemia is a 
sudden supply of food which results in the passage of undigested 
food and C.perf ringens type D organisms from the rumen to the 
intestines, this is followed by multiplication and epsilon 
prototoxin production by the organism in the intestine where 
proteolytic enzymes activate the epsilon toxin. The highly toxic 
epsilon toxin, increases intestinal permeability, enters the blood 
in substantial quantities and causes typically swollen hyperaemic 
kidneys, lung oedema, and excess of pericardial fluid. The kidneys 
become pulpy in'sheep, but not in cattle, within a few hours of 
death (Hauschild, 1971).
Nervousness is a principal clinical sign in sheep with acute 
cases of enterotoxaemia. It is believed (Buxton and Morgan, 1976) 
that epsilon toxin acts by binding the receptors in the walls of 
blood vessels in the brain causing vascular endothelial cells to 
degenerate, leading to leakage of serum proteins, and eventually 
red cells, to cause oedema. The oedema then produces the clinical 
signs of nervousness seen in cases of acute enterotoxaemia of 
sheep.
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Buxton (1978) used a mouse model and found that epsilon toxin 
bound to the luminal surface of the endothelial lining of blood 
vessels in the brain, liver, lungs, heart, the distal convoluted 
tubules in kidney, and to the hepatic sinusoids. No binding was 
detected in the large or small intestines or smooth and skeletal 
muscles in the body. He suggested that the intestine does not have 
receptor sites for the toxin.
(iv) Iota toxin
Iota toxin, formed only by strains of type E, is produced as a 
relatively non-toxic prototoxin that can be activated by proteo­
lytic enzymes. The prototoxin is formed during the period of 
active growth of the organisms and is usually activated by the 
proteolytic enzymes produced by them (Smith, 1975a). The 
prototoxin may be demonstrated in filtrates of young cultures, 3 to 
8 hours old, especially if these have been grown in medium 
containing meat particles to lessen the activity of the native 
proteolytic enzymes (Smith, 1975a).
It has been reported (Orcutt et al., 1978) that iota toxin has 
an estimated molecular weight of about 70,000. Iota toxin is 
markedly heat-labile, being inactivated by temperatures as low as 
55°C and it is rapidly inactivated by pH values between 5.2 and 4.2 
(Craig and Miles, 1961).
Craig and Miles (1961) demonstrated that iota toxin causes an 
increase in capillary permeability when injected intradermally into 
a guinea-pig; larger doses injected intradermally cause necrosis. 
When injected intravenously, the toxin is lethal. It is believed 
(Stern and Batty, 1975) that types E strains do not appear to play 
a role in pathogenicity. However, Orcutt et al. (1978) showed that 
type E strains producing iota toxin may be responsible for entero­
toxaemia, or haemorrhagic typhlitis in rabbits that have 
experienced diet-related stress. Another report (LaMont et al. , 
1979) described a toxin from caecal contents of rabbits with 
colitis that was neutralised by C.perfringens type E antiserum. It
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was suggested that the toxic material might be iota toxin but 
C.perfringens type E was not isolated. Since•then Borriello and 
Carman (1983) have shown Clostridium spiroforme could be isolated 
from caecal contents of affected rabbits and showed that it 
produced toxin that was neutralised by C.perfringens type E 
antitoxin. Wilkins et al. (1985) have suggested that C.spiroforme 
produces the iota toxin responsible for enterotoxaemia and colitis 
in rabbits and that C.perfringens type E is not responsible.
(v) Theta toxin
All types of C.perfringens produce theta toxin which is 
responsible for the zone of clear haemolysis that surrounds 
colonies on blood agar plates (Smith, 1975a). Theta toxin is 
cytolytic, haemolytic and lethal, belonging to a group of oxygen- 
labile haemolysins (Yamakawa et al., 1977). The same group 
contains streptolysin 0, cereolysin, tetanolysin and listeriolysin 
produced by Streptococcus pyogenes, Bacillus cereus, Clostridium 
tetani and Listeria monocytogenes, respectively. These haemolysins 
share common properties, being activated by thiol compounds and 
inhibited by a small amount of cholesterol (Yamakawa et al. ,
1977). Close serological relationships have teeh demonstrated among 
these haemolysins (Bernheimer, 1976).
The molecular weight of theta toxin has been variously 
determined as 35,000 (Hauschild et al., 1973); 46,000 (Smyth,
1974); 51,000 (Yamakawa et al., 1977). The most reproducible value 
appears to be about 55,000 obtained by polyacrylamide gel 
electrophoresis (Smyth, 1975). The isoelectric point has been 
determined at pH 6.5 (Smyth and Arbuthnott, 1972).
Theta toxin is thermolabile and markedly temperature-dependent 
in that its activity rises sharply as temperature increases to 37°C 
but drops off sharply as the temperature is raised above 37 °C 
(Duncan, 1975). The haemolytic activity is also markedly dependent 
upon pH with the optimum activity at pH 6.7-6.8. Hydrogen ion 
concentrations above or below these values cause rapid loss of 
activity (Smith, 1975a).
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The haemolytic activity of theta toxin is abolished if the 
toxin is pre-incubated with erythrocyte membranes (Smith, 1975a). 
It has been shown (Hose et al., 1975) that theta toxin appears to 
bind to erythrocyte membranes and that the inactivating substances 
in membranes is lipid and must be a fraction containing 
cholesterol. Binding of theta toxin to cells appears, unlike 
haemolysis, to be independent of temperature. Binding occurs at 
0°C while lysis does not. If cells bound with theta toxin are 
raised in temperature to 37°C they lyse (Hose et al., 1975).
Many studies on mechanisms of action reported for other 
substances such as C.perfringens alpha toxin and neuraminidase have 
been shown to be contaminated with theta toxin (Smyth, 1975). It 
has been shown (Smyth et al., 1975) that commercial preparations of 
alpha toxin caused arc-shaped structures to form in the membranes 
of horse erythrocytes. These same structures were found when the 
erythrocytes were treated with highly purified theta toxin, while 
they were absent when treated with highly purified alpha toxin 
(Smyth et al., 1975).
Theta toxin has been shown (Soda et al. , 1976) to be lethal 
upon intravenous injection into mice. They postulated that theta 
toxin, when co-injected with alpha toxin into mice, enhances the 
speed of death even though the dose of toxin necessary to kill the 
animal is not lowered. Muscle tissue is not thought to adsorb 
theta toxin and may even suppress its production, thus theta toxin 
may not play a role in clostridial myonecrosis (Duncan, 1975).
(vi) Delta toxin
C.perfringens delta toxin is one of the three haemolytic 
toxins released by a number of type C strains and some type B 
strains (Alouf and Tixier, 1976). There appears not to be any 
correlation between delta toxin production and isolation of 
organisms from diseased animals (Smith, 1975a). Strains of type B 
associated with lamb dysentery have been shown to produce delta 
toxin while strains from enterotoxaemia of sheep and goats in Iran
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reportedly have not (Smith, 1975a). Type C strains which have been 
isolated from sheep with struck in Britain, and cattle in Japan are 
producers of delta toxin (Yamogishi et al., 1971) while type C 
strains isolated from calves and lambs in the United States, and 
man in Germany and New Guinea do not appear to be active producers 
(Smith, 1975a).
Delta toxin has been shown to be haemolytic only for 
erythrocytes of sheep, goats, pigs and cattle but not for those of 
other animals (Alouf and Tixier, 1976). It is lethal but not 
necrotizing upon intradermal injection (Smith, 1975a).
The molecular weight of delta toxin has been estimated to be 
about 42,000 and the isoelectric point is at pH 9.1 (Alouf and 
Tixier, 1976).
Optimum production of delta toxin has been shown to occur 
during the logarithmic phase of growth of the organism within a 
narrow pH range between 7.5 and 8.0 (Alouf and Tixier, 1976).
Smith (1975a) considered that delta toxin is of no importance 
in the pathogenesis of necrosis of the intestine brought about by 
the strains of type C that produce it.
(vii) Kappa toxin
Kappa toxin, a collagenase and gelatinase, is produced by 
strains of types A, D and E and by some strains of types B and C 
(Smith, 1975a).
Kappa toxin was purified by Kameyama and Akama (1971) who 
concluded that the toxin is a protein, free of carbohydrate and 
phosphorus, heat labile being inactivated by 60°C for 10 minutes, 
and sensitive to low pH being inactivated at pH 4.5. The molecular 
weight was estimated to be about 80,000.
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Kappa toxin has ben shown (Kameyama and Akama, 1971) to be 
lethal and necrotic when injected into mice. When injected 
subcutaneously into rabbits it produces haemorrhages which appear 
as early as 5 minutes after injection and necrosis at the site 
develops within a few days. Extensive haemorrhage in the lungs but 
not in other organs was noted after subcutaneous and intramuscular 
injection in guinea-pigs. Extensive destruction of connective 
tissue in the absence of visible changes in the muscle layer was 
noted in guinea-pigs injected subcutaneously with the toxin. The 
authors postulated from these observations that kappa toxin may 
play a role in the development of gas gangrene by softening muscle 
tissue and contributing to the spread of alpha toxin.
It has been reported (Kameyama et al., 1975) that guinea-pigs 
immunised with kappa toxin were resistant to challenge with type A 
organisms and kappa toxin but not the organisms and alpha toxin. 
On the other hand, guinea-pigs immunized against alpha toxin were 
resistant to challenge with the organisms and either alpha or kappa
toxin. The authors concluded that alpha toxin is the main
contributor to the development of local infection and gas gangrene.
(viii) Lambda, Mu, Nu and Neuraminidase toxins
Lambda toxin is a protease that is produced by strains of 
types B, E and some strains of D (Willis, 1977). Lambda toxin
degrades numerous proteins such as gelatin, casein and
haemoglobin. It^  can be distinguished from kappa toxin in that it 
does not degrade collagen (Willis, 1977). Lambda toxin is 
inhibited by normal non-immune serum, is destroyed by pH below 5 or 
above 9, is heat-labile, and is inhibited by egg albumin, cysteine, 
cyanide, and citrate (Smith, 1975a). It is believed (Smith, 1975a) 
that lambda toxin does not play a role in the pathogenesis of any 
infection although it may activate epsilon prototoxin in cases of 
enterotoxaemia.
Mu toxin, which is a hyaluronidase, is' produced in largest 
amounts by strains of type B, but is also produced by strains of
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types A and D, and possibly by type C (Smith, 1975a). It acts by 
releasing glucosamine from hyaluronic acid (Willis, 1977). Mu 
toxin is heat-labile being destroyed by temperatures above 50°C, is 
relatively resistant to high and low pH values (Smith, 1975a). Mu 
toxin has been demonstrated to have haemolytic, necrotic and lethal 
activities and has ben shown to increase skin permeability,
therefore it may contribute to more rapid spread of infection in 
gas gangrene cases. However, no relationship has been found 
between mu toxin production and virulence of the organisms (Smith, 
1975a).
Nu toxin, a deoxyribonuclease, is produced by strains from all 
five types of C.perfringens, though most frequently by types A and 
C (Smith, 1975a). Nu toxin is a leucocidin and its ribonuclease 
activity results in the destruction of nuclei of polymorphonuclear 
leucocytes and muscle cells when injected intramuscularly in
rabbits. Nu toxin's involvement in gas gangrene appears to be 
reflected by the absence of a leucocyte response during the disease 
(McDonel, 1980).
Neuraminidase has been shown to be produced by all types of 
C.perfringens (Fraser, 1978). Three neuraminidase enzymes produced 
by C.perfringens with molecular weights of 310,000, 105,000 and
64,000 have been described (Rood and Wilkinson, 1976). Neuramin­
idase may contribute to the virulence and invasiveness of an
organism but certain neuraminidase-negative organisms such as
C.novyi type A are invasive and cause gas gangrene, and there are 
neuraminidase-positive organisms such as C.tertium that are not 
thought to be pathogenic (Fraser, 1978). The effects of 
neuraminidase in enteric infections are not known.
(ix) Enterotoxin
C.perfringens enterotoxin, responsible for one of the most 
common types of food poisoning in humans is mainly produced by 
C.perfringens type A strains (Duncan, 1970). Enterotoxin 
production by strains of type C (Skjelkvale and Duncan, 1975) and 
type D (Uemura and Skjelkvale, 1976) have been described but the
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role in intestinal disease of enterotoxin produced by these strains 
is not clear.
The enterotoxin is not formed during the vegetative growth of 
C.perfringens but its synthesis is related to sporulation of the 
organism (Hauschild et al., 1970). Enterotoxin production appears 
to be directly related to the ability of the strain to sporulate, 
thus mutants with altered ability to sporulate also had altered 
ability to produce enterotoxin. A non-sporulating, non-entero- 
toxigenic strain that regained the ability to sporulate also 
regained the ability to produce enterotoxin (Duncan et al., 1972).
Enterotoxin from C.perfringens has only been demonstrated in 
sporulating cultures, and the toxin can be detected intracellularly 
about 3 hours after the inoculation of actively growing vegetative 
cells into a sporulation medium (Duncan, 1973). However, not all 
sporulating strains produce detectable levels of enterotoxin 
(Skjelkvale and Duncan, 1975). Difficulty in getting C.perfringens 
to sporulate in most laboratory media is well known (Labbe, 1981). 
Several media have been devised for sporulation by C.perfringens, 
the Ellner medium (Ellner, 1956) and the Duncan and Strong medium 
(Duncan and Strong, 1968) or minor modifications of it (Labbe and 
Rey, 1979; Levinson and Feeherry, 1978) have gained the widest 
acceptance. Inconsistency of sporulation by C.perfringens in 
different media has been reported (Skjelkvale and Duncan, 1975).
Enterotoxin production by C.perfringens varies according to 
the isolate. It has been reported (Yasukawa et al., 1975)
enterotoxin production by 51 of 66 strains associated with five 
outbreaks of food poisoning; the percentage frequency of 
enterotoxin-producing strains from the faeces of healthy humans and 
soil was less than one per cent. In contrast 5 Tsai et
al. (1974) reported that 42 of 65 strains isolated from chicken 
faeces and the meat, intestine and mesenteric lymph nodes of cattle 
were enterotoxigenic. In another study Uemura (1978) demonstrated
that 11 of 35 healthy humans were carriers of enterotoxigenic 
C.perfringens. A study (Niilo, 1978) reported that 27 of 114 
strains of C.perfringens isolated from the intestinal contents of 
cattle, sheep and chickens with enteritis were enterotoxigenic. A 
correlation between alpha toxin and enterotoxin production has been 
reported (Harmon and Kautter, 1976) suggesting that enterotoxin 
levels could be estimated by measuring the alpha toxin content of 
the food sample. In contrast, a study (Skjelkvale et al., 1979) 
reported that some strains of alpha toxin negative C.perfringens 
can produce large amounts of enterotoxin and Harmon and Kautterfs 
work seems unlikely to be true.
Sporulation and enterotoxin production have been shown to be 
dependent upon pH, temperature and the availability of carbohydrate 
in culture (Labbe and Duncan, 1975).
C.perfringens mutants blocked in sporulation earlier than 
stage III do not produce enterotoxin while those blocked at stage 
III produce small amounts, and ones blocked at late stage IV and 
stage V are able to produce enterotoxin (Duncan et al., 1972). It 
is concluded that the enterotoxin is a sporulation-specific gene 
product (Duncan et al., 1972). It has been suggested (Labbe and 
Duncan, 1977) that enterotoxin formation, which may involve a 
stable messenger RNA, appears to begin approximately 2.5-3 hours 
after inoculation into sporulation medium. This corresponds to 
late stage II or early stage III of sporulation. Polysomes have 
been isolated from cultures one hour after inoculation that 
produce enterotoxin in vitro (Smith and McDonel, 1980). Duncan et 
al. (1973) described paracrystalline inclusion bodies found only in 
sporulating enterotoxin-producing cells which they considered might 
be an aggregate of enterotoxin or enterotoxin-like spore coat 
protein material. When they studied sporulation mutants the 
inclusions appeared only in cells blocked no earlier than stage IV 
of sporulation. The relationship of enterotoxin to spore coat 
proteins has been studied (Frieben and Duncan, 1975) finding that 
anti-enterotoxin serum precipitated protein material extracted from 
spores of enterotoxin-positive as well as negative strains, it was
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concluded that the enterotoxin is a spore coat structural 
component. It has been shown (Smith and McDonel, 1980) that 
proteins synthesised in vitro by polysomes extracted from 
vegetative cells do not produce proteins precipitable by anti- 
enterotoxin serum
The molecular weight of enterotoxin has been determined to be
35,000 (Stark and Duncan, 1972), while the isoelectric point is at 
pH 4.3 (Stark and Duncan, 1972).
The enterotoxin molecule is heat labile, 60°C from 5 minutes 
destroys biological activity though serological activity can be 
retained even after 80 minutes at 60°C. Loss of serological 
activity is more rapid at 60°C if the pH is 6.0 or less (Naik and 
Duncan, 1978). If the enterotoxin is heat-inactivated in food 
samples, about 12 per cent of the serological activity destroyed by 
heating at 60°C can be restored by treatment with urea for one hour 
at room temperature (Naik and Duncan, 1978). The enterotoxin loses 
its activity during pronase and subtilisin treatment, but is 
insensitive to trypsin, chymotrypsin, lipase, steapsin, 
alpha-amylase, papain and neuraminidase (Duncan and Strong, 1969).
Several biological and serological assay systems have been 
developed for the detection and quantitation of enterotoxin (Table 
3). Enterotoxin biological activity has been tested by the rabbit 
ligated ileal loop test (Duncan and Strong, 1969). The minimal 
dose detectable by this assay has been reported to be 140-200 
erythemal units (EU) (Stark and Duncan, 1972). Hauschild (1970) 
reported that the enterotoxin, when injected intradermally, causes 
erythema in guinea-pig. The erythemal unit has been defined as 
that amount of enterotoxin that causes a zone of erythema 0.8 cm in 
diameter on the skin of a depilated guinea-pig which has received 
intradermal injections of the enterotoxin (Stark and Duncan,
1971). This assay can detect quantities of enterotoxin as low as
0.25-0.5 EU. Niilo (1975) reported that mouse lethality assay can 
detect about 5 EU when the enterotoxin is injected intravenously.
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Enterotoxin has also been assayed by its effects on Vero cells 
grown in tissue culture (McClane and McDonel, 1979), They reported 
that this assay detects less than 0.25 EU of enterotoxin.
Ouchterlony double-immunodiffusion method allows identi­
fication of enterotoxin detecting 3 pg per ml (Genigeorgis et al., 
1973). Duncan and Somers (1972) detected as little as 1 pg/ml of 
enterotoxin using electroimmunodiffusion. Counterimmunoelectro- 
phoresis has been used to detect 0.2 pg per ml of enterotoxin (Naik 
and Duncan, 1977). Fluorescent antibody has been'used to detect 
intracellular enterotoxin in small numbers of sporulating cells 
(Niilo, 1977). The limits of enterotoxin detection by some of 
these methods have been reviewed by Stringer (1985) and are given 
in Table 3.
It has been stated (Niilo, 1978) that there is no evidence
that negative or weakly toxigenic strains of C.perfringens can 
become strong enterotoxin producers and, since enterotoxin *is a 
spore-related toxin, the composition of the sporulation medium will 
have a considerable effect on the amount of toxin produced.
Culture conditions and heat treatment prior to inoculation into the 
sporulation medium are important factors for enterotoxin 
production. It has been shown (Uemura, 1978) that enterotoxin 
production was greatly enhanced in two of five food poisoning
strains of C.perfringens type A when the cultures were subjected to 
three successive heat treatments at 80°C for 10 minutes.
In a study (Uemura et al. , 1975) where monkeys were orally
infected with a C.perfringens type A enterotoxin-producer strain, 
enterotoxin was detected in most of the faecal specimens, but 
neither enterotoxin nor anti-enterotoxin could be detected in serum 
samples taken up to 21 days after challenge. It was concluded that 
a significant amount of enterotoxin was not absorbed from the 
intestine into the bloodstream. Skjelkvale and Uemura (1977) 
studied two incidents of food poisoning in which one person was 
involved in both. In the first outbreak, 13 to 16 pg of entero­
toxin per gram of faeces could be detected and in the second 
episode 8 months later, 3 to 4 pg of toxin per gram of faeces was
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TABLE 3
Sensitivity of some biological
and serological methods for the detection 
and assay of C.perfringens enterotoxin
Method Enterotoxin (pg)
Erythemal activity 0.125
Mouse lethality 1.8
Rabbit ileal loop 29.0
Single gel diffusion 0.3
Double gel diffusion 0.013
Electroimmunodiffusion 0.01
Counterimmunoelectrophoresis 0.002
Reversed passive haemagglutination 0.0005
Radioimmunoassay 0.001
Vero cells 0.001
ELISA 0.0001
(Stringer, 1985)
found. Enterotoxin was not detected in serum during the acute 
stage of the illness, but it was detected as a rise in antibody 
titre during the following 2 months.
It has been suggested (Dowell et al., 1975) that the detection 
of enterotoxin in faeces may serve as a diagnostic test for 
implicating C.perfringens type A as the cause of food-borne 
illness. A study (Itoh et al., 1979) of 130 faecal isolates
associated with 13 outbreaks of food poisoning revealed that 109 
contained enterotoxin 1-2 days after illness but not after 5 days 
and none of the faecal specimens from healthy subjects contained 
enterotoxin.
In a recent study in fattening pigs> Jestin et al. (1985)
demonstrated the presence of enterotoxin in the faeces of 25
diarrhoeic pigs in which no other pathogens could be demonstrated. 
C.perfringens type A enterotoxin was not detected in the faecgs of 
9 healthy pigs.
Enterotoxin has been identified as the factor responsible for 
diarrhoea experimentally induced in lambs (Niilo, 1971), calves 
(Niilo, 1973a), chickens (Niilo, 1974), rats (McDonel, 1974), 
rabbits (McDonel and Demers, 1982), monkeys (Hauschild et al. ,
1971) and humans (Strong et al., 1971). The ability of the
enterotoxin to cause fluid accumulation in intestinal loops was 
first demonstrated in rabbits (Duncan and Strong, 1969) and lambs 
(Hauschild et al. , 1970). The erythemal reaction to the
enterotoxin in guinea-pig skin (Hauschild, 1970) was used to 
develop an assay for its biological activity (Stark and Duncan,
1972), demonstrating also that the erythema is associated with an 
increase in capillary permeability. the increase in capillary 
permeability was reported (Niilo, 1971) to occur within 15-20 
minutes of intradermal injection. In the same report he described 
the systemic effects of the enterotoxin when injected intravenously 
into rabbits, lambs and guinea-pigs. Lambs developed transient 
diarrhoea, lachrymation, salivation, nasal discharge, lassitude and 
dyspnoea within 1 to 5 hours after inoculation. Animals that died 
from the injections had hyperaemic small intestinal mucosa,
and congestion in the liver, lungs, spleen and kidneys. Rabbits 
and guinea-pigs responded in a similar manner. It was also 
reported that atropine and adrenaline alleviated the clinical signs 
in lambs and guinea-pigs. It was concluded, that the enterotoxin 
exhibits a parasympathomimetic mode of action characterised by 
increased capillary permeability and vasodilation in the intestine, 
and increased intestinal motility. A similar study was done in 
calves (Niilo, 1973a) that showed marked differences from the 
responses seen in lambs and rabbits (Niilo, 1971). Calves injected 
intravenously with enterotoxin did not develop lachrymation,
salivation, nasal discharge, or diarrhoea, but, intestinal 
hyperaemia and some intestinal mucosal necrosis developed. These 
data were interpreted as indicative of a strong predilection of the 
enterotoxin for the intestinal capillary bed (Niilo, 1973a). 
Another report (Niilo, 1973b) established that fluid accumulation 
in bovine Thiry fistulas can occur within 30 minutes after exposure 
to the enterotoxin.
It was reported (McDonel, 1974) that in the rat ileum the
enterotoxin induces a reversal of transport from absorption in
controls, to secretion of fluid, sodium and chloride ions. Glucose
absorption was inhibited while transport of potassium and bicar­
bonate was unaffected. Fluid secretion was found to increase with 
enterotoxin dose, up to a point beyond which excess of enterotoxin 
had no effect upon fluid secretion. This saturation phenomenon was 
confirmed in another report in which rabbit ileal loops were 
challenged with* a range of 50 - minimum dose to cause fluid 
accumulation - to 1,000 EU of enterotoxin; the amount of fluid 
accumulation was indistinguishable in loops treated with each dose 
(McDonel and Duncan, 1977). Histological studies (McDonel, 1974) 
showed that desquamation of intestinal epithelial cells occurred at 
villus tips in enterotoxin-treated loops. It has been reported 
(Niilo, 1971) that epithelial desquamation occurs after the 
intravenous injection of enterotoxin.
It was reported (Yamamoto et al., 1979) that removal of
enterotoxin from mouse ligated loops caused a reduction in fluid
36
accumulation, even if the loop was exposed to enterotoxin for 30 
minutes prior to removal. It was concluded that the enterotoxin 
does not bind freely to the intestinal cells. In contrast a study 
(McDonel and Demers, 1982) demonstrated the binding of enterotoxin 
to the epithelial cells of the rabbit colon.
Studies with the rabbit have revealed that enterotoxin is most 
active in the ileum, mildly active in the jejunum, and nearly
inactive in the duodenum (Hauschild et al., 1973). Another study 
(McDonel and Demers, 1982) showed that the colon of the rabbit did 
not present any apparent response to the enterotoxin in the 
transport of fluid and electrolytes as compared with untreated 
animals.
It is postulated (McDonel, 1979) that C.perfringens 
enterotoxin acts by direct cell membrane damage. A study showed 
(McDonel and Duncan, 1975) that cycloheximide, an inhibitor of 
protein synthesis, does not present tissue damage and fluid and 
glucose transport alterations induced by the enterotoxin. This 
evidence indicates that induction of new synthesis of protein does 
not play a role in the mode of action. It appears that, rather
than activate new metabolic pathways, protein synthesis, or 
existing enzymes, the enterotoxin acts through interference with 
energy production and cellular maintenance of structure and 
function.
It has been reported (Gyobu and Kodama, 1978) that 
C.perfringens enterotoxin is cytotoxic for Vero cells. The cells 
have proven to be very sensitive in that enterotoxin alters their 
morphology, viability, and macromolecular synthesis. Gross
morphological damage was observed within 30 minutes of exposure of 
monolayers to enterotoxin, and approximately 75 per cent of the 
cells had detached within 40 minutes. McDonel (1979) studied the 
action of the enterotoxin in Vero cells and found that, contrary to 
his in vivo findings (McDonel and Duncan, 1975), the enterotoxin 
inhibits protein, RNA and DNA synthesis of Vero cells within 15 to 
30 minutes. Depending upon the dose used, the enterotoxin also
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causes loss of viability and detachment of the cultured cells from 
the surface on which they are growing. The plating efficiency of 
the Vero cells can be significantly reduced by as little as 1 ng of 
enterotoxin per ml and doses of 1 pg cause reduction of the plating 
efficiency of 100 per cent of the cells (McDonel, 1979).
It is believed (McDonel, 1980) that the enterotoxin alters the 
configuration or structure of some components of the membrane which 
results in structural and functional changes in the membrane.
Enterotoxin binding studies have been performed (McDonel,
1980) with cells isolated from rabbit intestine, liver, kidney and 
brain. The enterotoxin was found to bind equally to cells from the 
intestine, liver and kidney but not the brain. Reversibility of 
the binding was not demonstrated, and it was postulated that the 
enterotoxin interacts with a compound in the membrane in such a way 
as to become trapped, or to be absorbed into the membrane of the 
cell.
3. PROTECTION AGAINST AND IMMUNITY TO ENTERIC MICROORGANISMS IN 
THE PIG
Protection against C.perfringens type A infections of the 
intestinal tract and immunity to them has not been studied in 
detail in the pig. There is, however, much information about the 
general mechanisms of protection and immunity in the gastro­
intestinal tract of the pig and this is reviewed here with 
reference, where relevant, to C.perfringens. Protective immunity 
against infections with C.perfringens is well documented in other 
species and to some extent in C.perfringens type C infections in 
the pig. The subject has been reviewed here with particular 
reference to the pig.
(a) Non-specific defence mechanisms of the gastrointestinal 
tract
These mechanisms affect the entry of C.perfringens and its
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products to the gastrointestinal tract, the establishment of the 
organism and the production of pathogenic determinants such as the 
toxins reviewed above.
(i) Gastric barrier
The stomach is a potent bactericidal trap limiting the number 
of viable organisms which gain access to the small intestine. At 
pH values less than 4.0 there is significant bactericidal activity 
which becomes total at pH 3.0. Bactericidal activity in vivo can 
apparently be ascribed entirely to the effect of pH since it is 
abolished by neutralisation. The susceptibility of microorganisms 
to the effect of pH is variable. Staphylococcus epidermidis and 
Lactobacillus spp. are relatively resistant while E.coli appears to 
be more susceptible (Newby and Stokes, 1984). The spores of 
C.perfringens are almost certainly unaffected by gastric pH but no 
information is available about its effect on vegetative cells. The 
raising of gastric pH has a significant effect upon infection of 
the intestinal tract. In the immediate neonatal period, gastric pH 
is nearly neutral. This may have importance in allowing the 
establishment of an early gut flora and it may prevent denaturation 
of the antibodies received through colostrum (Kruse, 1983). It is 
known from volunteer studies in man that C.perfringens enterotoxin 
is inactivated by gastric acid (Stringer, 1985).
(ii) Biliary secretions
The resident microflora of the small and large intestine are 
relatively resistant to bile salts. When secreted into the 
intestine most of the bile acids are in conjugated form, however, 
intestinal bacteria such as Bacteroides, Enterococci, Clostridia 
and Bifidobacteria are able to deconjugate bile salts, releasing 
free bile acids. Some intestinal species tolerant of conjugated 
bile salts may be inhibited by free bile acids and this inhibition 
is most prominent in mildly acid conditions. Thus, growth of 
bacteria in the small intestine may be limited by production of 
acid and by deconjugation of bile salts (Newby, 1984).
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(iii) Epithelial barriers
The epithelial cells contribute to the integrity of the 
mucosal surface by their capacity to undergo rapid turnover and 
renewal (Eastwood, 1977). During infection of the small intestine 
the rate of turnover, including cell loss from the mucosa, 
increases, thus leading to removal of pathogen-infected cells 
(Eastwood, 1977). The rate of replacement of villous epithelium in 
the small intestine of pigs contributes to the innate age dependent 
receptivity to transmissible gastroenteritis (Moon et al., 1975). 
The apparent rate of regeneration of villi in the intestine of 3 
week-old pigs is more rapid than in the intestine of newborn pigs. 
The accelerated replacement of villous epithelial cells in older 
pigs contributes to the resistance of the animal to the disease 
(Moon et al., 1975).
Adherence to the epithelium is important for intestinal 
colonization and for production of the diarrhoeal disease caused by 
toxigenic E.coli. In pigs the expression of receptors for the 
E.coli adhesin K88 is controlled by a single autosomal dominant 
gene and animals lacking this gene are not susceptible to the 
enteritis caused by K88 positive organisms (Sellwood, 1981). There 
is no information about the intestinal receptors for C.perfringens 
type C.
(iv) Mucus
The mucosal surface of the gastrointestinal tract is covered 
by a layer of mucus which is being continuously shed into the lumen 
and is continuously being replaced by Brunners’ glands and the 
goblet cells of the intestinal epithelium. Mucus has a number of 
functions within the intestinal tract, it lubricates the epithelial 
surface, protects it from the low pH of the stomach, and acts as a 
medium in which digestion and absorption can occur. The mucus has 
direct antimicrobial effects by cleansing the epithelial surface. 
It can entrap bacteria and has been shown to possess regions 
mimicking the receptor sites for bacteria present on epithelial
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cells and this may facilitate this trapping (Clamp, 1981). The
relationship of C.perfringens to the mucus layer is not known.
(v) Lactoferrin and Lysozyme
These are found in intestinal secretions in association with 
mucus (Clamp, 1981). Lactoferrin, an iron-binding protein has 
bacteriostatic effects upon E.coli by successfully competing with 
the bacteria for iron (Reiter, 1978); it has been suggested that 
this protective effect may be subsidiary to its principle role as a 
regulator of iron absorption (Brock, 1980).
Lysozyme is synthesized within paneth cells at the base of the 
intestinal crypts. This enzyme has bactericidal activity by 
degrading the peptidoglycan of the cell wall of Gram-positive and 
the outer membrane of the Gram-negative organisms (Reiter, 1978). 
It may have some effect on clostridia in the gut.
(vi) Peristalsis
Peristalsis is probably the major factor reducing bacterial 
numbers within the small intestine. Bacteria introduced into the 
small intestine are cleared by peristalsis and drugs that inhibit 
peristalsis lead to increased bacterial numbers in the small 
intestine (Newby and Stokes, 1984). The effectiveness of bacterial 
clearance by peristalsis may be influenced by other factors. 
Villous movement in the small intestine appears to assist the 
mucous coating of bacteria on the surface of the mucosa. Antibody 
in intestinal secretions assists this mechanism both by agglutin­
ating bacteria and inhibiting bacterial adherence to the mucosa 
(McClelland, 1979). Rises in clostridial counts have been reported 
in cases of reduced gut motility in man (George and Finegold, 
1985).
(vii) Intestinal microflora
Bacteria colonise the intestine of the newborn pig within a
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few hours of delivery and rapidly reach levels of 10®-10^ per gram 
of faeces. The bacteria concerned include facultatively anaerobic 
bacteria such as Streptococcus spp. and Escherichia, micro- 
aerophilic organisms such as lactobacilli, oxygen tolerant 
anaerobes such as C.perfringens and strictly anaerobic bacteria 
such as Fusobacterium spp, Peptostreptococcus spp. and later, 
Bacteroides (Ducluzeau, 1983). Initial levels of bacteria such as 
C.perfringens may be high (106/gram), but rapidly decline to reach 
levels of 2.5 x lO^/gram (Mans son and Smith, 1962) in pigs 
receiving a conventional diet.
The normal flora can inhibit pathogenic organisms either 
through physical interference, occupation of the receptor sites, or 
by successfully competing for essential substrates. The indigenous 
flora can render the environment toxic to other species; 
Lactobacilli, by reducing the pH, inhibit the growth of E.coli, 
while many enteric bacteria produce substances such as colicins
«9
which are bactericidal for competing species (Newby, 1984).
Experiments with the colonisation of the neonatal gastro­
intestinal tract of the pig have been carried out mainly with 
E.coli. Prior colonisation of the intestine with a K88 positive, 
non-enterotoxin-secreting E.coli can protect the animal from 
infection with the enterotoxin-producing variant, presumably by 
occupying all the K88 receptors (Ducluzeau, 1983) but such 
protection has not been described for C.perfringens. It has been 
shown (Tlaskalova et al., 1983) that under conventional conditions 
the presence of normal microbial flora effectively competes with 
colonization of the intestine with artificially introduced strains 
of bacteria, including known enteric pathogens. The colonization 
of conventionallly raised animals with various strains of enteric 
bacteria is extremely difficult and transitional success is 
achieved only with very high doses of bacteria (10^  or more). This 
colonization resistance which represents a very important factor of 
anti-infectious resistance can be dramatically reduced, if normal 
flora is suppressed, for example, by suitable antibiotics, and 
completely eliminated under germ-free state conditions. Enteric
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bacteria applied perorally to germ-free animals readily multiply, 
with generation time similar to in vitro conditions; bacterial 
counts in the intestine reach a plateau within one or two days with 
maximal values in colon and terminal ileum (Tlaskalova et al.,
1983). The ease with which germ-free and colostrum-deprived 
animals can be colonised indicates the importance of either active 
or passive specific immunity in protection against common enteric 
bacteria. This immune protection is reviewed below.
(viii) Diet
Diet may also affect the levels of enteric bacteria. Mansson 
and Smith (1962) described the effects of an increase in dietary 
protein from normal to a high level. C.perfringens counts rose 
from 2.5 x 10^  per gram of faeces to 10^  per gram. Similar changes 
have been recorded in sheep with C.perfringens Type D entero- 
toxaemia and ’Pig Bel1 in man associated with C.perfringens type C 
infection (Walker, 1985) in which levels of clostridia remain 
constant on a low protein or restricted diet but rise dramatically 
when overeating or an increase in protein intake occurs.
It was reported (Stutz et al. , 1983) that an increase in the
numbers of C.perfringens occurred when chickens were fed with a
sucrose diet compared to chickens fed with a practical diet.
Another report (Stutz and Lawton, 1984) demonstrated that 
chickens fed with a standard corn and soya bean meal diet to which 
bacitracin was added, presented a significant weight gain and low 
numbers of C.perfringens in small intestine compared with chickens 
fed on the same diet without bacitracin. Growth depression was 
observed in these chickens and was correlated with an increase in
the numbers of C.perfringens in the intestinal tract.
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(b) Specific immune defence mechanisms of the gastro­
intestinal tract
Antigens which enter the gut or are produced there by enteric 
bacteria stimulate immunity in the same way in most species. 
C.perfringens produces toxins which may penetrate the intestinal 
epithelium and give rise to systemic effects and systemic humoral 
response but the bulk of the antigens produced are restricted to 
the intestine and local immunity is most important in protection 
against them. For this reason the development of local immunity is 
reviewed in greatest detail along with passive protection of the 
neonate and the development of the immune response in the young 
piglet. The development of cellular immunity to enteric organisms 
is only touched upon here.
(i) IgA
Antigens from the lumen of the gut, stimulate precursor 
B-lymphocytes in the Peyer’s patches to become antigen-stimulated 
IgA-precursor lymphoblasts (Genco et al., 1983). T-helper cells 
for IgA and T-suppressor cells for IgG, IgM and IgE are stimulated 
by antigens or mitogens that gain access to the Peyer’s patches. 
The IgA-precursor cells then migrate through the intestinal 
lymphatics - to the mesenteric lymph nodes which become enriched 
with IgA-plasma cells. From there, they enter the thoracic duct 
and circulation. The lymphoblasts in the circulation then home to 
the lamina propr-ia of the gut and to the interstitial tissue of 
exocrine glands such as the lacrimal glands, salivary glands, 
mammary glands and to the respiratory, intestinal and genital 
urinary tracts (Genco et al., 1983). Antigens may function at
several levels in mucosal immunity. An antigenic stimulation of 
gut-associated lymphoreticular tissue (GALT) such as Peyer's 
patches may occur from the intestinal lumen after oral adminis­
tration of antigen. A parenteral inoculation may sensitise the 
GALT, including the Peyer's patches, with blood-borne antigen. 
This type of immune response is seen experimentally when animals 
are hyperimmunised parenterally and exhibit a secretory immune
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response, but it is probably not a major mechanism for inducing 
secretory immunity. A local antigen application would provide an 
antigen-induced stimulation of the GALT leading to the maturation 
and persistence of IgA-producing lymphoblasts in the distal 
exocrine glands and in the lamina propria (Genco et al., 1983).
After release from plasma cells in the lamina propria, the IgA 
molecules bind to receptors composed of secretory components on the 
outside of the epithelial cell membrane. The secretory IgA thus 
formed then undergoes pinocytosis and is transported through the 
cytoplasm of the epithelial cells, whence it is released by reverse 
pinocytosis into the intestinal lumen (Brandtzaeg, 1981). The time 
lapse between the presentation of antigen to the intestinal 
epithelium and a measurable IgA response depends upon the
techniques used. It may be hours in in vitro tests but in the gut, 
the primary response is usually considered to take 14-21 days. 
Specific IgA antibody production can be demonstrated for 120-360 
days after immunisation. Memory of the response persists irf' the 
lamina propria in lymphoblasts and a secondary response to antigen 
takes 5 days to become detectable and lasts for 120-700 days 
(Porter et al., 1974).
Once released into the lumen, secretory IgA coats the
epithelial cell surface by combining with mucin. Its capacity to 
bind to mucosal cell surfaces implicates its role in the inhibition 
of adherence of bacteria, and neutralization of viruses and toxins 
(McCaughan and Basten, 1983). IgA antibody raised against purified 
K88 pilus antigen and present in sow's milk protects newborn pigs 
from experimental infection with K88-bearing E.coli (Newby, 1984) 
and this protection is associated in vivo and in vitro with 
inhibition of adhesion between the bacteria and enterocyte i.e. the 
IgA antibody found in milk is specifically directed against 
antigens experienced by the sow.
Immunisation of rats with V.cholerae enterotoxin induces the
appearance of secretory antibodies to the toxin which are
protective against the effects of the toxin. Antibodies to the 
toxin present in the milk of immunised rats proved to be also
protective to their litters when challenged with the toxin (Rowley,
1983). This indicates the ability of secretory IgA to neutralise 
toxins in the gut. A suggestion that this type of protection may 
be relevant, in C.perfringens disease has been made by Kliegman 
(1985) who associated diminished intestinal IgA levels with an 
increase in numbers of C.perfringens and other bacteria in neonatal 
necrotising enterocolitis. He considered that IgA might neutralise 
toxins produced by the organisms impeding their effects in the 
intestine.
Studies with V.cholerae killed whole cells demonstrated to
some degree of protection to the disease after oral immunisation.
A secretory IgA anti-toxin response was demonstrated in the
immunised individuals (Rowley, 1983). A study showed that the
formation of antigen-secretory IgA complexes in the intestinal
lumen not only results in neutralisation of antigen but, in
addition, causes stimulation of goblet cells with release of mucus;
«»
the mucus then interferes further with access of antigen to the 
epithelial cells by creating an impermeable barrier and by 
retaining the secretory IgA-antigen complexes in its glycocalyx for 
a sufficient period of time to allow degradation of antigen by 
intestinal enzymes (Ottaway et al., 1979).
Secretory IgA has been involved in bactericidal and
parasiticidal activities by cooperating with lysozyme (Porter,
1979); with lactoperoxidase (Befus and Bienenstock, 1982); or with
lactoferrin in 'IgA mediated bacteriostasis of E.coli (Newby,
1984). No such studies appear to have been carried out with
Clostridium perfringens.
(ii) IgG
IgG plasma cells are present in significant numbers in the 
porcine intestinal lamina propria (Brown and Bourne, 1976), 
contributing significant immunoglobulin to the intercellular fluid 
of the lamina propria. Thus IgG may act locally in the lamina 
propria to neutralise antigen which penetrates the epithelial
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barrier. It may also leak into the intestinal lumen through
inflammatory lesions but its action here has not been studied in 
detail. Some of the locally-produced IgG may supplement plasma IgG
levels produced elsewhere in the body (mesenteric lymph nodes,
spleen and body lymph nodes) either from lymphoblasts primed in the 
lamina propria or from lymphoblasts primed in these other sites by 
antigen derived from gut infections.
A primary response of specific IgG secretion takes 7-14 days 
from presentation of the antigen to the gut to demonstration of 
antibody and is often preceded by IgM production. The primary
response may last for 90-120 days in the absence of stimulation. A 
secondary response may develop within 5-7 days of re-stimulation 
and be detectable for 120-700 days (Porter et al., 1974).
The activities of IgG include those described by Newby (1984)
i.e. that IgG antigen complex formation in the intestinal mucosa 
might produce a cellular inflammatory response resulting in 
collateral damage to tissues resulting in increased permeability of 
the mucosa.
It may also trigger the release of mucus from goblet cells by 
the formation of immune complexes on the mucosal surface, the 
increased flow of mucus may have pronounced flushing effects upon 
the epithelial surface and contribute to the removal of micro­
organisms and parasites from the epithelial surface (Ottaway et 
al., 1979). ,
IgG also protects against systemic effects of toxins produced 
at intestinal level. Sheep immunised with C.perfringens epsilon 
toxin toxoid develop high serum IgG titres to the toxin which are 
correlated to the degree of protection to the effects of the 
disease (Cameron, 1980).
(iii) IgM
IgM is a major secretory immunoglobulin in the intestinal
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tract of animals and during the first few weeks of life IgM-produc- 
ing cells are numerically predominant to IgA cells at all levels of 
the intestine (Porter, 1979).
It is suggested (Allen and Porter, 1973) that IgM plays an 
initiating role in the onset of antibody response in mucosal immune 
system, in much the same manner as it does in the systemic response 
to parenterally administered antigens. Its appearance early in 
development, both of the individual and of an immune response, 
suggests that IgM may have the same role in early defence in 
secretions that is seen in serum (Porter, 1979). The low 
concentration reported for this immunoglobulin in secretions 
(Bourne, 1973) may be partly due to the rapid breakdown of this 
immunoglobulin in the intestinal lumen by proteolysis, and may not 
reflect its true concentration in intestinal secretions (Newby,
1984).
A primary response of IgM secretion takes 2-5 days - from 
presentation of ,the antigen to the demonstration of antibody and 
lasts for 30-60 days when a switch to IgG production often occurs. 
Secondary responses take 1-2 days to develop and may last for 30-60 
days (Porter et al. , 1974). IgM antibody in porcine colostrum has 
been shown to have powerful opsonic activity against E.coli 
(Sellwood, 1981), suggesting the role it may play in antimicrobial 
defence.
(iv)  ^IgE
IgE is present only in minute amounts in secretions being
associated with mast cells. IgE responses are usually only seen 
following stimulation of the immune system with parasitic antigens 
(Jarrett and Miller, 1982).
It is suggested that the way in which IgE protects against
parasitic infection in the intestinal tract is by degranulation of 
the mast cell as a result of cross-linking of surface IgE by
antigen, producing the release of vasoactive amines that increase 
the vascularity of the mucosa and renders the epithelium more
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permeable to serum proteins, which, entering the lumen of the gut, 
can attack the parasite (Jarrett and Miller, 1982).
IgE antibodies complexed to antigen within the intestinal 
lumen have also been shown to trigger the release of mucus from 
goblet cells, the increased mucus flow may prevent the parasite 
from coming into proper contact with the mucosa and also causes a 
significant proportion of parasites to become trapped in the mucus 
(Ottaway et al., 1979).
(v) Lymphokines
Lymphokines released by immune T-lymphocytes have been 
reported in the lamina propria of the pig following infection with 
transmissible gastroenteritis virus, porcine enterovirus and after 
oral immunisation, with protein antigen (Newby, 1984). It has been 
proposed (Ferguson and MacDonald, 1977) that lymphokines within the 
intestine may increase the rate of enterocyte turnover. In viral 
and some parasitic conditions where the enterocyte is the target 
cell of the pathogen, this increased shedding of cells might result 
in the expulsion of pathogens together with the epithelial cell.
Cepica and Derbyshire (1980) detected spontaneous cytotoxicity 
against transmissible gastroenteritis virus in intra-epithelial 
lymphocytes isolated from normal pigs. Peripheral blood mono­
nuclear cells, transferred to neonatal pigs, partially protected 
the recipients * from experimental challenge, and the recipients 
intraepithelial lymphocytes demonstrated spontaneous cytotoxicity.
(vi) Activated macrophages
Macrophages are common in the intestinal mucosa, thus some 
antigens are immediately available to macrophages upon completion 
of transport by the follicle-associated epithelium (Bockman e_t al., 
1983). Intraepithelial macrophages are phagocytic when killed 
Salmonella typhi is administered orally to rabbits previously
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sensitised intravenously (Kimura, 1977), Intraepithelial
macrophages have also been shown to be capable of phagocytising 
intraluminally administered ferritin in non-immunised rats (Bockman 
et al., 1983).
It has been shown (Richman et al., 1981) that macrophages from 
Peyer’s patches are capable of antigen presentation, thus they may 
participate in the induction of humoral immune responses at 
intestinal level.
(vii) Phagocytosis by neutrophils in the immune animal
Pigs immunised parenterally and subsequently challenged Into 
gut loops with the same antigen showed a rapid influx of neutro­
phils into the lumen. These neutrophils were able to kill bacteria 
either by phagocytosis or by the release of lysozomal enzymes after 
their death and disruption in the lumen (Newby, 1984).
(c) Intestinal immunocompetence of the neonatal pig
The neonatal pig is practically devoid of defences to enteric 
organisms. Protection againt C.perfringens and its products has to 
be obtained by passive immunity transferred at birth from the dam 
to the new-born piglet.
Studies on the intestinal immunocompetence of the neonatal pig 
are reviewed beldw:
Lymphoid cells producing IgM antibodies are detected in 
Peyer’s patches at day 55 of gestation, occurring prior to 
development of immunocytes in other organs. This lymphoid 
differentiation occurs in the absence of antigenic stimulus 
(Porter, 1981).
In the newborn pig there are very few lymphoid cells in the 
lamina propria and the lymphoid follicles are poorly defined.
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After birth these structures develop and the lamina propria becomes 
infiltrated with lymphocytes and plasma cells probably due to 
responses to bacterial challenge, since there is no comparable 
development in germ-free piglets (Porter, 1981). Oral
administration of E.coli antigens to germ-free piglets results in 
an early appearance of IgM-containing plasma cells, followed by 
those containing IgA. Thus IgM appears to play an initiating role 
in antibody response of the intestinal immune system (Porter,
1981). The predominant immunoglobulin-producing cells in the 
newborn pig intestine are of the IgM type for the first 3 to 5 
weeks, then IgA-producing cells become established and are in 
greater numbers throughout adult life (Husband, 1980).
Humoral antibody to antigenic challenge exposure first appears 
within 10 days in the newborn pig. Without the continuous presence 
of the antigen, the antibody decreases to zero values by 4 weeks of 
life. On re-exposure, antibody appears again but as a primary 
immune response, indicating that memory cells do not develop in the 
intestinal-associated lymphoid tissue (Husband, 1980).
(d) Transmission of passive immunity to the newborn pig
The transmission of passive immunity from sow to piglet occurs 
postnatally by way of colostrum. It is established that there is 
normally no transmission of maternal immunoglobulins across the 
placenta of the pig. As a result the pig is born devoid of immuno­
globulins and relies on colostrum as a source of circulating 
antibody during the early part of its life (Kruse, 1983).
If immunoglobulins are found in foetal or newborn pig serum 
they must be of foetal origin following antigen stimulation or have 
been passively transferred from the sow across a damaged placenta. 
It has been demonstrated that the foetal pig, like many other 
mammalian foetuses, is immunocompetent to a variety of antigens 
when exposed either naturally or by artificial means. However, 
under normal circumstances antigen exposure does not occur until 
soon after birth. In consequence, the newborn pig is equipped with
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a rudimentary immune system, which has not hitherto been primed to 
function (Kruse, 1983).
In the sow, antigen-sensitised cells migrate from the 
intestinal tract to the mammary gland. The immunoblasts become 
antigen primed at the level of Peyer’s patches. These immunoblasts 
destined to secrete IgA antibodies migrate via the mesenteric lymph 
nodes and thoracic ducts into the general circulation, with the 
mammary gland as one of their target sites (Opdebeeck, 1982). This 
intestinal-mammary immunological link has been observed in orally 
immunised sows with E.coli (Evans et al., 1980).
Newborn piglets have very low levels of serum immunoglobulins 
and hence obtaining immunoglobulins from colostrum reduces their 
vulnerability to disease. The immunoglobulin concentration of 
colostrum is highest at birth and then declines, the rate- of 
decline depending on the amount of colostrum which is being 
removed. In sows which have been sucked, the immunoglobulin 
concentration drops to 50 per cent by 5 hours after the first 
piglet is born and the level is close to that of normal milk by 16 
hours (Bourne, 1969).
The importance of colostral immunoglobulins in the resistance 
to infectious diseases in newborn pigs is universally recognised 
(McCallum et al. , 1977; Bourne et al. , 1978). It has been
reported that 90 per cent of piglets deprived of colostrum died 
before weaning (McCallum et al., 1977).
There is approximately 15g of whey proteins in 100 ml of 
colostra.1 whey from sows and 60-70 per cent of these proteins are 
immunoglobulins (Kruse, 1983). Colostral proteins fed to the 
newborn pig are not degraded and used as a food source but reach 
the small intestine intact. Because the proteolytic activity in 
the digestive tract is low, and is further minimised by the 
presence of trypsin inhibitor in colostrum (Jensen, 1978). 
IgG-rich colostral whey passes quickly through the stomach and into 
the small intestine. For the first 24-36 hours after birth the
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small intestine is lined with highly vacuolated, immature mucosal 
epithelial cells which are capable of absorbing macromolecules. 
The colostral immunoglobulin is thus transported from the lumen of 
the intestine, via the absorptive epithelial cells and intestinal 
lymphatic system, to the blood. Colostral immunoglobulins in the 
lumen of the intestine are first internalised by enterocytes via 
pinocytosis in the uptake phase, and internalised macromolecules 
are thereafter transported to the blood (Kruse, 1983). The uptake 
and transport of macromolecules is qualitatively non-selective in 
the pig and includes a variety of heterologous and homologous 
' proteins, dextrans and polyvinylpyrolidone. Proportions of the 
different classes of immunoglobulins in serum after ingestion of 
colostrum reflect therefore the proportions in colostrum when 
absorption is completed (Kruse, 1983).
The intestinal epithelium of the newborn pig retains the 
ability to pinocytose macromolecules for only a short time before 
the highly vacuolated epithelium is replaced by mature epithelial 
cells (Moog, 1979). The ability to absorb immunoglobulins drops to 
a low level after 24 hours although starved piglets may still be 
able to absorb immunoglobulins up to 4 days of age (Broom, 1983). 
In general, permeability is highest immediately after birth and 
declines rapidly thereafter.
The cessation of pinocytosis, a phenomenon called closure, 
apparently signals a shift in the membrane producing capacity of 
the epithelial cells, the endocytotic type of membrane is no longer 
being synthesised (Moog, 1979). The intestinal cells that absorb 
immunoglobulins are replaced by a more mature cell population with 
enzymes that characterise the mature microvillus surface and the 
cells are no longer engaged in pinocytosis. Closure appears to be 
controlled by endocrine influences and coordinated with the 
development of the enzymes that characterise the mature microvillus 
surface (Moog, 1979). Cessation of the uptake of colostral 
immunoglobulins occurs from the proximal to the distal part of the 
small intestine. There is evidence that pinocytosis in the 
epithelium disappears 2 hours after birth in the duodenum but
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not before 72 hours in the ileum. The period of absorption, 
however, is not limited to a certain critical time period after 
birth but is dependent upon the type of food ingested (Kruse, 
1983).
IgG accounts for about 80 per cent of the total immunoglobulin 
content in colostrum of pigs but rapidly declines so that a 30-fold 
decrease occurs during the first week of lactation, and remains a 
minor component of milk during the remainder of lactation (Curtis 
and Bourne, 1971). Although the level of IgA in colostrum is only 
16 per cent of that of IgG, it declines only 3-fold and soon 
becomes the predominant immunoglobulin in milk (Curtis and Bourne, 
1971). IgM is at low levels in both colostrum and milk. In 
colostrum, nearly all of the IgG and 40 per cent of IgA are derived 
from serum; but in milk more than 90 per cent of IgA and IGM, and 
70 per cent of IgG are produced in the mammary gland (Bourne and 
Curtis, 1973). The transition from colostrum to milk occurs during 
the first 3 to 7 days of lactation, with the predominant change 
occurring during the first 24 hours (Bourne and Curtis, 1973).
Sows immunised parenterally with C.perfringens type C toxoid 
provide good levels of protective antibodies in colostrum and milk 
(Djurickovic et al., 1975). These antibodies are possibly induced 
by the presentation of processed antigen by circulating lymphocytes 
or macrophages to the immunoblasts present at intestinal level or 
by a direct stimulation of immunoblasts present in the mammary 
gland (Opdebeeck,’ 1982).
Milk immunoglobulins ingested by the suckling pig bathe 
the mucous membranes of the intestine and provide passive 
protection against enteric infection (Bourne and Curtis, 1973). 
Studies in fistulated pigs (Porter et al., 1970) have shown that 
after a single feed IgA continues to pass along the intestine for 
more than 90 minutes, thus milk IgA provides an almost continuous 
coating of antibody for the small intestine.
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Although the major immunoglobulin in porcine milk is IgA and 
is largely responsible for protection, both IgG and IgM antibodies 
are present often in significant amounts and can provide 
significant protection (Newby, 1984).
Using neonatal E.coli diarrhoea of pigs as a model, it has 
been shown that immune milk from immunised sows protects the young 
from experimental challenge, inhibits the adhesion of bacteria to 
enterocytes in vitro and prevents their attachment to the 
intestinal mucosa in vivo (Newby, 1984).
(e) Immunisation of sows against enteric organisms to protect 
the newborn pig
Studies on immunisation of sows against certain enteric 
organisms such as E.coli are extensive, but those on immunisation 
to C.perfringens are concerned, in the case of the pig, only^with 
immunisation against C.perfringens type C infection. General sow 
immunisation studies are reviewed below with reference to 
C.perfringens where possible.
To stimulate a mucosal immune response that is protective 
against enteric infection, a variety of rates of antigen 
presentation and combination of adjuvants have been used. 
Effective vaccination commonly requires previous infection with the 
live organism. Oral administration of dead bacterial antigens may 
lead to the production of IgA antibodies in the gut secretions of 
pigs (Porter et al., 1974). By making use of the link that exists 
between the gut and mammary gland, it has been possible to compare 
in lactating sows the effects of oral immunisation with live and 
heat-killed E.coli. The IgA response in both milk and gut 
secretions to heat-killed organisms was both reduced and delayed in 
appearance (Evans et al., 1980).
Oral immunisation of sows with E.coli lipopolysaccharide 
antigen followed by parenteral immunisation leads to an antibody 
response in serum primarily of the IgM class and can provide the
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suckling piglet with colostral antibody which is protective 
(Chidlow and Porter, 1978).
In general, inactivated microorganisms given orally produce a 
relatively poor immune response. The response is strongly 
dependent upon the size of the administered dose, and in order to 
maximise the local response, very large amounts of antigen are 
required. In pigs, the optimal dose of bacteria is of the order of 
1 x 1 0 but even these extremely large doses of. antigen give a 
response which is inferior to that produced by viable organisms 
(Evans et al., 1980). It appears that active colonisation of the 
intestine is essential since a response is only seen in animals in 
which the bacteria can be cultured from the faeces (Newby, 1984), 
and pigs lacking the binding receptor for K88 do not mount a 
significant response to the K88 bearing E.coli (Sellwood, 1981).
However, certain inactivated vaccines have been showjj to
produce a degree of immunity protecting against challenge. It has 
been reported that pigs orally immunised with antigens of E.coli 
were partially protected against challenge (Newby, 1984). A study 
(Porter and Linggood, 1983) reported that the daily administration 
of antigenic extracts of heat-inactivated E.coli to pregnant sows, 
from day 60 of gestation to parturition with an intramuscular 
injection on day 95, effectively protected the progeny of the
vaccinated sows against challenge. The protection was associated 
with high titres of antibody to the 0-antigen of E.coli 
predominantly of ’the IgM class.
It was reported (Furer et al., 1983) that pregnant sows
immunised intramuscularly with heat-inactivated cholera toxin, 5 
weeks and 2 weeks prior to parturition, conferred protection to 
their progeny against challenge with pathogenicK88 E.coli. High
titres of antibodies of the IgG class against the cholera toxin 
were found in colostrum and serum of vaccinated animals which 
neutralised the LT toxin of E.coli.
Ciosek et al. (1983) failed to find effective protection of
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piglets against E.coli infection when pregnant sows were 
parenterally immunised with commercial multi-adhesin E.coli
vaccines. Nagy and Walker (1983) reported the immunisation of 
pregnant gilts with a multi-adhesin vaccine combining the 
components K88, K99 and 987P plus the beta toxoid of C.perfringens, 
the animals were immunised subcutaneously 6 and 2 weeks before
parturition. The progeny of vaccinated gilts was effectively
protected against challenge with K88, K99 and 987P E.coli cultures.
Injections of C.perfringens type C antitoxin into newborn pigs 
have been effective in preventing the disease, both in field cases, 
and in experimentally produced infections. The antitoxin is 
effective if injected either subcutaneously or intraperitoneally 
(Bergeland, 1972). Sows vaccinated 4 and 2 weeks before
parturition with a commercial C.perfringens type C toxoid produced 
detectable antitoxin levels in milk and colostrum which were 
transferred to their progeny (Djurickovic et al., 1975). In a
study (Hogh, 1976) serum from immunised sows with C.perfringens 
type C toxoid was administered subcutaneously to piglets after 
birth, resulting in protective serum titres of beta antitoxin. In 
the same study, immunised sows developed high titres of antitoxin 
detectable in colostrum and milk and when passively transferred to 
their progeny, resulted in an effective protection of the piglets 
against C.perfringens type C challenge.
(f) Immunisation of species other than pigs against 
C.perfringens components
Immunisation to C.perfringens cells and toxins in species 
other than pig is reviewed below.
Sheep can effectively be protected against the enterotoxaemia 
caused by C.perfringens type D by the immunisation with an 
aluminium hydroxide-absorbed epsilon toxoid (Jansen, 1967). This 
immunity is of relatively short duration, and in order to maintain 
a constant level of protection, repeated immunisations are 
required. A study (Cameron, 1980) reported the immunisation of
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pregnant ewes with 2 doses of an oil adjuvant-absorbed toxoid 
followed by a single dose of aluminium hydroxide-absorbed toxoid, 
elicited a good immunity and high antitoxin titres persisted for 
12-15 months. Immunisation of lambs against enterotoxaemia has 
been achieved successfully with single doses of formalin-killed, 
aluminium-hydroxide absorbed whole culture and with aluminium 
hydroxide-absorbed toxoid, both preparations being equally 
effective to protect against enterotoxaemia (Pierson, 1968).
In a study (Bousicaux et al., 1974), the immunisation of sheep 
with 2 doses of a multi-component bacterin containing formalin- 
killed whole cultures of C.perfringens types A, B, C and D, 
elicited serum titres of antibodies to alpha, beta and epsilon 
toxins which were considered to be protective in field trials.
It has been shown (Fleenor and Stott, 1983) that the 
parenteral immunisation of pregnant cows, 6 and 3 weeks prior
parturition, with a bacterin containing C.perfringens types C and 
D induced a significant rise in serum and colostrum of antibodies 
to beta and epsilon toxins which were passively transferred to 
their calves and demonstrated in sera.
In a study (Lozano et al., 1970) calves were given
subcutaneous inoculations with horse serum C.perfringens beta 
antitoxin; calves of a second group were given the same antitoxin 
orally, and a third group received colostrum from immunised cows. 
All calves given the subcutaneous antitoxin inoculations developed 
detectable amounts of antitoxin in serum only 2 of.9 calves given 
the antitoxin orally presented detectable antitoxin in serum and, 
all calves that ingested colostrum showed antitoxin in serum. When 
challenged with C.perfringens type C all the animals of the first 2 
groups developed diarrhoea, whereas the calves of the third group 
were partially protected, developing a mild form of the disease.
Alpha toxin of C.perfringens has been considered to be a poor
antigen (Oakley, 1970). The effectiveness of alpha antitoxin in
prevention of experimental gas gangrene in guinea-pigs was reported
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(Evans, 1943). There have been conflicting data, however, as to 
the efficacy of the active immunisation with alpha toxoid in 
prophylaxis of gas gangrene. It was reported (MacLennan, 1962) 
that it was impossible to convert C.perfringens alpha toxin to a 
toxoid. The inconsistent immunogenic!ties of alpha toxin toxoid 
were pointed out raising a serious problem in hyperimmunisation of 
horses (Yamamoto et al., 1970). It was reported (Ito, 1968) that 
alpha toxin was easily destroyed by formalin and that a careful 
control of various conditions during toxoiding was necessary to 
maintain the antigenicity. Ito (1970) showed that alpha toxin
could be converted to a toxoid of high immunogenicity and could 
protect immunised guinea-pigs against gas gangrene.
Niilo et al. (1971) immunised lambs parenterally with
formalised cell extract, or bacterin, prepared from sporulating 
cultures of an enteropathogenic strain of C.perfringens type A. 
This procedure induced an antibody in the serum which neutralised 
the enteropathogenic activities of the cell extract. However, 
protective immunity was not evident when the immunised lambs were 
challenged by the intraduodenal and the ligated intestinal loop 
methods with toxic cell extract or with whole cells of 
C.perfringens.
It has been shown (Uemura et al., 1975) that intraluminal
enterotoxin challenge in monkeys confers no detectable serum 
anti-enterotoxin titres in the animals. Anti-enterotoxin sera have 
been prepared (Bartholomew and Stringer, 1983) by immunisation of 
rabbits with a mixture of purified enterotoxin and Freund's 
complete adjuvant at 7-day intervals for a period* of 7 weeks. 
These antisera, however, have not been proved to be protective to 
entero-toxin challenge.
4. CONCLUSIONS FROM THE LITERATURE AND OUTLINE OF THE 
EXPERIMENTAL APPROACH
C.perfringens type A is a potential pathogen of the
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gastrointestinal tract of e number of animal species, but little 
attention has been paid to the role of the bacterium and its toxins 
in the pig. The strongest association between disease in the pig 
and C.perfringens type A is in neonatal diarrhoea and diarrhoea in 
young pigs. The occurrence of C.perfringens type C diarrhoea and 
its association with vegetative cells and toxin suggests that 
vegetative cells and alpha toxin may be involved in C.perfringens 
type A infections in the enteric tract of the neonate. There is 
some evidence for the involvement of alpha toxin in enteric disease 
in poultry and cattle but some of the evidence is not convincing.
Recently French workers have described the association of 
enterotoxin with diarrhoea in fattening pigs and there is a 
well-marked association between enterotoxins and diarrhoea in 
several species, principally man.
In view of these conclusions, the role of C.perfringens type A 
in gastroenteritis was studied. At first (Chapters 3 and 4) 
studies were carried out on vegetative cells and alpha toxin by 
isolation from clinical and post-mortem samples. Experimental 
studies which included animal infection, and protection experiments 
were carried out. Detailed studies of the relationship of alpha 
toxin to the disease were carried out and are described in Chapter
5.
Finally, the role of sporulating C.perfringens type A and 
enterotoxin in porcine gastroenteritis was studied and the results 
are presented in Chapter 6.
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CHAPTER 2 
MATERIALS AND METHODS
1. PIG POPULATIONS SURVEYED FOR ORGANISMS AND ANTIBODY
The populations surveyed fell into 3 groups:
(a) 3 local pig farms. Farms 1, 2 and 3.
(b) Diagnostic material.
(c) 4 large pig farms in Eastern Scotland (Farms 4,5,6 and 7)
(a) Local pig farms
Farm 1 was initially a 120 sow herd but grew to 220 sows 
during the period of study. It fattened all progeny to bacon 
weight and had a high perinatal mortality problem with some 
diarrhoea in neonates, diarrhoea at 10 days of age and post-weaning 
diarrhoea. C.perfringens type A had been isolated by Olubunmi 
(1982) and this farm was the source of his experimental isolate. 
Parvovirus, coccidia, K88+ve E.coli, Campylobacter mucosalis, C. 
hyointestinalis, C.coli and some non-T.hyodysenteriae spirochaetes 
had all been isolated from enteric disease on this unit.
Farm 2 was a 30-35 herd stocked with National Pig Development 
High Health Pigs fattening progeny to pork weight but had a 
perinatal mortality problem and diarrhoea in young pigs 10 days of 
age. Incidents of C.perfringens type C enteritis had occurred and 
coccidia, Cryptosporidia, rotavirus, porcine epidemic diarrhoea 
virus and non-T.hyodysenteriae spirochaetes had all been isolated 
previously. This farm was used as a source of sows for 
hysterectomy and for those used in vaccination studies.
61
Farm 3 is a 200 sow herd fattening all progeny to cutter or bacon 
weight. Perinatal mortality and post-weaning mortality is low but 
incidents of post-weaning diarrhoea caused by K88+ E.coli had been 
recorded in the past and were controlled by vaccination. Fewer 
details of other enteric pathogens were available.
(b) Diagnostic material
This consisted of carcases, organs, faecal samples or faecal 
swabs submitted to 3 laboratories for diagnosis. The three 
laboratories were: Glasgow University Veterinary School (whole
period of this study), Leeds Veterinary Investigation Centre (4 
weeks August - September 1983) and Norwich Veterinary Investigation 
Centre (2 weeks November 1985).The farm of origin was recorded 
for each sample and some details such as the problem, the nature of 
the sample and the results of other examinations performed were 
available. No history of treatment of the individual pigs 
providing the samples were available. Material was obtained from 6 
farms in the Glasgow area including Farms 1, 2 and 3, from 2 farms
at Leeds and from 15 farms at Norwich, a total of 84 samples.
(c) 4 large Eastern Scottish pig farms
All 4 farms belonged to the Pig Health Scheme and were
essentially healthy with no obvious enteric disease problems. 
Only one of these was visited - Farm 4, samples from the remaining 
farms were takeji by Mr. D. Wood the Ministry of Agriculture
Veterinarian on routine Pig Health Scheme visits.
Farm 4 was of 500 sows fattening all progeny to bacon weight. 
No antimicrobial treatments were being used and the management was 
good.
Farms 5, 6 and 7 were all breeder-fatteners and no enteric 
disease problems were reported.
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2. NECROPSY PROCEDURES
Throughout this study pigs for post-mortem examination were 
killed and examined according to the following procedure, whether 
the animals were submitted for diagnosis or were experimental in 
origin. All examinations could not be performed in every case.
(a) Euthanasia
All live animals were killed by the injection of pentobarbitone 
sodium (Euthatal May and Baker Ltd. , Dagenham) into the anterior 
vena cava and then exsanguinated. Blood samples were taken from 
the anterior vena cava prior to euthanasia.
(b) Post-mortem examination
(i) Gross examination *•
A post-mortem examination was carried out as soon after death 
as possible; in all cases this was within 24 hours of death. 
Particular attention was paid to the gastrointestinal tract and the 
organs of the abdominal and thoracic cavity were examined for the 
presence of gross lesions. The gross changes noted were recorded.
The appearance of the mucosal surfaces and the consistency of 
the contents were noted. Sample lengths of the gastrointestinal 
tract were opened and the various segments were examined for the 
location and distribution of the gross lesions.
Samples of small intestine were opened in sterile physiological 
saline and viewed by low power microscopy to observe the villous 
architecture.
(ii) Histological procedures
Samples for light microscopy were fixed in 10 per cent neutral
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buffered formol saline for at least 48 hours before trimming and 
embedding. The samples were embedded in paraffin wax and sections 
were cut at 4-6 pm and stained routinely with haematoxylin and 
eosin. All the stained sections were examined under the light 
microscope and the results recorded.
Frozen sections of tissue were prepared for immunofluorescence 
by excision in blocks from the intestine or spleen of freshly- 
killed pigs. They were placed in individual plastic containers and 
embedded in O.C.T. compound (Tissue Tek, Ames Laboratories) for all 
examinations other than for alpha toxin studies and frozen in 
liquid nitrogen immediately. Samples were then stored at -70°C 
until sectioning. 4-6 pm sections were prepared in a cooled 
cryostat at -20°C and placed on slides for staining by direct and 
indirect fluorescence using the materials and methods described 
below under immunofluorescent techniques. All sections were fixed 
in cold acetone.
(iii) Bacteriological procedures
Both rectal faeces samples or swabs and material taken at post­
mortem examination were examined bacteriologically. A general 
procedure was adopted which is given here. Special examinations 
e.g. for spores and for the presence of toxins were carried out but 
are given in the appropriate section below.
Direct smears. Direct smears were made on glass slides and heat 
fixed. The material was taken from faeces directly but that from 
the stomach, duodenum, jejunum, ileum, caecum, colon and liver was 
taken with a stiff bacteriological loop after the surface of the 
organ had been seared. Fixed smears were stained by Gram's method 
and examined by light microscopy using oil immersion. Direct 
smears could not be made from swabs submitted in transport medium.
Cultural examination. A limited number of routine cultural
procedures was carried out on all specimens. All samples were
inoculated into 7 per cent sheep blood agar plates (Oxoid Blood
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Agar Base No. 2, Oxoid CM271 with added foraolised sheep blood, 
Gibco Biocult Ltd.) and MacConkey Agar Plates (Oxoid CM7 with added 
1 per cent neutral red) for aerobic incubation. A 7 per cent horse 
blood agar plate (containing 7 per cent defibrinated horse blood 
Oxoid SR50) was inoculated for anaerobic incubation. A 5 per cent 
Egg Yolk Agar Plate (5 ml Egg Yolk Agar Suspension, Oxoid SR47, 
added to sterile molten Nutrient Agar Base No. 2, Oxoid at 55°C) 
was also inoculated for anaerobic incubation. A Campylobacter 
medium plate (7 per cent horse blood agar supplemented with 
antibiotic SR69, Oxoid Ltd.) was also inoculated and incubated 
microaerophilically.
A single sample from the gut of each animal and each faecal 
sample was examined for the presence of Salmonella spp. by the 
inoculation of tetrathionate broth (Oxoid, CM29) incubation for 24 
hours and plating on Salmonella Shigella Agar (Oxoid CM99) or 
Desoxycholate Citrate Agar (Oxoid CM35). Non-lactose-fermenting 
colonies were examined further to confirm their identity- as 
salmonellae.
Atmospheric conditions. Cultures were incubated in aerobic, 
microaerophilic and anaerobic conditions. Cultures for aerobic 
incubation were placed directly into the incubator.
Microaerophilic conditions were produced by evacuating loaded 
anaerobic jars with no catalyst (Whitley Scientific Ltd) to a 
pressure of 20 inches of mercury, using a vacuum pump. The jars 
were then flooded with a 5 per cent carbon dioxide and 95 per cent 
hydrogen mixture (British Oxygen Co. Ltd., Special Gases Division).
Anaerobic conditions were produced by evacuating anaerobic jars 
containing the cultures and fitted with cold catalysts to a 
pressure of 24 inches of mercury using a vacuum pump. The 
evacuated jars were then filled with the carbon dioxide-hydrogen 
mixture. Gassed jars were evacuated once more and gassed again in 
order to flush out any remaining oxygen.
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Temperature and period of incubation. Cultures were incubated at 
37°C for 24 hours except those in Selective medium for Campylo­
bacters which were incubated for 48 hours.
Examination of inoculated plates and the identification of 
bacterial isolates. This was carried out on a presumptive basis in 
most cases. Examination of colonies was made by the naked eye and 
under dissecting microscope. The colonies seen were described in 
terms of their morphological characters such as size, elevation, 
outline, colour, consistency' and their effect on the medium. 
Colonies were presumptively identified by these characters. Smears 
were made from colonies on slides, air dried and heat fixed. They 
were stained by Gram's method. The stained slides were examined 
under the oil immersion lens. This method made it possible to 
determine the cellular morphology of the bacteria and their 
reaction to Gram's stain. Further identification of bacteria was 
carried out in more detail using the criteria for identification of 
Cowan and Steel (1974) in the initial stages of the study and when 
considered necessary later. The only exception to this was the 
identification of C.perfringens which is described in detail below.
(iv) Methods for the identification of Clostridium 
perfringens
Colonial morphology. Colonies with the morphology and haemolysis 
characters described for C.perfringens in Chapter 1 were considered 
to belong to that species on presumptive grounds.
Cellular morphology and Gram staining reaction. Smears of colonies 
considered to be C.perfringens were prepared and stained by Gram's 
method. The presence of bacteria with the morphological characters 
of C.perfringens was considered to be additional evidence of 
identification.
Confirmation by biochemical tests. Colonies presumed to be those 
of C.perfringens were subjected to the biochemical tests outlined 
by Cowan and Steel (1974). These were carried out in anaerobic 
conditions at 37°C.
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Utilisation of sugars was tested using sugar broth base No, 2 
prepared using the following ingredients in the basal medium; Lab 
Lemco beef extract (Oxoid) 5g; Oxoid bacteriological peptone lOg; 
Sodium chloride (May and Baker) 3g and disodium hydrogen phosphate 
May and Baker) 2g were dissolved in 1 litre of deionised water and 
steamed for 30 minutes. When the medium was cool, the pH was
adjusted to 7.2 to 7.3 and 12 ml of indicator (O.lg Bromothymol 
blue, May and Baker; 2.5 ml 0.1 M NaOH (Analar) and 47.5 ml of 
distilled water) were added per litre. This medium was dispensed 
in 100 ml volumes. One gram of the appropriate sugar (Glucose, 
Maltose, Lactose, Salicin and Sucrose) was added to 100 ml of this 
medium. When each sugar was dissolved, it was dispensed in 4 ml 
volumes into Bijou bottles containing Durham tubes. The bottles 
were then sterilised by tyndallisation. Bijou bottles were 
inoculated with cultures of bacteria under test. The results were 
recorded after 24 hours but inoculated cultures were not discarded 
until 7 days after inoculation.
Indole production was determined by growing the culture in 1 
per cent peptone water (Oxoid) and testing with Kovacs reagent.
Nitrate reduction was determined on cultures grown in nutrient 
broth supplemented with 0.1 per cent potassium nitrate (Analar) and 
incubated for 5 days. They were then tested for the presence of 
nitrite.
Hydrogen sulphide production was assessed on Triple Sugar Iron 
agar (TSI) - Oxoid. Slopes of TSI were inoculated and incubated 
for 48 hours. Production of hydrogen sulphide was indicated by a 
black colour.
Litmus milk (Oxoid) was used in 10 ml quantities and incubated 
for 7 days at 37°C when the result was recorded.
Gelatin liquefaction was determined using Nutrient gelatin 
(Oxoid) after 15 days of incubation at 37°C. Cultures were placed 
in a refrigerator at 4°C for 2 hours before being recorded as 
positive.
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Urease production was determined by the inoculation of Urea 
Broth Medium (Oxoid) with added Urea solution at 40 per cent 
(Oxoid). Inoculated broth was incubated and examined after 24 
hours.
The appearance of cultures on egg yolk agar was determined by 
inoculation onto plates and incubated for 24 hours. The changes in 
the medium were recorded.
Digestion of cooked meat was determined . following the 
inoculation of Cooked Meat Medium (Difco) and incubation at 37°C 
for 14 days. During the study both Cooked Meat medium (Oxoid) and 
Cooked Meat medium (Difco) were used. Both media were prepared 
with deionised water and dispensed in 10 ml volumes in Universal 
glass bottles and in 50 and 100 ml volumes in medical flat bottles.
Tests for toxin production. Haemolytic toxin effects were 
determined by streaking cultures on 7 per cent sheep blood $nd 7 
per cent horse blood agar plates. These were incubated
anaerobically at 37°C for 24 hours and haemolytic activity around 
colonies was recorded.
Nagler's reaction. On one-half of an egg yolk agar plate two 
or three drops of C.perfringens antitoxin A (Wellcome Reagents 
Ltd.) were spread and allowed to dry. The plate was then
streak-inoculated with cultures of clostridia. Plates were 
examined after anaerobic incubation for 24 hours. Inhibition by 
antiserum of the production of an opalescent halo was a positive 
reaction.
Serum neutralisation tests in mice. Cultures were seeded in 
cooked meat medium previously enriched with 1 ml of a sterile 
glucose solution (10 per cent weight-volume) and 0.5 ml of a 
sterile solution of calcium chloride (25 per cent weight-volume) 
and incubated overnight. 23g white mice were challenged 
intraperitoneally with 0.5 ml of the supernatant previously
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filtered through a cellulose acetate filter of approximate pore 
diameter (APD) 0,22 pm (Millipore Ltd.). The identity of the toxin 
was determined by neutralisation tests involving the incubation of 
1.3 ml volumes of the culture supernatant with 0.3 ml volumes of 
specific antisera anti C.perfringens types A, B, C, D and E 
(Wellcome Reagents Ltd.), and with filtered supernatants treated 
rtiuwtsywith 0.1 per cent trypsin (Difco 1:250) similarly neutralised with 
the various antisera; these mixtures were allowed to stand at 37°C 
for 30 minutes and 0.5 ml was inoculated intraperitoneally into 
each of two mice. The animals were observed from time to time for 
the next few hours and kept for 48 hours.
Criteria for the identification of an isolate as C.perfringens 
type A. Isolates identified presumptively as C.perfringens were 
confirmed as such by the biochemical tests described above. 
Identification as type A was based on the absence of toxins of 
other types by the neutralisation test.
Maintenance of cultures of C.perfringens Type A. Pure 
cultures of Clostridium perfringens type A were maintained in 
Cooked Meat medium in a dark place at room temperature. All 
isolates were, subcultured into a fresh Cooked Meat medium at least 
once every 6 months.
(v) Virological and parasitological procedures
Virological examinations. These were carried out from 
intestinal contents taken from a small number of piglets presenting 
diarrhoea. Each sample was suspended in sterile physiological 
saline (0.85 per cent of sodium chloride in deionised water) and 
centrifuged at ll,000g for 15 minutes as a clarification run. The 
supernatant was taken and centrifuged at 30,000g for 45 minutes. 
The pellets were resuspended in a few drops of physiological saline 
and negatively stained. These samples were examined using an AEI 
6B electron microscope for the presence of viral particles. 
Presence or absence of viral particles was recorded.
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Cases examined at Norwich V.I. Centre were examined by the 
laboratory staff for Transmissible Gastroenteritis and Porcine 
Epidemic Diarrhoea viruses by immunofluorescence on frozen 
sections.
Parasitological examinations. Scrapings of ileal mucosa and 
faecal samples were examined for Cryptosporidium using light 
microscopy. Giemsa stained smears of faeces or intestinal 
scrapings were used to detect Cryptosporidia. The presence or 
absence of Cryptosporidia was recorded. Histological sections of 
the small intestinal mucosa were examined for the presence of 
Isospora suis when such sections were available.
3. STUDIES WITH CLOSTRIDIUM PERFRINGENS TYPE A
Isolates of C.perfringens type A obtained in local pig farms 
and diagnostic materials stored as described above were used for 
these studies. Two types of study were carried out. One was on 
the vegetative cells to determine alpha toxin production and to 
produce crude and later pure alpha toxin. The other was on the 
ability of strains to sporulate and to produce enterotoxin and the 
production of pure enterotoxin.
(a) Studies on vegetative cells and alpha toxin
(i) Tests of C.perfringens type A isolates for alpha 
toxin production
Stored cultures were plated on horse blood agar and incubated 
anaerobically for 16 hours. A single colony was picked from each 
isolate for further investigation. This colony was then used to 
inoculate peptone medium containing meat particles and incubated 
for 6 hours at 37°C. The media were centrifuged at 20,000g for 30 
minutes at 4°C. The supernatants were then filtered through a 
cellulose acetate filter of A.P.D. 0.45 pm (Millipore Ltd.) and 
tested for the presence of alpha toxin activity. Alpha toxin 
activity was tested by means of turbidity in saline extract of egg
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yolk (Smyth and Arbuthnott, 1974); haemolysin acitivity in sheep 
erythrocytes suspension (Mollby et al., 1976) and the neutral­
isation test in mice.
Turbidity in saline extracts of egg yolk. The substrate was 
prepared from egg-yolk emulsion (Oxoid), diluted 1 in 10 with 
physiological saline solution. The saline extracts were adjusted 
to neutrality with Sodium bicarbonate. The test was performed by 
adding 0.5 ml of the egg-yolk solution to an equal volume of serial 
twofold dilutions of alpha toxin samples to be tested. The tubes 
were incubated for one hour at 37°C and examined for turbidity
which indicated lecithinase activity. Suppression of the reaction 
by anti-alpha toxin antiserum or by C.perfringens type A diagnostic 
antiserum was performed as evidence of the presence of alpha toxin 
in samples.
Haemolysin activity in sheep erythrocytes. Sheep erythrocytes 
were washed three times by centrifugation at l,000g in 0.02M 
Tris-HCl buffer pH 7.0 containing 0.15M of Sodium Chloride, the
packed erythrocytes were resuspended as a 1 per cent suspension in
the same buffer. Serial twofold dilutions of test samples were 
made in microtitre plates and an equal volume of erythrocyte
suspension was added. Haemolysis was estimated visually after one 
hour at 37°C and finally determined after 2 hours at 4°C when the 
erythrocytes had settled. Anti-alpha toxin antiserum was used for 
neutralisation of haemolysis.
Mouse Lethality Test. This test was carried out by making 
serial twofold dilutions of the supernatant from a culture of each 
isolate in physiological saline solution. 1 ml amounts were 
injected intraperitoneally into 23g Swiss White mice. Each 
dilution was tested in 2 mice and the mice were observed for 48 
hours for signs of illness or death. A mouse lethal dose was a 
reciprocal of the highest dilution of the toxin which was lethal to 
the 2 mice within 48 hours.
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(ii) The preparation of crude alpha toxin
C.perfringens type A isolate used was isolate No. 7, also used 
for the experimental infection of piglets described below and in 
Chapter 3. It was grown in a peptone medium containing meat 
particles according to the method of Takahashi et al. (1981). The 
medium contained the following constituents per litre (5 litres 
were prepared): 45g of proteose peptone (Difco), 14.32g of Na2
HPO4, .12 H2O, 1.36g of KH2PO4, 0.2g of MgSC>4. 7H20, 0.5g of yeast 
extract (Difco), 5.75 mg of ZnS04. 7H20, 3.94 mg of MnCl2* 4^0, 
lOg of fructose, 7 mg of FeS04. 7H20, lg of KHCO3, O.Olg of sodium 
thioglycollate, and 5g of meat particles (Difco). The medium was 
adjusted to pH 7.6 with 10 N NaOH and sterilised in the autoclave. 
When the medium cooled down to 37°C, it was inoculated with the 
C.perfringens type A isolate. After incubation for 6 hours at 
37°C, the organisms were removed by centrifugation at 10,000g for 
60 minutes at 4°C. The sediment was discarded and the supernatant 
was precipitated with solid ammonium sulphate at 50 per *,cent 
saturation in a cold water bath at 4°C, the ammonium sulphate was
added slowly to the supernatant, starting with a saturation of 5
per cent and increasing by 5 per cent until 50 per cent saturation 
was reached. The precipitate was centrifuged at 10,000g for 60 
minutes at 4°C. The supernatant was discarded and the sediment was
dissolved in one litre of 0.05M Tris-HCl buffer pH 7.5 and dialysed
exhaustively against the same buffer. The dialysis residue was 
centrifuged to remove the precipitate formed and the supernatant 
fluid was concentrated to a 100 ml volume by dialysis against 
polyethylene glycol (molecular weight 20,000, Analar) at 4°C. The 
dialysis tubing was rinsed in tap water to remove the excess of 
polyethylene glycol and the concentrated fluid was collected.
Toxin levels were determined by dilutions of the concentrated 
toxin in physiological saline injected intraperitoneally in 20-23g 
Swiss white mice in 1.0 ml quantities. The toxin titre was the 
highest dilution causing death in 24 hours.
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(iii) The preparation of pure alpha toxin
The Clostridium perfringens type A isolate used in the 
preparation of alpha toxin described above was used for the 
production of pure alpha toxin. The steps described above for the 
production of crude concentrated alpha toxin were followed, the 
only variable was the production of alpha toxin from 10 litres of 
medium instead of 5.
100 ml of concentrated toxin were dialysed against 0.05M 
Tris-HCl buffer pH 7.5 containing 0.15M of Sodium Chloride. The 
toxin was applied to a column (2.6 x 90 cm) packed with Ultrogel 
AcA-34 (LKB Instruments Ltd.) equilibrated with the same buffer. 
Filtration proceeded at a flow rate of 7.2 ml/hour. Fraction and 
exclusion volumes were 5 and 110 ml respectively. A plot of 
absorbance at 280 nm and enzyme activity of the fractions was 
recorded. Fractions containing alpha toxin activity from ten 
column runs were pooled and concentrated in dialysis tubing against 
polyethylene glycol-20,000.
Isoelectric focusing of concentrated fractions. The
concentrated fractions (20 ml in total) were subjected to
preparative isoelectric focusing following the method described by 
Johnstone and Thorpe (1982). The concentrated material was
dialysed against a solution of 1 per cent glycine for 18 hours. 4g 
of Ultradex gel (LKB Instruments Ltd.) were added to a solution
containing the .concentrated fractions to be focused, 20 ml, 
distilled water, 80 ml and 5 ml of carrier ampholytes (Ampholine pH 
5-8 , LKB Instruments Ltd.) at a final concentration of 5 per
cent. This solution was placed onto a glass plate (20 x 12 x 0.4 
cm). The gel layer was air dried until 20 per cent of water was 
evaporated. The plate was mounted horizontally on a cooling block 
with circulating water at 4°C and contact with phosphoric acid 1M 
on the anodic side and potassium carbonate 1M in the cathode was 
made by paper strips. Focusing was carried out at a constant
voltage of 200V for 4 hours followed by a constant voltage of 600V 
for 12 hours. The gel was removed from the chamber and covered
73
with a piece of filter paper to blot focused proteins. The paper 
was removed, dried and washed in several changes of 10 per cent 
trichloroacetic acid and then stained with Coomassie brilliant blue 
at 0.025 per cent. Protein bands in the gel were located by 
comparison with the stained paper. Proteins localised in the gel 
were scraped off, resuspended in phosphate buffered saline pH 7.2, 
mixed thoroughly and centrifuged at 400g for 5 minutes. The 
supernatants of different fractions were removed and precipitated 
with solid ammonium sulphate at 95 per saturation then centrifuged 
at 2,500g for 10 minutes. The pellets were resuspended in small 
volumes of phosphate buffered saline pH 7.2 and passed through a 
Sephadex G-25 column for rapid desalting. Protein content in 
fractions was estimated by their absorbance at 260 nm and 280 nm in 
a spectrophotometer.
Collected fractions were tested for their alpha toxin activity 
by haemolysis of sheep erythrocytes and by turbidity in egg yolk 
suspensions.
The focused fraction which presented alpha toxin activity was 
subjected to purity tests by double diffusion and by 
immunoelectrophoresis by the methods described in the section on 
immunological methods below and by polyacrylamide gel 
electrophoresis.
Polyacrylamide gel electrophoresis. Crude ammonium sulphate 
precipitated alpha toxin, fraction eluted from Ultrogel AcA-34, 
colum and isoelectric focusing purified alpha toxin were 
electrophoresed on a polyacrylamide gel according to the method 
described by Johnstone and Thorpe (1982). Purified alpha toxin 
(Phospholipase C XII, Sigma London Chemical Company Ltd.) was used 
as a reference standard. Samples were dialysed against 0.125M 
Tris-HCl buffer pH 6.8 for 24 hours. Supporting medium for 
electrophoretic separation consisted of a homogeneous mixture of 7 
per cent acrylamide and 0.16 per cent NN'-methylene bisacrylamide 
in distilled water. 50 pi of N,N,N,Nf-tetramethylethylene diamine 
(TEMED) and 25 mg of ammonium persulphate were added for each 100
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ml of the reaction medium. The gel solution was poured into a gel 
mould (LKB Instruments Ltd.) The gel plates used were 16 x 16 cm, 
3 mm thick. A stacking gel containing 3 per cent of acrylamide and 
0.08 per cent of bisacrylamide was polymerised on top of the
separating gel. The samples were adjusted to a protein
concentration of 300 pg per ml and loaded into the slots of the
stacking gel. Electrophoresis was carried out in a Tris-glycine 
buffer pH 8.3 at 50V for 30 minutes and then the voltage was 
increased to a constant value of 200V for 6 hours. The mould was 
cooled with circulating tap water. Bromophenol blue was used to 
monitor the progress of the electrophoresis. The polyacrylamide 
gel was stained with Coomassie brilliant blue at 0.025 per cent.
Purified alpha toxin was stored frozen at -20°C until 
required.
(b) Studies with sporulating cells and enterotoxin
(i) Culture media
All C.perfringens type A isolates were tested for their 
ability to sporulate and to produce enterotoxin. All isolates were 
tested in 3 sporulation media: Duncan and Strong medium (Duncan
and Strong, 1968) comprised of: 1.5 per cent proteose peptone, 0.4 
per cent yeast extract, 0.1 per cent sodium thioglycollate (Oxoid 
L120), 0.4 per cent raffinose (BBL) and 1.0 per cent Na2HP04* 
7H20; Ellner medium (Ellner, 1956) consisting of: 1.0 per cent
proteose peptone, 0.3 per cent yeast extract, 0.3 per cent starch 
(BBL), 0.01 per cent MgSO^, 0.15 per cent KH2PO4 , and 5 per cent 
Na2HP04» 7^0; and Tsai medium (Tsai et al. , 1974) comprised of:
1.5 per cent proteose peptone, 0.3 per cent yeast extract, 0.3 per 
cent starch, 0.01 per cent MgS04, 0.1 per cent sodium 
thioglycollate, and 1.1 per cent Na2HP04» 7^0.
(ii) Cultural methods for sporulation studies
Stock cultures in cooked meat medium were kept in the dark at
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room temperature. 2 ml of stock culture were inoculated into 10 ml 
of fluid thioglycollate medium (BBL Code 11720), heat-activated at 
80°C for 10 minutes and incubated at 37°C for 18 hours. 2 ml of 
this culture were then transferred to 10 ml of fluid 
thioglycollate, heat-activated at 80°C for 10 minutes and incubated 
for 6 hours at 37 °C. Volumes of 0.5 ml of this culture were 
inoculated into each of 10 ml volumes of the 3 sporulation media. 
These media were previously heated in boiling water and then cooled 
rapidly in ice before being inoculated. The inoculated media were 
incubated at 37 °C for 6-12 hours to obtain maximum numbers of 
sporulating cells, or for 24 hours to test enterotoxin released 
into the culture supernatant.
Smears of sporulation cultures were stained by Gram’s stain. 
Vegetative cells and spores were observed and enumerated in the 
transmitted light microscope. Percentage of sporulation in the 
cultures was obtained from the ratio of the number of spores to the 
total number of vegetative cells and spores. ^
(iii) Methods for the enumeration of vegetative cells 
and spores in faecal samples from pigs
Porcine faecal specimens were examined for vegetative cells 
and spores as follows: lg of the sample was added to 10 ml of
sterile phosphate buffered saline and homogenised. Ten-fold serial 
dilutions were carried out in sterile phosphate buffered saline, 
then 30 pi amounts of the dilutions were inoculated onto the 
surface of a commercially prepared tryptone-sulphite agar medium 
(Oxoid, CM543) containing a concentration of D-Cycloserine (Sigma, 
C6880) of 400 pg/ml. For assessment of spores the same dilutions 
were heated in a water bath at 80°C for 10 minutes before 
inoculation of tryptone-sulphite agar plates. Inoculated plates 
were left to dry at room temperature and then inoculated 
anaerobically for 24 hours. Following incubation, the plates were 
examined for the presence of blackened colonies which were 
counted. The count was considered to give the number of colony 
forming units. (Miles and Misra, 1938).
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(iv) The production and purification of enterotoxin
C.perfringens type A isolate No. 29 previously tested for its 
ability to sporulate and produce enterotoxin as described was used 
for the production and purification of enterotoxin. The isolate 
which was maintained in cooked meat medium was inoculated onto 
horse blood agar plates and incubated anaerobically at 37°C for 18 
hours. Three to five colonies from the horse blood agar plate were 
then inoculated into freshly steamed cooked meat medium, and 
incubated at 37°C for 18 hours; the culture was heat-activated at 
80°C for 10 minutes and 1 ml inoculated into 10 ml of fluid 
thioglycollate medium and incubated at 37°C for 18 hours, the 
culture was then heat-activated at 80°C for 10 minutes and 
inoculated into 100 ml of freshly prepared thioglycollate medium 
and incubated at 37°C for 6 hours. The entire culture was then 
inoculated into 10 litres of Duncan and Strong medium. No special 
precautions were taken to obtain anaerobic conditions other than 
the inclusion of sodium thioglycollate and stationary incubation of 
the culture. The culture was incubated at 37°C and after 4 hours 
samples were removed at various time intervals and examined by 
Gram's stain for growth and sporulation. When more than 50 per 
cent of the cells had produced spores, (usually 5 to 8 hours) the 
culture was cooled at 4°C, the cells were harvested by 
centrifugation at 10,000g for 60 minutes at 4°C and washed twice, 
by centrifugation at the same speed, using phosphate buffered 
saline.
Extraction of enterotoxin from sporulated cells. The washed 
cell pellet was resuspended in 400 ml of phosphate buffered saline, 
and the suspension was subjected to intervals of ultrasonic 
treatment at an amplitude of 14 pm by means of an ultrasonic 
disintegrator until all sporangia were disrupted and only free 
spores were detected. Sonication was monitored by the examination 
of Gram's stained smears. The suspension was centrifuged at 
15,000g for 30 minutes at 4°C. The sediment was discarded and the 
supernatant precipitated with solid ammonium sulphate at 40 per 
cent saturation. The precipitate was centrifuged at 10,000g for 60
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minutes at 4°C and the sediment was redissolved in 100 ml of
phosphate buffered saline. The protein solution was adjusted to 15 
per cent saturation with respect to ammonium sulphate, centrifuged 
at 10,000g for 60 minutes at 4°C and the resulting precipitate
dissolved in 30 ml of phosphate buffered saline. This solution was 
dialysed overnight against the same buffer and any precipitate 
removed by centrifugation.
Gel filtration on Sephadex G-200. The protein solution from 
the preceding step was applied to a column (2.6 x 90 cm) packed 
with Sephadex G-200 (Pharmacia) equilibrated with phosphate 
buffered saline 0.02M pH 7.2. The filtration proceeded with the 
same buffer at a flow rate of 8.7 ml/hour. Fraction and exclusion 
volumes were 4.5 and 90 ml respectively. A plot of absorbance at 
280 nm of the fractions was recorded. The fractions presenting 
enterotoxin activity from three column runs were pooled, 
freeze-dried and stored at -20°C.
Polyacrylamide gel electrophoresis. The ammonium sulphate 
precipitates and the active fraction eluted from Sephadex G-200 
column were electrophoresed on a polyacrylamide gel, following the 
method previously described. All samples were adjusted to a 
protein concentration of 500 pg per ml. Purified enterotoxin 
provided by M. Stringer, Central Public Health Laboratory, London,
was used as a reference standard.
(v) Methods to test enterotoxin activity
Toxicity test in mice. For the toxicity test in mice, serial 
double dilutions of crude or purified enterotoxin in 0.02M 
phosphate buffered saline pH 7.2, were inoculated intraperitoneally 
in 0.5 ml amounts into each of two mice per sample. Swiss White 
mice of either sex weighing 20 to 25g were used. The animals were 
observed at intervals for 48 hours to determine lethality of the 
samples. The mouse lethal dose (MLD)/ml was expressed as the 
reciprocal of the highest dilution which was lethal to two mice 
within 48 hours.
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Toxicity test in Vero cells. Vero (African green monkey 
kidney) cells were purchased (Gibco Europe Ltd.) and subcultured in 
75 cm^  tissue culture flasks (Gibco) with Medium 199 supplemented 
with 5 per cent foetal calf serum (Gibco) and 0.75 per cent sodium 
bicarbonate. When monolayers reached confluency they were removed 
by trypsinization with 0.25 per cent trypsin in calcium and 
magnesium-free Hank's balanced salts solution (Gibco). Trypsinized 
cells were then subcultured in the same supplemented Medium 199 to 
a microplate-96 wells (Gibco). Each well was inoculated with 150 
pi of a cell suspension containing approximately 5 x 10  ^cells/ml. 
Culture plates were incubated for 24 hours, at 37°C in a humidified 
atmosphere containing 5 per cent CO2 in air, allowing growth to 
confluency. The cells were washed once with 150 pi of calcium and 
magnesium-free Hank's balanced salts solution, and dilutions of 
samples to be tested for enterotoxin in Medium 199 without serum 
added. Samples were either filtrates of cultures or filtrates of 
pig faeces.
Plates were read after 16 hours' incubation under an inverted 
microscope. Morphological damage to Vero cells was recorded. 
Toxic units (TU)/ml were expressed as the reciprocal of the highest 
dilution of enterotoxin which produced morphological changes of 
Vero cells.
4. IMMUNOLOGICAL METHODS
(a) Preparation of antigen
(i) Preparation of whole culture antigen
Clostridium perfringens type A (Isolate No. 7) was grown in 
the peptone medium with meat particles described above. Five 
litres of the medium were inoculated and incubated for 16 hours at 
37°C. The culture was centrifuged at 2,000g for 30 minutes to 
remove meat particles. The supernatant was taken and the sediment 
discarded.
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Viable counts of bacteria present in the suspension were 
determined.
One ml 0.6 per cent formaldehyde was added per 100 ml of whole 
culture for its inactivation and kept at 37°C for 14 days, after 
this time the whole culture bacterin was concentrated to a 600 ml 
suspension in a dialysis tubing covered by polyethylene glycol 
20,000.
Sterility tests were performed by inoculating* 1.0 ml amounts 
of the bacterin in 5 flasks containing 50 ml of thioglycollate
broth and incubating them at 37°C for 8 days. The incubated broths 
were inspected visually for signs of bacterial growth and cultured 
on horse blood agar plates incubated aerobically and 
anaerobically. The presence of colonies was considered to indicate 
contamination or incomplete inactivation.
Detoxification was assessed by the intraperitoneal injection 
of 0.5 ml of the formalised suspension into 2 White Swiss Mice 23g 
in weight. These were observed for signs of illness for 48 hours. 
In the absence of clinical signs the material was considered
inactivated.
The protein concentration of the suspension was estimated by 
the method of Lowry et al. (1951). The bacterin was absorbed to a 
suspension of aluminium hydroxide (Alhydrogel, Superfos Export Co. 
Denmark) to give a final concentration of 2.18 mg of aluminium
hydroxide per ml of bacterin. The pH of the adsorbed material was 
adjusted to pH 7.0 with IN HC1. Agitation was constant during its 
addition to the bacterin. The bacterin was preserved with 
thiomersal at 0.005 per cent, dispensed in 10 ml Universal bottles 
and kept at 4°C. The finished product appeared as a floccular
precipitate which could be resuspended by gentle shaking.
(ii) Preparation of freeze-dried whole cell oral antigen
Clostridium perfringens type A isolate No. 7 was grown in the
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peptone medium with meat particles described above. 10 litres of 
the medium were inoculated and incubated for 16 hours at 37°C. The 
culture was centrifuged at 10,000g for 60 minutes. The supernatant 
was discarded and the sediment which contained the bacterial cells 
was resuspended in sterile phosphate saline buffer, the cells were 
washed twice with the same buffer by centrifugation and resuspended 
in 250 ml of the buffer.
Viable counts of bacteria present in the suspension were 
determined by the method described by Miles and Misra (1938). The 
bacterial cells were inactivated by the addition of 1 ml 0.6 per 
cent formaldehyde per 100 ml of suspension and kept at 37°C for 14 
days.
Sterility and completeness of detoxification were tested as 
described above.
The protein concentration of the suspension was determined by 
the Lowry method and recorded.
The bacterial cell suspension was freeze-dried in 10 ml 
volumes in glass Universal bottles using a Modulyo Freeze Dryer 
(Edwards). The freeze-dried material was stored in sealed sterile 
containers at 4°C until used. 95g freeze-dried cells were mixed 
with 950g Maize starch (Cornflour, Fine Fare Ltd.).
(iii) Preparation of crude toxoid
Crude alpha toxin was prepared as described above.
Detoxification was carried out using the method of Ito (1968) in
which 0.2 ml of formaldehyde 40% w/v (Koch Light Labs) to 100 ml of 
the crude toxin to which 1-Lysine (BDH) had been added to give a 
final concentration of 0.05M. The toxin was kept at a temperature 
of 28°C for 8 days. The inactivated crude toxin was then tested 
for the presence of residual toxicity every 4 days by mouse
inoculation and haemolysis of sheep red cells until complete
inactivation was attained.
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Sterility was assessed using the method described above.
Protein concentration of the toxoid was estimated by the Lowry 
method •
The toxoid was adsorbed to a commercial formulation of 
aluminium hydroxide giving a final concentration of 2.18 mg of 
aluminium hydroxide per ml of toxoid. The pH of the adsorbed 
material was adjusted to 7.0 with IN HC1. The toxoid was preserved 
with thiomersal at 0.005 per cent, dispensed in 10 ml Universal 
flasks and kept at 4°C. The adsorbed toxoid appeared as a 
floccular precipitate which, when required for inoculation, could 
be resuspended by gentle shaking.
(iv) Preparation of pure alpha toxin and enterotoxin
These products were prepared as above but not inactivated 
before use. «.
(v) Preparation of pure porcine secretory IgA
Secretory IgA was purified, to produce an antiserum against 
it, according to the method described by Bourne (1969).
Treatment of sowfs milk. Milks from 3 sows from Farm B were 
pooled (220 ml) and centrifuged at 20,000g for one hour then the 
whey between the floating fatty layer and the pellet was collected 
(140 ml) and mixed with 70 ml of physiological saline and 
centrifuged again at 20,000g for one hour. The clarified whey was 
collected. 100 ml of clarified whey were precipitated with solid 
ammonium sulphate at 50 per cent saturation under gentle agitation 
at 4°C for 6 hours then the precipitate was centrifuged at 7,000g 
for 30 minutes. The supernatant was discarded and the pellet 
resuspended in 10 ml of physiological saline and left in dialysis 
against the same solution for 16 hours. The dialysed solution was 
stirred and the pH was brought to 4 by the addition of hydrochloric 
acid, and the solution was centrifuged at 30,000g for 30 minutes at
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4°C. The pellet was discarded and the supernatant neutralised with 
2M Tris. The solution was centrifuged again at 30,000g for 30 
minutes and the supernatant passed through a 0.45 pm filter to give 
a final volume of 5 ml.
Gel filtration on Sephadex G-200. This 5 ml of purified whey 
solution was applied to a column (3.2 x 100 cm) packed with 
Sephadex G-200 (Pharmacia Ltd.) equilibrated with 0.1M sodium 
phosphate buffer pH 6.8. Filtration was carried out with the same 
buffer at 5.6 ml/hour. The exclusion volume was 260 ml. A plot of 
absorbance at 280 nm was recorded (Fig. 1). Fractions eluted from 
the first major peak were pooled together and concentrated by 
dialysis against polyethylene glycol MW 20,000.
Ion exchange chromatography. The sample was dialysed against 
.02M Tris-HCl buffer pH 7.4 and applied to a column (1.5 x 20 cm) 
of diethylaminoethyl (DEAE) cellulose (Pharmacia Ltd.) equilibrated 
in the same buffer. The column was eluted with about 400 ml of the 
buffer followed by stepwise elution with the same buffer at 
different molarities (0.02, 0.05, 0.1, 0.125, 0.15, 0.2, 0.3 and 
0.5M). Absorbance at 280 nm was monitored (Fig. 2). Peaks eluted 
with 0.1M and 0.125M buffers were collected and subjected to IgA 
purity tests by means of immunoelectrophoresis and double diffusion 
tests as described below. A single arc of precipitation was 
observed when the presumed IgA was tested by immunoelectrophoresis 
against commercial rabbit anti-swine whole serum (Miles) (Fig. 3) 
and by double immunodiffusion (Fig. 4). The 0.125M peak contained 
most IgA. The purified IgA was stored at -20°C in sealed vials 
until required.
(b) The production of antisera and other immune products
(i) Animal species used
Antisera were prepared in mice, rabbits and pigs. Both 4 
month old weaned pigs and pregnant sows were used.
Mice. Mice used in the studies were Swiss White mice bred in
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FIG, 1: Separation of secretory IgA from porcine milk on sephadex
G-200.
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FIG. 2: Separation of secretory IgA from porcine milk on
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FIG. 3: Immunoelectrophoresis pattern of purified secretory IgA
(A) compared to normal porcine serum (S) and porcine milk (M). 
Rabbit anti-porcine serum in the longitudinal troughs.
Note the single line of precipitation produced by the purified
secretory IgA (arrow).
FIG. 4: Double immunodiffusion pattern obtained with fractions
eluted from DEAE-cellulose column. Molarity of eluted fraction: 
(a) 0.05; (b) 0.1; ( O  0.125; (d) 0.15; (e) 0.2; (f) 0.3.
Rabbit anti-porcine serum in the central well.
Note lines of identity produced by the 0.125M and 0.1M fractions 
(arrow). Most of the secretory IgA was contained in the 0.125M
fraction.
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the Animal House of the Department of Veterinary Pathology,
University of Glasgow. Adult mice (20-25g) of both sexes were 
used. They were young, fed on a laboratory mouse diet (diet 41, 
J.Ogston Ltd.). The mice were housed in polythene cages containing 
wood shavings and bedding. Feed and water were available ad 
libitum.
Rabbits. The rabbits used for the experiments were New
Zealand White purchased from Olac Ltd. Young adult animals of both 
sexes were used. They were fed on a laboratory rabbit diet (diet 
18, J. Ogston Ltd.). Each rabbit was individually housed in a
floor slatted cage containing no bedding. Feed and water were 
freely available.
Pigs. All pigs used in the study were of minimal disease 
origins (National Pig Development High Health Status) and were 
obtained from the University of Glasgow, Animal Husbandry 
Department. They were of 2 types, conventional weaned pigs ag’&d 12 
weeks, and conventional pregnant sows.
Conventional weaned pigs were produced by normal farm practice 
and when obtained had been weaned and maintained in flatdeck
accommodation since weaning at 3 weeks of age. All were 
individually identified using a numbered ear tag. They were housed 
in unheated pens with concrete floors and straw bedding. They were 
fed on a barley-based ration containing no non-nutrient additives 
standard to the Department of Animal Husbandry. Water was freely 
available.
All the pregnant sows were kept in the dry sow house in 
individual stalls at an ambient temperature of 20°C. The animals 
were fed on a barley-based ration for pregnant sows standard to the 
Department of Animal Husbandry. Water was freely available. 
Three-four days before farrowing, each sow was moved to an 
individual farrowing cage where the temperature was 22-24°C until 
weaning.
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(ii) Blood sampling procedures
Blood samples were taken from mice only after cervical 
dislocation. The blood was taken from the heart. Rabbits were 
bled from the ear vein and at the end of the study were 
anaesthetised with pentobarbitone sodium and large volumes were 
taken by cardiac puncture. Pigs were bled from the jugular vein 
and, after stunning, from the stick wound at slaughter.
Blood samples were allowed to clot, serum was removed and 
centrifuged at l,600g for 10 minutes. The clear serum was removed 
and stored at -20°C in sealed Bijou or Universal bottles.
(iii) Milk and colostrum samples
Milk and colostrum samples were taken by milking sows after 
the intramuscular injection of oxytocin (Intervet Labs. Ltd.). 
Samples were spun at 10,000g for 1 hour and the middle fraction 
collected and stored at -20°C until required.
(iv) Immunisation procedures
Pre-inoculation blood samples were taken from rabbits and 
pigs, but not from mice, and the sera stored.
Immunisation of mice was performed by inoculating groups of 6 
mice each with the adjuvanted toxoid and whole culture bacterin, 
each mouse receiving a dose of 0.5 ml of the preparations. A 
second immunisation was given two weeks later; fourteen days after 
the mice were bled out by cardiac puncture, the sera were 
collected, pooled and stored at -20°C. Sera from non-immunised 
mice were collected as a control.
Immunisation of rabbits was carried out after the 
pre-inoculation bleed by the subcutaneous or intramuscular 
injection of the antigens given in Table 4. The volumes and the 
adjuvants used and the injection schedule are given in the table.
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TABLE 4 Antigens and immunisation procedures
for the production of rabbit antisera
Antigen Adjuvant Inoculation Inoculation
schedule
Crude alpha Alhydrogel s/c 2.0 ml DO
toxin toxoid s/c 2.0 ml D14
22.9 mg Protein/ml Bleed D28
Whole culture Alhydrogel s/c 2.0 ml DO
bacterin s/c 2.0 ml D14
73.6 mg Protein/ml Bleed D28
Pure alpha toxin Freund *s s/c 2 ml DO
.590 mg Protein/ml Complete 1:1
Freund’s
incomplete 1:1 s/c 2 ml D14
Repeated D28
«•
Repeated D42
Repeated D56
Bleed D70
Pure enterotoxin Freund ’ s 4 sites 0.5 ml/ DO
.200 mg Protein/ml Complete 1:1 2 s/c, 2 i/m site
Repeated D28
Repeated D42
Bleed D56
Secretory IgA Freund’s 1:1 4 sites 0.5 ml/ DO
.180 mg Protein/M Complete 2 s/c, 2 i/m site
Freund's 4 sites 0.5 ml/ D14
Incomplete 1:1 2 s/c, 2 i/m site
Repeated D28
Repeated D42
Repeated D56
Bleed D70
s/c = subcutaneous i/m = intramuscular D = Day
Immunisation of pigs was carried out after the pre-inoculation 
bleed by the subcutaneous, intramuscular or oral administration of 
the antigens given in Table 5. The volumes and the adjuvants 
administered and the schedule of administration are given in Table 
5, as are the immune products harvested.
(v) The preparation of fluorescent antibody to secretory 
IgA
Rabbit antibody to secretory IgA was prepared using the 
antigens and the immunisation schedule above. The serum was 
precipitated with 40 per cent solid ammonium sulphate. The 
precipitate was dissolved in 0.01M phosphate buffered saline pH 7.2 
at approximately one-third the original volume of serum. The 
residual ammonium sulphate was removed by column chromatography on 
Sephadex G-25 (Pharmacia Ltd.) using the same phosphate buffer for 
elution.
The eluted fraction was dialysed in a 0.25M sodium carbonate 
buffer containing 0.1M sodium chloride. The protein concentration 
of the globulins was adjusted to 20 mg per ml with the same sodium 
carbonate buffer. Fluorescein isothiocyanate (Sigma London 
Chemical Company Ltd.) was used at the ratio of 0.05 mg per mg of 
protein. The dry fluorescein powder was dissolved in the sodium 
carbonate buffer pH 9.0 (5 per cent volume of the protein solution) 
and added by drops to the protein solution. The mixture was stored 
at 4°C for 20 hours. The pH was adjusted to 7.5 and the mixture 
passed through a Sephadex G-25 column to remove excess of 
fluorescein and carbonates, elution was done with 0.01M phosphate 
buffered saline pH 7.5. Globulin estimation and
fluorescein/protein ratios were determined spectrophotometrically 
by the method of Johnstone and Thorpe (1982). The final conjugated 
globulins were filtrated through a 0.22 pm membrane filter and 
stored at -20°C. The conjugate was titred to find the dilution 
most suitable for use.
The dilution most suitable for use was determined using fixed
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•TABLE 5 Antigens and immunisation procedures
for the production of pig immune sera and milks
Antigen Adjuvant Inoculation Inoculation
schedule
A. Weaned pigs
Crude alpha 
toxin toxoid
22.9 mg Protein/ml
Crude alpha 
toxin toxoid
22.9 mg Protein/ml
Whole culture 
bacterin
73.6 mg Protein/ml
Crude alpha toxin 
toxoid and 
whole culture 
bacterin 1:1 
Crude toxoid and 
whole culture 
mixture as above 
Washed freeze-d^ied 
C.perfringens 
cells 10% in corn­
starch
Pure enterotoxin 
.200 mg Protein/ml
Alhydrogel
Alhydrogel
Alhydrogel
Alhydrogel
Alhydrogel
None
Freund’s 
Complete 1:1 
Freund’s 
Incomplete 1:1
s/c 
s/c
s/c
s/c
s/c
s/c
s/c
5.0 ml
5.0 ml 
Bleed
B. Sows
5.0 ml
5.0 ml
DO
D14
D28
DO
D14
Bleed at Farrowing 
Milk
As for crude 
Alpha toxin toxoid 
(sows and weaned pigs) 
As above for 
weaned pigs 
and sows
5.0 ml DO
oral 3.75g/day DO
in feed farrowing
Bleed at Farrowing 
Milk
2.0 ml DOs/c
s/c 2.0 ml D14
Repeated D28 
Bled D56
s/c = subcutaneous i/m = intramuscular D = Day
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frozen sections of pig spleen. The anti-porcine secretary IgA 
conjugate was applied to the tissue and incubated in the dark for 
30 minutes at room temperature in a moist chamber. The slides were 
washed twice for 15 minutes each in phosphate buffered saline. 
Slides were mounted with cover slips using 10 per cent glycerol in 
phosphate buffered saline pH 9.0 and observed with the fluorescence 
microscope. Intensity of specific fluorescence was recorded.
(vi) The absorption of sera
Aliquots of antisera used on intestinal tissue sections 
(anti-alpha toxin and anti-enterotoxin) were absorbed with pig 
liver powder to prevent non-specific fluorescence. Sera from some 
experimental animals were also absorbed with vegetative 
C.perfringens cells.
Absorption with pig liver powder. Antiserum was absorbed 
according to the method of Johnson (1961). Pig liver powdep was 
prepared by homogenizing 500g of fresh pig liver in a 500 ml volume 
of physiological saline in a stomacher. The homogenized tissue was 
transferred to a measuring cylinder and precipitated with 5 volumes 
of acetone. The supernatant was removed by suction and washed 
three times with saline by filling the cylinder, allowing the 
tissue particles to sediment and removing the supernatant. The 
lipids were removed by further washing with acetone and then 
transferred to a Buchner funnel and washed through with acetone. 
The material was spread on filter paper and allowed to dry in an 
incubator at 37°C. The material was ground in a mortar and passed 
through a fine sieve to remove fibrous particles. Phosphate 
buffered saline pH 7.2 was added to the powder, centrifuged at 
2,000g and the supernatant discarded. The powder was stored at 
-20°C until used.
Serum was absorbed by mixing two volumes of serum to one 
volume of liver pig powder. The mixture was gently rotated for 20 
minutes at 4°C and then centrifuged at 2,000g, collecting the
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supernatant. The absorbed sera were stored at -20°C until 
required.
Absorption of sera with vegetative C.perfringens type A. 
Vegetative cells of C.perfringens type A isolate 29 (used for 
enterotoxin production and experimental infections) were grown in 
thioglycollate medium for 12 hours. The cells were harvested by 
centrifugation at 8,000g. The pellet was washed in PBS, pH 7.2, 
centrifuged and washed again. After a final centrifugation the 
cells were resuspended in the sera to be absorbed to a concen­
tration of 2 x 107 cells/ml, incubated at 37°C for 30 minutes and 
then centrifuged again at 8,000g. The supernatant was filtered 
through a cellulose acetate filter of APD 0.22 pm and stored at 
-20°C until required.
(vii) Inactivation of sera
All sera used for immunofluorescence were inactivated by 
heating at 56°C for 30 minutes.
(c) Immunological techniques
The following techniques and methods were used throughout the 
study to evaluate the serological response elicited by 
C.perfringens and its products in field and experimental material.
(i) Counterimmunoelectrophoresis
Agarose (L.K.B. Instruments Ltd.) at one per cent 
concentration was dissolved by heat in 0.025 ionic-strength 
barbital-acetate buffer pH 8.6. Slides were layered with melted 
agarose and allowed to harden for at least 20 minutes and stored in 
a moist chamber until used.
Barbital-acetate buffer pH 8.6 was prepared in distilled 
water. The composition of stock buffer was 3.09 per cent sodium 
barbital, 0.552 per cent barbital and 1.23 per cent sodium
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acetate. The buffer solution was heated to approximately 90°C for 
15 minutes to dissolve the buffer salts and was then diluted to a 
0.025M ionic-strength buffer with distilled water. Parallel rows 
of wells 0.3 cm in diameter were cut 0.5 cm apart in the agar. Ten 
microlitres of antigen were placed in wells near the cathode. The 
samples (sera, colostra and milks) to be tested were placed in the 
wells near the anode in similar volumes. the electrode vessel 
contained barbital-acetate buffer of the same ionic strength, 
(0.025M) as was used for the gel preparation. Electrophoresis was 
carried out in an electrophoresis chamber (Gelman Instrument Co.) 
at room temperature with a constant current of 6mA per slide for 60 
minutes. Filter paper was used as an electrode wick. After 
electrophoresis, the slides were removed to a moist chamber and 
allowed to develop for 30 minutes. For a permanent record the 
slides were washed for 24 hours in phosphate buffered saline and 
for 6 hours in distilled water before staining with Coomassie
brilliant blue at 0.025 per cent.
(ii) Immunoelectrophoresis
Slides covered with a layer of one per cent agarose 1.0-1.5 mm 
thick containing 0.01 per cent thiomersal in 0.025 ionic-strength 
barbital-acetate buffer pH 8.6. The slides were set on a levelling 
platform and allowed to harden for at least 20 minutes. Troughs
0.4 cm wide by 5 cm long and wells 0.3 cm in diameter were cut out 
of the agar with a cork borer and a scalpel. The distance between 
the troughs and -the wells was 0.3 cm. A drop of bromothymol blue 
added to one well acted as an electrophoretic marker. Separation
was achieved with a potential of 100-150V for 3-4 hours, the gel
being cooled with tap water. The agar was then removed from the
troughs, antiserum was placed in the troughs and diffusion of 
antiserum and antigens allowed to take place over the central 
compartment of the electrophoretic tank or in petri dishes lined 
with moist blotting paper at room temperature. After an incubation 
time of 18-24 hours the slides were washed for 24 hours in 
phosphate buffered saline and for 6 hours in distilled water. The 
slides were allowed to dry up at.room temperature before staining 
with Coomassie brilliant blue at 0.025 per cent.
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(iii) Double inraiunodiffusion
Plastic petri dishes 3.5 cm in diameter were covered with a
layer of one per cent agarose 1.0 - 1.5 mm thick containing 0.01
per cent thiomersal in phosphate buffered saline pH 7.2. The agar 
was allowed to solidify and wells 0.3 cm in diameter and 0.4 cm 
apart were cut out of the agar. Ten microlitres of samples to be 
tested were placed in the wells and diffusion of antiserum and 
antigens allowed to take place for 24-48 hours at room
temperature. The petri dishes were washed in phosphate buffered 
saline and distilled water, the gel allowed to dry at room
temperature and stained with Coomassie brilliant blue at 0.025 per 
cent.
(iv) Immunofluorescence
Indirect immunofluorescence was used in a number of studies in 
this thesis.
Indirect immunofluorescence on bacterial smears. Colonies of 
Clostridum perfringens type A grown for 16 hours in horse blood 
agar were picked and resuspended in a small amount of physiological 
saline solution then the suspension was smeared on pre-cleaned 
microscope slides, air-dried and fixed in acetone pre-cooled at 
4°C, for 10 minutes. Smears of other Clostridia (C.tertium,
C.chauvoei, C.septicum and C.haemolyticum) were used as controls. 
Dilutions of sera, colostra or milks to be tested were spread over 
the smear and incubated in the dark room for 30 minutes at room 
temperature in a moist chamber. After incubation, the slides were 
washed twice for 15 minutes each in phosphate buffered saline pH 
7.2. Fluorescein-conjugated rabbit anti-swine IgG, rabbit 
anti-swine IgM, rabbit anti-mouse IgG and sheep anti-rabbit IgG 
(Miles Laboratories Ltd.), and the fluorescein conjugated rabbit 
anti-porcine secretory IgA prepared by the methods described above 
were all used. The fluorescent antisera were placed on the smear 
and incubated again in the dark for 30 minutes at room 
temperature. The slides were washed twice for 15 minutes each in
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phosphate buffered saline pH 7.2 and mounted with cover slips using 
10 per cent glycerol in phosphate buffered saline (pH 9.0) and UG-1 
filters. The intensity of the specific fluorescence produced was 
recorded.
Indirect immunofluorescence on frozen sections. Specific 
antiserum was layered on the sections and incubated in the dark for 
30 minutes at room temperature in a moist chamber. After 
incubation, the slides were washed twice for 15 minutes each in 
phosphate buffered saline pH 7.2 and fluorescein conjugated 
anti-rabbit IgG applied to the sections which were incubated 30 
minutes at room temperature then they were mounted and observed in 
the fluorescence microscope as described above. A negative rabbit 
serum was used as a control in each case.
Indirect immunofluorescence on Vero cells. Vero cells were 
cultured into Lab-Tek (Miles Laboratories) chamber slide wells (1 
cm2 surface area/well) and allowing growth to confluency* (24 
hours). The cells were washed once with 1 ml of calcium and 
magnesium-free Hank’s balanced salts solution, and enterotoxin in 
Medium 199 without serum added. After 4-6 hours of incubation at 
37°C in a humidified atmosphere containing 5 per cent CO2 in air, 
the slides were fixed in cold acetone for 10 minutes. 
Decomplemented anti-enterotoxin serum (56°C - 30 minutes) was
layered on the slides and incubated in the dark for 30 minutes at 
room temperature in a moist chamber. After incubation the slides 
were washed in ,phosphate buffered saline pH 7.2 and commercial 
fluorescein conjugates (anti-rabbit IgG or anti-pig IgG) was 
applied to the slides which were incubated 30 minutes at room 
temperature and washed in phosphate buffered saline pH 7.2. They 
were mounted and observed in the fluorescence microscope as 
described above. Fluorescence was recorded.
(v) Toxin neutralisation studies
These were carried out in mice, Vero cells and by the 
prevention of haemolysis.
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Toxin neutralisation studies in mice. Toxin neutralisation
tests were carried out in mice using antibody from immunised 
animals of other species (pigs) or in the mice themselves as a 
means of assessing the effectiveness of immunisation.
Toxin neutralisation tests. Antitoxin activity of sera, 
colostra or milks was tested by the neutralisation of specific 
amounts of alpha-toxin. The procedure consisted of making serial 
two-fold dilutions of the secretion to be tested in physiological 
saline solution. To each of the series of dilutions 1 ml of toxin 
containing 16 mouse lethal doses was added. A mouse lethal dose 
was the reciprocal of the highest dilution of the toxin which was 
lethal to two mice within 48 hours. The reactants were mixed and 
allowed to stand at room temperature for 30 minutes.
Groups of two mice were used, one for each dilution to be 
tested. Each mouse received 1 ml of the toxin:antitoxin mixture. 
A positive control was carried out using the toxin and dilutions of 
an antiserum of known antitoxic activity. Dilutions of normal pig 
serum and toxin provided a negative control. The mice were 
observed for 48 hours and the results were recorded.
Mouse protection tests. Mice were immunised in order to test 
the antigenicity of the adjuvanted crude alpha toxoid and the 
adjuvanted whole culture bacterin prepared as described above. 
Groups of five mice were inoculated sub cutaneous ly with 0.5 ml of 
dilutions of the crude toxoid or the whole culture bacterin. A 
second immunisation using the same dilutions was given 14 days 
later. Fourteen days after the second immunisation the mice were 
challenged intraperitoneally with 0.5 ml of a C.perfringens type A 
supernatant culture containing 16 M.L.D/ml. The animals were kept 
under observation for 48 hours and the number of animals which died 
was recorded.
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Neutralisation of haemolysis. Serum neutralisation of 
specific amounts of haemolysin activity of alpha toxin was used to 
determine the antitoxin content of sera. Serial doubling dilutions 
of sera to be tested were made in physiological saline solution in 
microtitre plates (Becton, Dickinson and Co.). To each of the 
wells in the series of dilutions, 60 pi of toxin containing 64 
sheep erythrocyte haemolytic units were added. A haemolytic unit 
was the reciprocal of the highest dilution of the toxin which 
caused a complete haemolysis of a one per cent erythrocyte 
suspension. The mixture was allowed to stand at room temperature 
for 30 minutes then 60 pi of a one per cent suspension of washed 
sheep erythrocytes in physiological saline solution was added to 
each well. The reactants were mixed and placed at 37°C for one 
hour, and then the microtitre plates were placed at 4°C for 18 
hours. Specific neutralisation of toxin was achieved with 
standardized antitoxin for each titration. Reciprocals of serum 
dilutions neutralising 64 haemolytic units were considered as, the
♦r
anti-haemolytic levels of assayed serum samples.
5. PIG EXPERIMENTAL STUDIES
Two types of study were carried out. In the first, 
hysterectomy-derived colostrum-deprived (HDCD) animals were 
infected and maintained for some days for observation. In the 
second both conventional and HDCD piglets were anaesthetised and 
gut surgery was performed.
(a) Source and maintenance of animals
(i) Hysterectomy-derived, colostrum-deprived piglets
The hysterectomy-derived, colostrum-deprived piglets were 
produced and reared by the general methods described by Betts et 
al. (1960). Sows were obtained from the Veterinary School Farm at 
Cochno and were of National Pig Development High Health stock.
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Hysterectomy was carried out on the 112th day of pregnancy. 
After stunning the sow electrically, the whole uterus was removed 
aseptically into an antiseptic solution in a large bin. The 
piglets were removed from the uterus on a disinfected operating 
table. The umbilical cords were clamped (Piglet umbilical clamps, 
Veterinary Drug Co. York) after respiration was established.
Hysterectomy-derived piglets thus produced were retained, for 
gut loop inoculation studies in a clean but not sterile environment 
at 35°C, and those intended for infection studies were placed in a 
clean, non-sterile box lined with sterile paper and moved to a 
formalin fumigated loose box containing racks of 9 cages and heated 
by electricity and gas to a constant temperature of 35°C. The 
piglets were placed in groups of 2 animals per cage and arranged in 
the racks according to the experimental protocol (see Chapters 3, 4 
and 6). All piglets were fed on evaporated tinned full cream milk 
(Fine Fare Ltd.), diluted as appropriate with tapwater. The 
feeding started about 2 hours after delivery with 20 ml diluted 
milk. The piglets were fed 3 times per day. Water was available 
ad libitum. The feeding was supplemented with vitamins (Abidec 
Multi-vitamins, Park Davis Ltd.) for the first three days of life. 
After each feed, the feeding trays were washed in a solution of 
Chloros (10 per cent alkaline sodium hypochlorite, I.C.I. Ltd.) and 
then rinsed in water. The milk fed was gradually increased in 
amount to 50 ml at each feed. Animals were individually identified 
using skin marks and cage numbers.
(ii) Conventional newborn piglets
Two newborn piglets were obtained from the Cochno herd (Farm 
2) and were segregated from the sow before they were thought to 
have ingested colostrum. The animals were placed in clean boxes as 
were the hysterectomy-derived piglets, and maintained at 35°C until 
required.
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(b) Infection studies with Clostridium perfringens type A and
its products
A total of 3 experiments was carried out according to the 
protocols described in Chapters 3, 4 and 6. Control animals were 
housed in separate cage racks in the same room and negative 
controls were handled first during feeding and sampling 
procedures.
(i) Sampling procedures
Clinical signs including body condition, skin colour and 
faecal consistency were recorded in all 3 experiments. Rectal 
temperatures were recorded only in the experiment described in 
Chapter 4 (Experiment 2). Morbidity and mortality were recorded.
Rectal faecal samples were taken daily using cotton-tipped 
swabs with Amies charcoal transport medium and the samples examined 
by the procedures outlined in Section 2 of this chapter.
(ii) Inoculation procedures
Some pigs were protected using sterile immune products given 
by parenteral injection into the peritoneum and some by oral dosing 
with the product prior to the first feed to avoid the closure 
phenomenon. The amounts of immune products given and its identity 
are given in the appropriate chapters. Infection was always oral 
and measured volumes of the culture were given before feeding which 
followed 15-30 minutes later.
(iii) Post-mortem examinations
These were performed as described in Section 2 of this 
chapter.
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(c) The intestinal inoculation of anaesthetised piglets
Piglets were anaesthetised for the intraluminal inoculation of 
toxins and bacterial cultures into both gut loops and directly, by 
laparotomy into the intestinal lumen.
Both hysterectomy-derived and conventional supposed colostrum- 
deprived piglets were used.
(i) Anaesthesia and analgesia
Anaesthesia was induced with halothane using a conical face 
mask and piglets were maintained on a halothane-oxygen mixture for 
the duration of the surgical procedures. After surgery piglets 
were allowed to recover and given Pentazocine (Fortral, Sterling 
Research) every two hours intramuscularly to maintain analgesia.
(ii) Surgical procedure *
Anaesthetised piglets were tied in a lateral position, the 
skin was washed and disinfected with an iodine-based scrub 
(Pevidine Veterinary Scrub) and a lateral abdominal approach 
carried out. The small intestine was exteriorised and kept moist 
by the use of sterile saline on gauze packs. The region of the 
intestine exteriorised was identified and inoculated with toxin in 
the case of intraluminal inoculation studies or made into gut 
loops. Gut loops were prepared by ligating the small intestine 
with nylon at 10 cm intervals beginning at a point at least 20 cm 
proximal to the ileocaecocolic junction. The prepared loops were 
inoculated.
Inoculated intestines were replaced in the abdominal cavity 
and the cavity closed with nylon sutures.
(iii) Observation period
Recovered animals were observed for 12 hours and given intra-
m i
peritoneal injections of saline at hourly intervals to counter
dehydration. Clinical signs which developed during this period 
were observed. At the end of the period the animals were killed by
the intracardiac injection of pentobarbitone sodium.
(iv) Post-mortem examination
Animals were opened immediately after death and the appearance 
of the intestine recorded. Each ligated loop was examined 
externally checking for fluid accumulation, then each loop was slit 
lengthwise for examination of the contents. Segments of the loops 
were preserved in 10 per cent neutral buffered formol saline and 
also kept frozen at -70°C for immunofluorescence studies. The 
intestines inoculated intralumenally were examined by similar
procedures.
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CHAPTER 3
INITIAL STUDIES OF THE DISTRIBUTION OF CLOSTRIDIUM PERFRINGENS 
TYPE A IN PORCINE GASTROINTESTINAL DISEASE AND THE EXPERIMENTAL 
REPRODUCTION OF DISEASE IN PIGLETS USING A PURE CULTURE
1. INTRODUCTION
The studies described in this chapter comprised an initial 
survey of pig diagnostic material to confirm the work of Olubunmi 
(1982) who had found C.perf ringens type A to be common in the 
faeces and intestines of pigs with enteritis. This initial survey 
provided a number of isolates of C.perfringens type A for further 
study. One of these was used to infect hysterectomy-derived, 
colostrum-deprived pigs in order to test the pathogenicity of the 
isolate for pigs. *"
2. INITIAL SURVEY OF THE INCIDENCE AND DISTRIBUTION OF
C.PERFRINGENS TYPE A IN DIAGNOSTIC MATERIAL FROM PIGS
(a) Material surveyed
The material surveyed in this study comprised that submitted 
for diagnosis to Glasgow University Veterinary School from Farms 1, 
2 and 3 and from other sources and material submitted to Leeds 
Veterinary Investigation Centre (Chapter 2, Section 1). It 
consisted of faecal samples and dead piglets. More than 1 sample 
(whether faecal or carcase) was submitted in most cases and each 
submission was examined in detail. The details of the submissions 
are given in Table 6. All' samples in this survey were from 
diarrhoeic animals.
(b) Methods used
The methods used in the survey have been described in detail 
in Chapter 2, Sections 1, 2 and 3.
TABLE 6
Samples examined in the initial survey; 
farm details and history
Submission
number
Farm
number
Number of 
samples
Age of animals 
affected
Nature
Carcase
of sample 
Faeces
1 1 4 2 weeks +
2 3 4 1 week +
5 3 weeks +
3 1 6 4-7 days +
4 3 3 3 days +
5 2 2 3 weeks +
1 6 days +
3 1 day +’
6 D.M.L. 2 3 months +
7 2 3 3 days +
8 D.M.G. 1 1 week +
9 2 3 2-5 days +
10 D.M.G. 4 2 weeks +
11 1 2 3-5 days +
12 D.M.G. 4 5-7 days +
13 D.M.G. 1 5 days +
14 D.M.G. 4 2 weeks +
15 2 ’ 3 2-3 days +
16 1 3 2 weeks +
17 2 2 3 days +
D.M.L. = Diagnostic Material from Leeds Veterinary Investigation 
Centre
D.M.G. = Diagnostic Material from Glasgow University Veterinary 
School
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(c) Results
C.perfringens was isolated from 30 of 60 samples. The results 
are given in Table 7. Positive samples were identified in 11 of 
the 17 submissions. The pigs concerned were aged from 2 days of 
age to 3 months of age.
Isolates of C.perfringens obtained in this survey and stored 
for further study were numbered in order of their isolation (Table 
7). One colony was picked from each plate and stored as described 
in Chapter 2.
The other bacteria isolated are indicated in Table 7. 
Campylobacter coli was isolated from 8 samples from diarrhoeic pigs 
(Submisions 1, samples 1, 2, 3 and 4; Submissions 5, samples 26 and 
27; Submission 11, samples 42 and 43). None of these samples 
yielded C.perfringens. The organism was not found in profuse 
culture in any case. However, as no other potentially pathogenic 
agent was found, the conditions observed were correlated with the 
presence of this bacterium. p-haemolytic E.coli were isolated in 
profuse numbers from 15 animals of 2 days to 3 months of age. It 
was isolated from 5 of the 17 submissions. It was present both in 
the presence of C.perfringens (Submission 9) and in its absence 
(Submission 10). None of the other bacteria isolated: non-
haemolytic Escherichia coli; Streptococcus spp.; Clostridium spp.; 
Bacillus spp.; Proteus spp.; Peptostreptococcus spp.; Bacteroides 
spp.; Fusobacterium spp.; Lactobacillus spp.; Staphylococcus spp.; 
Pseudomonas spp.; Corynebacterium spp.; Sarcina spp., were 
considered significant and no protozoa or viruses were demonstrated 
in these samples.
(i) The C.perfringens isolates
Twenty seven of the 30 isolates of C.perfringens were 
identified as belonging to type A and 3 isolates were identified as 
belonging to type C. These were all isolated from the same 
submission, Submission 7 and were recovered from all 3 samples.
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TABLE 7
Results of the survey
Submission Sample number C.perfringens Other agents
number and type isolated demonstrated
1 1 (F) - B, c, E, N
2 (F) - B, c, E, N
3 (F) - B, C, E, N
4 (F) B, C, E, N
2 5 (F) + B, C, K
6 (F) + B, C, K
7 (F) ++ B, c, E, K
8 (F) ++ B, c, E
9 (F) - B, C, K, L
10 (F) - B, c, E, L
11 (F) - B, c, I, L
12 (F) - B, E, L
13 (F) - B, c, E, I, K, L
3 14 (F) + B, c, E, F, H, I
15 (F) - B, c, E, I, K
16 (F) - B, c, E, F
17 (F) ++ B, c, E, F, H, I, K
18 (F) - B, c, E, F
19 (F) - B, c, I, K
4 20 (c) ++ B, c, I
21 (C) ++ B, c, I
22 (c) ++ B, c, I
5 23 (F) - A, B, c, H, I, L
24 (F) - A, B, c, H, L
25 (F) - B, C, H, I
26 (F) - B, c, E, K, N
27 (F) - B, c, E, I, N
28 (F) - B, c, E, K
TABLE 7 (Continued)
Submission Sample number C.perfringens Other agents
number and type isolated demonstrated
6 29 (F) + A, B, E
30 (F) ++ A, B, E, M
7 31 (C) ++* B, E, I, K, L
32 (C) ++* B, C, E, K, L
33 (c) ++* B, E, I, L
8 34 (c) + B, F, J, K , L
9 35 (c) + A, B, c, D, F, G, M
36 (c) ++ A, B, c, G, L, M
37 (C) ++ A, B, c, D, F, L
10 38 (F) - A, B, E, F, K, L
39 (F) - A, B, F, I, I.
40 (F) - A, B, E, F, I, L
41 (F) - A, B, E, F, I, K
11 42 (c) - B» c, E, L, N
43 (c) - B, c, E, L, M, N
12 44 (c) + B, c, E, I, L
45 (c) ++ B, E, H, I, L
46 (c) ++ B, C, E, H, I, L
47 (c) + B, C, E, H, I, L
13 48 (c) - B, c, E, 0
14 49 (F) - A, B, E, H, L
50 (F) - A, B, c, E, H
51 (F) - A, B, c, E, L
52 (F) - A, B, E, H, L
15 53 (F) + B, c, E, I, L
54 (F) ++ B, c, E'
55 (F) + B, C, L
16 56 (F) ++ B, c, E, M
57 (F) + B, C, E, H, I, J
58 (F) .++ B, c, E, H, J, L
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TABLE 7 (Continued)
Submission Sample number C.perfringens
number and type isolated
Other agents 
demonstrated
17 59 (C)
60 (C)
+
+
B, C, F, L 
B, C, I, L
(F) = faeces (C) = carcase
Number of C.perfringens colonies in horse blood agar plates 
+ = 1-8 colonies. ++ = more than 8 colonies.
++* = C.perfringens type C.
A = 0-haemolytic E.coli 
B = Non-haemolytic E.coli 
C = Streptococcus spp.
D = Peptostreptococcus spp. 
E = Bacillus spp.
F = Clostridium spp.
G = Corynebacterium spp.
H = Proteus spp.
I = Bacteroides spp.
J = Fusobacterium spp. 
K = Lactobacillus spp.
L = Staphylococcus spp. 
M = Pseudomonas spp.
N = Campylobacter coli 
0 = Sarcina spp.
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Of the 27 C.perf ringens type A isolates, 25 were haemolytic 
C.perfringens type A, and 3 were non-haemolytic C.perfringens type 
A.
C.perfringens type A was presumptively identified in primary 
cultures by its morphology and haemolysis pattern. Double zones of 
haemolysis were characteristically produced on horse blood agar 
plates (Fig. 5). Non-haemolytic C.perfringens type A was 
recognised by its colonial morphology. The organism was further 
tested for its biochemical reactions, and the identity of the 
organism as Clostridium perfringens type A confirmed by the methods 
described in Section 2.
(ii) Clinical signs associated with the isolation of 
C.perfringens in the absence of other obvious pathogens
Eight submissions and 25 samples yielded C.perfringens as the 
only potential pathogen to be identified (Submissions 2, 3, 7,
8, 12, 15, 16, 17). In all cases in which large numbers of
colonies of C.perfringens type A were isolated alone, the animals 
had a history of diarrhoea and the majority of animals were aged 
one week or less. The faeces of the piglets were yellowish to 
brownish and creamy in consistency (Fig. 6).
The bodily condition of the pigs ranged from poor to fair, at 
the time of examination. The flanks of most of the live and dead 
piglets were hollow and the hindquarters were stained with faeces 
(Fig. 7). In the case of Farm 1, a history of successful treatment 
of the diarrhoea by the use of parenteral penicillin injections was 
also available.
The three cases in Submission 7 from which C.perfringens type 
C was isolated were typical of C.perfringens type C disease in that 
the piglets had died suddenly or after a brief period of blood 
stained diarrhoea by 3 days of age.
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FIG. 5: C.perfringens type A colonies isolated from sample 7. 24
hour primary isolation culture on horse blood agar.
Note the double zone of haemolysis around the colonies (arrow).
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FIG. 6: Piglet with diarrhoea (sample 7) from which C.perfringens
type A was isolated in profuse culture. Note the bodily condition 
of the animal (arrow).
FIG. 7: Perineal region of a diarrhoeic piglet (sample 17) 
from which C.perfringens type A was isolated in profuse culture. 
Note the staining of the hindquarters with faeces.
111
Post-mortem findings associated with the isolation of
C.perfringens in the absence of other pathogens
Five submissions consisted of carcases from which no other
pathogenic organisms were isolated (Submissions 4, 7, 8, 12 and
17). The 3 piglets in Submission 7 were cases of C.perfringens
type C enteritis and were typical of that disease. The carcases
were pale, in fair bodily condition and slightly decomposed.
Blood-stained faeces were present on the perineum and more could be
expressed from the rectum. The gross post-mortem findings were
SetArQz..-- ifi the small intestine, the serosal surface of which was
dark red (Fig. 8). The large intestinal serosa was less severely
affected. The intestinal contents were blood stained and the small
intestinal mucosa haemorrhagic. Large numbers of Gram-positive
bacteria resembling C.perfringens were seen in smears made from
these contents. C.perfringens type C was isolated from the regions
of the gut shown in Table 8. No histological examination was
. ^
performed.
The remaining 4 submissions contained the carcases of 10 
animals with the following pathological features.
Affected animals were aged 3 days to 1 week. The bodily 
condition ranged from poor to fair with hollowed flanks and 
hindquarters stained with creamy or brown faeces. Gross changes 
were confined to the gastrointestinal tract (Fig. 9).
The stomach was either empty or half-filled with feed. The 
changes seen in the gastric mucosa ranged from slight localised 
hyperaemia to moderate congestion in some.
The small intestine was often distended with fluid contents, 
and the serosa was usually congested to a variable extent. Changes 
were least obvious in the duodenum in which the contents were fluid 
and often normal in appearance; some cases presented a mild 
congestion of the mucosa. The contents of the jejunum were fluid 
and on occasions, contained small particles of necrotic material. 
The mucosal surface was congested in all cases and haemorrhagic in 
a few cases. Villi were usually reduced in height and occasionally
TABLE 8
Sites from which C.perfringens was isolated in animals 
examined at post-mortem and the abundance of colonies
Submission Sample Site of isolation
number number Stomach Duodenum Jej unum Ileum Caecum Colon
4 20 + ++ ++ ++ ++ +
21 - + ++ ++ ++ +
22 - + ++ ++ ++ +
7 31* - - ++ ++ + +
32* - + ++ ++ ++ +
33* - - ++ ++ + +
8 34 + + + + + *• +
12 44 - + + + + +
45 + ++ ++ ++ + +
46 + + + ++ ++ +
47 - + + + + +
17 59 - - + + + -
60 + + + + +
Number of C.perfringens colonies in horse blood agar plates.
- = no colonies detected
+ = 1-8 colonies
++ = more than 8 colonies
* = isolation of C.perfringens type C
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FIG. 8: Gross appearance of the abdominal viscera of a piglet
from which C.perfringens type C was isolated (sample 32).
Note the reddened small intestine (arrow).
114
FIG. 9: Gross appearance of the intestine of a piglet (sample 21)
from which C.perfringens type A was isolated in profuse culture. 
Note distension and congestion of the small intestine (arrow).
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covered with flakes of fibrinous or necrotic material. The ileum 
was similar in appearance although the contents differed slightly 
in that they contained gas bubbles and were foamy in appearance. 
The mucosal appearance resembled that of the jejunum.
The large intestinal contents were fluid and bulky in some 
cases while in others they were pasty and adherent to the mucosal 
surface. The mucosal changes varied from slightly generalised 
congestion to localised areas of hyperaemia and pinpoint 
haemorrhages.
The mesenteric blood vessels were in most cases congested and 
a variable degree of enlargement and congestion was seen in the 
mesenteric lymph nodes.
In the few cases (Submissions 4, 8, and 17) that
histopathology was carried out, the histological changes were most 
pronounced in the small intestine, particularly in the jejunum and 
ileum. In every case the mucosa was congested and villi slightly 
shortened. An excess of mononuclear cells and polymorphs was 
present in the lamina propria. Changes in the caecum and colon 
were less apparent. The mucosal surface was intact in most cases. 
Fibrin and cell debris could be seen on the lumenal surface of the 
epithelium. In some cases there was slight congestion of blood 
vessels of the lamina propria.
In Gram-stained smears made from the small intestinal 
contents, large numbers of Gram-positive stout rods were seen. 
Large numbers of colonies of C.perfringens type A were isolated 
from the mucosa of the duodenum, jejunum and ileum of some 
animals. The organism was isolated less commonly from the gastric 
mucosa but was recovered in small numbers from the large intestinal 
mucosa of most animals in which it was present (Table 8). It was 
never recovered from sites outside the gastrointestinal tract.
In all cases C.perfringens type A was accompanied by other 
bacteria such as non-haemolytic E.coli, faecal streptococci,
116
Bacillus spp., Bacteroides spp. and Lactobacillus spp. as the most 
common species isolated. In certain cases, however C.perfringens 
type A colonies clearly outnumbered those of other bacterial 
species.
3. EXPERIMENTAL INFECTION OF HYSTERECTOMY-DERIVED, COLOSTRUM-
DEPRIVED PIGLETS WITH CLOSTRIDIUM PERFRINGENS TYPE A ISOLATE 7 
(EXPERIMENT 1)
(a) Experimental design
Five HDCD piglets 8 days of age produced by the methods 
described in Chapter 2 were available for this study. They were 
housed individually in a block of 6 cages in the same rack and 
numbered U1-U5. Two animals were kept as uninfected controls U1 
and U2, and the other 3 were infected.
Isolate 7, obtained from a case of C»perf ringens type A 
enteritis, was used in this study. It had been cloned and stored 
in cooked meat medium for 8 weeks. It was passaged twice on horse 
blood agar prior to use (Fig. 10). It was then subcultured into a 
200 ml bottle containing cooked meat medium enriched with glucose 
and calcium chloride as described in Chapter 2. The culture was 
incubated at 37°C for 16 hours. Viable cell counts present in the 
inoculum were determined according to the method of Miles and Misra 
(1938).
5 ml of inoculum containing approximately 3.0 x 10^  
organisms/ml were given to each piglet after it had been fasted for 
18 hours.
After an observation period of 8 days the piglets were killed 
and post-mortem examinations were carried out. The methods used 
for clinical, bacteriological and pathological examination are 
described in Chapter 2.
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FIG. 10: Pure culture of C.perfringens type A (isolate 7) used for the
experimental infection of hysterectomy-derived, colostrum-deprived piglets 
(Experiment 1). 24 hour culture on horse blood agar.
Note the double zone of haemolysis around the colonies.
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(b) Results
(i) Clinical findings
Changes in faecal consistency were noted in all 3 infected 
piglets within 24 hours of inoculation. Softening of the faeces 
was observed. 48 hours post-infection piglet U5 developed 
diarrhoea which was profuse, creamy-yellowish in colour and stained 
the hindquarters of the piglet. Piglet U3 developed diarrhoea at 
72 hours post-infection, whereas diarrhoea was not observed in 
piglet U4 until the 4th day post-infection. The faecal changes 
persisted in all the 3 piglets until the end of the observation 
period. The faecal changes are summarised in table 9.
The infected piglets were weak and in poor bodily condition. 
None of the clinical signs were observed in the control piglets.
(ii) Bacteriological examination of rectal swabs
C.perfringens type A was isolated in profuse culture from the 
rectal swabs of the infected animals from the first day after 
inoculation. The organism was isolated from the control U1 from 
the second day of experiment and from control U2 from the sixth 
day, but few colonies were detected in the cultures from faecal 
swabs of these animals (Table 9).
(iii) -Pathological findings
Pathological changes were similar in all infected animals. 
The general bodily condition was poor. The eyes were sunken and 
the flanks hollowed. The perineal region was matted with dry 
crusts of faeces (Fig. 11).
The thoracic organs were normal. In the abdominal cavity, the 
liver was pale in all infected animals. Spleen and kidneys were 
normal. The stomachs of these piglets were distended with milk and 
some gas. The gastric mucosa of piglets U3 and U5 were slightly
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TABLE 9
Faecal consistency changes of HDCD piglets following the 
inoculation of pure cultures of C.perfringens type A, 
and isolation of the organism from faecal swabs
Piglet Infected Day of experiment
No. 0 1 2 3 4 5 6 7 8 9
U1 N N N N N N N N N N
- - + + + + + + + +Sa
U2 N N N N N N N N N N
- - - - - - + + + +Sa
U3 + N S S D D D D D D D
+ + + + + + + + +Sa
U4 + N s s S D D D D D D
- + + + + + + + + +Sa
U5 + N s D D D D D D D D
— + + + + + + + + +Sa
N = normal faeces 
S = soft faeces 
D = diarrhoea
- = no C.perfringens type A isolated
+ = C.perfringens type A isolated
Sa = sacrificed
congested while that of piglet U4 presented a normal appearance. 
The gastric serosal surface of piglet U5 and the lower portion of 
the duodenum to the mid-jejunum appeared reddened from the serosal 
surface; in piglet U4 the serosal surface of the lower jejunum to 
the mid-jejunum appeared pale. The duodenum of piglet U5 contained 
fluid with some gas and the mucosal surface was mildly congested. 
Piglet U3 did not have gas in the duodenum, its mucosa was slightly 
congested. The duodenal mucosal surface of piglet U4 appeared
normal. Jejunal contents of piglets U3 and U5 were frothy and 
brownish in colour (Fig. 12). Necrotic debris could be seen on the 
mucosa which was congested. The jejunal mucosa of piglet U4 was 
slightly congested. The ileal contents of all 3 animals were fluid 
with some necrotic material, some mucoid tags were seen on the 
mucosa which was congested and inflamed. Pinpoint haemorrhages 
were present in some areas of the mucosal surface of the ileum of 
all animals.
The serosal surface of the large intestine in all infected
piglets was reddened with congested areas (Fig. 13) which in piglet 
U3 were present throughout most of the entire large intestine
(Fig. 14). The mucosa of the caecum and colon of all infected
animals was extensively congested with some pinpoint haemorrhages; 
the contents were brownish and pasty with some mucoid tags. The
mesenteric lymph nodes were enlarged and mildly congested.
Control piglets U1 and U2 were in good bodily condition, their 
gastrointestinal’ tract, mucosa and contents were all normal in 
appearance.
(iv) Bacteriological findings
Colonies of C.perf ringens type A were isolated in large 
numbers from the mucosa of the stomach, duodenum, jejunum, ileum, 
caecum and colon of piglet U3. Isolations of the organism from
stomach, colon and caecum of piglets U4 and U5 were fewer in
number. Fewer colonies of the organism were isolated from the
control piglets (Table 10).
FIG. 11: Perineal region of piglet U3, 9 days post-inoculation
with C.perfringens type A.
Note the soiling of the perineum with faeces and the poor 
condition of the piglet. -
FIG. 12: Segment of jejunum and contents of piglet U5, 9 days
post-inoculation with C.perfringens type A.
Note the congestion and the frothy contents.
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FIG. 13: Macroscopic appearance of the serosal surface of the
large intestine of piglet U 5 , 9 days post-inoculation with
C.perfringens type A.
Note the congestion of the serosa (arrow).
FIG. 14: Macroscopic appearance of the serosal surface of the
large intestine of piglet U3, 9 days post-inoculation with
C.perfringens type A.
Note the extensive areas of congestion.
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TABLE 10
Sites from which C.perfringens type A was isolated from 
the HDCD piglets of Experiment 1 examined at post-mortem 
following inoculation with pure cultures of the organism
Piglet Infected Site of isolation
No. Stomach Duodenum Jejunum Ileum Caecum Color
U1 + N.T. N.T. +
U2 - - - - N.T. N.T. +
U3 + ++ ++ ++ ++ ++ ++
U4 + + + ++ +4- + +
U5 + + + ++ ++ + +
= No colonies of C.perfringens type A isolated.
+ = Between 1 and 8 colonies of C.perfringens type A isolated.
++ = More than 8 colonies of C.perfringens type A isolated.
N.T. = Not tested.
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Gram-stained smears prepared from the mucosa of these organs 
contained Gram-positive rods with no demonstrable spores, with 
morphology similar to that of C.perfringens type A. A few 
Gram-positive rods with this morphology were found in the smear 
from the jejunal mucosa of piglet Ul; they were absent from the 
mucosal smears of other organs and in all organs of piglet U2.
Other bacteria were also isolated. They were non-haemolytic 
E.coli, Streptococcus spp. and Bacillus spp. isolated from 
different sites of both infected and control piglets.
(v) Virological and parasitological findings
No virus particles were demonstrated in negatively stained 
preparations from the intestinal contents of all animals when 
viewed by electron-microscopy.
No e v i d e n c e  o f  C r y p t o s p o r i d i a  was fo u n d  i n  m u c o s a l  s m e a r s  o f  
d i f f e r e n t  o r g a n s  o f  i n f e c t e d  and c o n t r o l  p i g l e t s .
4. DISCUSSION
(a) The initial survey
(i) The limitations of the survey
The initial’ survey was not extensive. Only 17 submissions 
were examined comprising 60 animals or samples. The material was 
presented with little or no history. This meant that treatments 
given to the animals prior to sampling were not recorded and may 
have eliminated some Clostridia or perhaps other bacterial 
pathogens. The samples submitted were often submitted with no 
clear history of the length of time since they were taken or since 
the animal died. Most piglets submitted entire were from farrowing 
houses where the ambient temperature is high and decay can be 
rapid. It is known (Prevot et al., 1967) that C.perfringens can 
multiply rapidly after death and this type of delay may have 
affected the results obtained.
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In this survey full examination for viruses and parasites was 
not carried out in every case. The examinations carried out for 
Cryptosporidia would not have revealed coccidial oocysts and too 
little histology was carried out for accurate diagnosis to have 
been made by that means. No rotaviruses were demonstrated by the 
direct E.M. examination of faeces in this study but the detection 
of coronaviruses would have been unlikely using this method. Full 
characterisation of the E.coli isolates, was not carried out as the 
study concentrated on C.perfringens. Even the isolation of this 
organism might have been improved by the use of specific media such 
as tryptone-sulphite-cycloserine agar.
(ii) C.perfringens isolations
In this study C.perf ringens could be isolated from 30 of the 
60 samples examined. The use of non-selective media such as horse 
blood agar inevitably leads to the masking of organisms present in 
small numbers by those in larger numbers and it is likely that 
C.perfringens is present more often than appears in the present 
survey. Thus, the lower than expected isolations of C.perfringens 
type A may in part be accounted for by the masking of these 
organisms in mixed populations. If suitable selective media* such 
as tryptone-sulphite-cycloserine agar as employed in the studies of 
Chapter 6, had been employed, it is likely that a higher rate of 
isolation would be achieved for C.perfringens. However, a 
relationship may exist between the numbers of C.perfringens present 
in the gastrointestinal tract and the number of colonies found in 
non-selective media such as horse blood agar. Thus, abnormally 
high numbers in the gut might be indicated by an increase in the 
number of colonies of the organism isolated on blood agar.
The 30 positive cases appeared to contain 3 cases of 
C.perfringens type C. All these cases were from the same 
submission and C.perf ringens type C was not demonstrated in any of 
the other 27 positive cases. Of these 27 cases from which 
C.perfringens type A was isolated, 2 non-haemolytic isolates were 
identified and the remaining 25 were haemolytic. As haemolytic 
colonies are more obvious on isolation plates other non-haemolytic
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isolates may have been present but would not have been detected if 
they were present in smaller numbers, Haemolytic colonies were 
much more obvious when present in low numbers. This finding 
corresponds with what is reported to be the case for C.perf ringens 
type A isolated from humans in which haemolytic strains are far 
more frequently isolated than are non-haemolytic strains 
(Skjelkvale et al., 1979). There are no reports about the 
incidence of haemolytic and non-haemolytic strains from the pig.
The techniques used to confirm the identity of these organisms 
as C.perf ringens type A were biochemical and cultural. No other 
toxins apart from alpha toxin were found in cooked meat filtrates 
and this technique was considered to confirm their identity as 
C.perfringens type A.
It is of interest that no C.perfringens spores were recorded 
from smears made in this study. Re-examination of those smears 
still available suggests that few if any were present. None of the 
cultures obtained were seen to sporulate at the time but in further 
studies using these isolates (Chapter 6) it was clear that some 
isolates were capable of sporulating.
(iii) Significance of the C.perfringens isolations
It has been reported that an increase in the numbers of 
C. perf ringens type A in faeces is related to outbreaks of 
diarrhoea. In ’ humans, faeces of patients suffering diarrhoea 
contained significantly higher numbers of C.perfringens type A than 
healthy individuals (Sutton, 1966). Neonatal diarrhoea of piglets 
was associated with an increase of the number of C.perfringens type 
A in intestinal contents of diseased animals (Secasiu, 1984). All 
the pigs in this series were diarrhoeic, but C.perf ringens was 
isolated from only half the submissions. The possible reasons for 
this isolation from only half the submissions have been outlined 
above. In addition, organisms may have been present during disease 
prior to submission but have disappeared. No counts were carried 
out at this stage and only qualitative results are available.
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The results obtained here (Table 7) resembled those obtained 
by Olubunmi (1982), As in his study, other bacteria such as E.coli 
and Campylobacter coli were identified and other pathogens might 
not have been detected. The clinical signs and post-mortem 
findings in the 28 cases apparently associated with the isolation 
of C.perfringens alone were described in the results above. They 
resemble those described by Olubunmi (1982) and Nabuurs et al. 
(1983). All the animals affected were young, but the majority of 
samples submitted were from pigs aged 1-3 weeks apart from 1 
submission from 3-month old animals (Table 6) and this finding 
can not, therefore, be significant. The clinical signs and 
post-mortem findings associated with C.perfringens type A were 
distinct from those associated with C.perfringens type C and could 
not be confused with those of that disease. Especially noteworthy 
was the loss of condition and the low mortality in C.perf ringens 
type A disease.
The post-mortem findings were described above but certain
features were particularly prominent in all of the 10 animals in 
which, at post-mortem, C.perfringens type A was isolated in profuse 
to moderate amounts. The mucosa of the small intestine was 
congested to a variable extent. Lesions were more prominent at 
jejunal and ileal level. The changes were milder in the mucosa of 
the large intestine. In most cases the jejunum and ileum appeared 
distended with fluid contents and gas. Villi were usually reduced 
in height but not destroyed. The mucosa of the large intestine was 
usually congested. The changes were complicated by the rapid onset 
of decay in some of these animals.
Decay meant that few samples were taken for histopathology and 
in those few cases only mild changes were recorded, possibly
because the changes develop rapidly (Olubunmi, 1982). In none of
the samples examined here were the lesions as extreme as those he
showed in experimentally-infected piglets killed in extremis. Some 
villous atrophy and congestion was noted, and villous atrophy was 
clearly present in gross specimens not processed for histology.
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The C.perfringens type A was isolated from the intestines 
of 10 piglets and the distribution of the organism was shown in 
Table 8. C.perf ringens type A was isolated from the stomach of 
4 piglets and from the duodenum of 9 piglets. In humans, except 
under disease conditions, C.perfringens type A is not found in the 
stomach or duodenum, while it is commonly isolated from the ileum 
(Vince et al. , 1972). C.perf ringens type A is not present in the 
stomach and duodenum of the healthy piglet (Ducluzeau, 1985). The 
presence of the organism in these sites in piglets in this survey 
indicates abnormality and may be associated with diarrhoea. It is, 
however, possible that these results may have been affected by
post-mortem change. Although this could have happened within the 
gut it clearly did not happen in the carcase as a whole for no C. 
perfringens type A was isolated from sites other than the gut in 
this series.
The isolation of C.perfringens type A from the samples
examined in this survey suggests that, both on the evidence
presented and that from the literature, C.perf ringens type A was 
associated with both diarrhoea and enteric lesions in the animals 
surveyed.
(b) Experimental reproduction of C.perfringens type A 
enteritis in piglets
(i) The reproduction of clinical disease
C.perfringens type A isolate 7 appeared to cause a syndrome in 
the inoculated 8-day old hysterectomy-derived, colostrum-deprived 
piglets similar to that seen in the field and that described by
Nabuurs et al. (1983). Profuse creamy diarrhoea was noted in the 
inoculated animals. All three infected piglets survived to the end 
of the period of observation but remained in poor condition with 
diarrhoea throughout this period. Their survival was in contrast 
to the findings of Olubunmi (1982) who used slightly younger 
piglets.
129
The incubation period appeared to be 24-48 hours (Table 9). 
Softening of the faeces was observed in all piglets 24 hours 
post-inoculation and frank diarrhoea developed in piglet U5 24
hours later; piglets U3 and U4 presented diarrhoea until 48 and 72
hours, respectively, after the appearance of first changes in
faecal consistency. At the end of the period of observation the 
piglets were emaciated, with hairy coats and soiled hindquarters. 
The control piglets remained in good condition until killed and 
passed normal faeces, providing a marked contrast with the 
inoculated animals.
The duration of the diarrhoea (6-7 days) was similar to that 
found by Nabuurs et al. (1983) although the animals in this study 
were killed while still diarrhoeic.
(ii) The relationship between C.perfringens type A and 
the clinical signs
C.perf ringens type A was recovered from the faeces of the 
infected piglets within 24 hours of inoculation (Table 9) and was 
found consistently throughout the period of observation denoting 
its establishment in the intestinal tract. The organism was 
isolated from the faeces of the uninfected controls, from control 
U1 from the second day of experiment and from control U2 from the 
sixth day. This fact may be due to an external contamination with 
the organism involving a different strain of C.perfringens type A 
rather than the one used in the experiment, or to a 
cross-contamination involving the same strain used for infection. 
Although precautions were taken to avoid contaminations, 
C.perf ringens type A is so ubiquitous that the maintenance of 
animals free of the organism is only possible under gnotobiotic
conditions. It is possible that the organism was already present 
in the intestine of all piglets prior to the start of the 
experiment, although in numbers undetectable by the techniques 
used. C.perfringens colonies were always detected in considerably 
fewer numbers in the faeces of control piglets than in the infected 
animals, and it may be that the numbers present were too low to 
cause disease.
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(iii) The relationship between C.perfringens type A and 
the post-mortem findings
C.perfringens type A was isolated from the mucosa of the 
stomach and duodenum of all infected animals while the organism 
could not be isolated from these sites of uninfected controls 
(Table 10). From the jejunal mucosa of the inoculated piglets the 
organism was isolated in large numbers while no organisms were 
isolated at this level from control piglet U2 and control piglet U1 
presented significantly fewer colonies of C.perfringens type A than 
the infected animals. As the assessments of the number of 
organisms present was merely qualitative, any association between 
lesions and numbers of organisms cannot be absolute. This is 
particularly the case since post-mortem examination was not carried 
out until 6-7 days after the onset of diarrhoea.
Gross pathological changes apparently attributable to 
C.perfringens type A infection were observed in all infected 
piglets. The lesions were confined to the gastrointestinal tract. 
A correlation between the number of colonies of C.perfringens type 
A isolated and the severity of lesions observed appeared to exist. 
Congestion of the stomach, small and large intestine was more 
apparent in piglet U3 from which larger numbers of colonies of the 
organism were isolated than from the other two infected animals. 
The mucosa of the small intestine, particularly that of the ileum, 
was congested with pinpoint haemorrhages in all infected piglets. 
The mucosa of caecum and colon presented also large areas of 
congestion and pinpoint haemorrhages. The uninfected control 
piglets had no pathological changes in their gastrointestinal 
tracts, in keeping with the low number of C perfringens isolated 
from them (Table 10).
Nabuurs et al. (1983) gave no account of gross pathological 
lesions in their study except the mention of abundant gas in the 
lumen of the small and large intestine. Olubunmi (1982) found more 
severe lesions, with congestion and necrosis in the small intestine 
as well as in the large intestine. His results may differ because
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of the age of the piglets used and because the piglets died early 
in the disease. The lesions described here do not differ 
substantially from those in his surviving piglet.
(c) Conclusions
The results of this survey indicated that C.perfringens type A 
could be isolated in large numbers from cases of diarrhoea in 
piglets. The organism was associated with a syndrome in which 
diarrhoea, loss of condition and pasting of the perineum occurred. 
Mortality was low in contrast to infection with C.perfringens type 
C. The pathological changes found included congestion of the small 
intestine with villous atrophy and necrosis and similar 
inflammatory changes in the large intestine associated with the 
presence of large numbers of C.perfringens type A organisms. 
Twenty seven isolates of C.perfringens type A were stored for 
further examination and one of these, isolate 7, was shown to be 
pathogenic for piglets and to cause an enteritis similar to that 
found in piglets in the survey and described in the literature.
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CHAPTER 4
STUDIES ON THE IMMUNISATION AND PROTECTION 
OF PIGS AGAINST INFECTION WITH C.PERFRINGENS TYPE A
1. INTRODUCTION
The results of the survey presented in Chapter 3 indicated that
C.perfringens Type A was associated with enteric disease in
piglets. This supposition was confirmed in Experiment 1 in which 
one of these C.perf ringens type A isolates, isolate 7 was used to 
reproduce diarrhoea in hysterectomy-derived, colostrum-deprived 
piglets. The literature surveyed in Chapter 1 did not allow any 
clear idea to be formed about the possible mechanism of this 
diarrhoea. In an attempt to study the relevance of various 
fractions of the bacteria and its products, an immunisation study 
was set up and its results assessed by the protection of neonatal 
hysterectomy-derived, colostrum-deprived piglets using sera, 
colostra and milks produced from immunised animals.
This chapter describes the production and testing of the 
antigens in part 2, the assessment of the antibodies produced in 
sows in part 3 and the final protection test in part 4. The 
results are discussed in part 5.
2. PRODUCTION AND EVALUATION OF C. PERFRINGENS TYPE A TOXOID AND
BACTERIN
(a) Production of antigens
(i) Alpha toxin toxoid
This was produced by the methods described in Chapter 2 from 
C.perfringens type A isolate 7 obtained in the survey and shown to
be pathogenic for piglets in Experiment 1.
Assay of the culture supernatant indicated that its mouse 
lethal dose (MLD) was 16 MLD per ml. The toxin titre increased to 
128 MLD per ml after concentration of the supernatant by ammonium 
sulphate precipitation and dialysis against polyethylene glycol.
The antigenicity of the toxin was tested in vitro by 
counterimmunoelectrophoresis using commercial C.perfringens type A 
antiserum. It showed a toxin titre of 1:8 which was increased to 
1:64 by concentration. The concentrated toxin was tested for the 
progress of detoxification daily by the haemolysis test using sheep 
red blood cells described in Chapter 2. Complete absence of 
haemolysis was observed at the 12th day of incubation; 5 mice were 
then inoculated intraperitoneally with the detoxified material and 
kept under observation for 48 hours. This material did not cause 
any symptoms in the inoculated mice. This concentrated toxoid was 
then tested for sterility and found to be sterile.
The toxoti contained 22.9 mg of protein per ml and was combined 
with aluminium hydroxide as an adjuvant as described in Chapter 2. 
The sterility test was repeated and the toxoid was found to be 
sterile.
(ii) Whole culture bacterin
This was prepared by the methods described in Chapter 2. The 
clarified culture contained 3.5 x 10^ colony-forming units per ml 
when counts were performed. Inactivation was carried out as 
described in Chapter 2 and no bacteria could be isolated by the 
14th day after inactivation began. At this stage a safety test was 
performed in 5 mice all of which survived. Sterility tests were 
also carried out and the material found to be sterile. Its protein 
concentration was found to be 73.6 mg of protein per ml and it was 
then mixed with adjuvant as described in Chapter 2. The final 
adjuvanted whole culture bacterin was tested for sterility and 
found to be sterile.
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(iii) Freeze-dried washed cell bacterin
This was prepared by the methods described in Chapter 2 and 
contained 6.0 x 10  ^ colony forming units per ml after washing and 
before inactivation. The efficiency of inactivation was tested 
daily as for the whole culture bacterin and also found to be 
complete within 14 days of inactivation. It was both sterile and 
safe for all 5 mice inoculated. The protein concentration of the 
cell suspension was 96.7 mg protein per ml before freeze-drying.
(b) Potency testing of the 3 antigens
The potency of the freeze-dried bacterin was not tested but 
that of the crude toxoid and the whole culture vaccines was tested 
for potency in rabbits, mice and pigs using the methods and 
schedule described in Chapter 2. IgG, IgM and IgA antibody levels 
against whole C.perfringens cells were detected using the indirect 
immunofluorescence test described in Chapter 2. Serum or **milk 
protein was tested at 5 dilutions, neat, 1:10, 1:100, 1:1,000 and 
1:10,000. Antibody to alpha toxin was detected by counterimmuno- 
electrophoresis and the Nagler reaction methods also described in 
Chapter 2.
(c) Results of potency testing
(i) Mouse protection tests
Mouse protection tests indicated a 100 per cent protection 
against challenge by the immunisation of mice with a dilution of 
the adjuvanted toxoid up to 1:4 and up to 1:2 for the adjuvanted 
whole culture bacterin. Other dilutions of both immunogens offered 
different degrees of protection (Tables 11 and 12).
(ii) Serological responses to the antigens
Immunisation of mice and rabbits either with adjuvanted toxoid 
or adjuvanted whole culture bacterin, elicited a detectable 
serological response which was identical for both groups. IgG
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TABLE 11
Potency testing of concentrated alpha toxin toxoid 
Mouse protection test
Dilutions of Immunisation Challenge toxin Number
toxoid dose (a) dose (MLD/M1) survived (b)
1:2 .5 ml 16 5/5
1:4 .5 ml 16 5/5
1:8 .5 ml 16 4/5
1:16 .5 ml 16 2/5
1:32 .5 ml 16 0.5
non-vaccinated - 16 0/5
controls
(a) Immunised twice subcutaneously at 14 day intervals.
(b) Dead/alive
TABLE 12
Potency testing of concentrated whole culture bacterin 
Mouse protection test
Dilutions of Immunisation Challenge toxin Number
bacterin dose (a) dose (MLD/M1) survived (b)
1:2 .5 ml 16 5/5
1:4 .5 ml 16 4/5
1:8 .5 ml 16 1/5
1:16 .5 ml 16 0/5
1:32 .5 ml 16 0/5
-vaccinated - 16 0/5
controls
(a) Immunised twice subcutaneously at 14 days intervals.
(b) Dead/alive
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titres to C.perfringens type A cells were greater than 1:1,000 
(Fig. 15). Uninoculated control mouse sera were negative (Fig. 16) 
but antibody was detected in neat serum from the uninoculated 
control rabbit. Anti-alpha toxin antibodies were detected in both 
groups by counterimmunoelectrophoresis and by the Nagler reaction 
(Fig. 17); no attempts were made to determine the anti-alpha toxin 
titre (Table 13). No antibody was demonstrated in these tests in 
the uninoculated control sera. Immunisation of pigs with 
adjuvanted toxoid, adjuvanted whole culture bacterin and with 
toxoid-bacterin mixture elicited or enhanced an antibody response 
to C.perf ringens type A cells and to alpha toxin. The pig 
immunised with a mixture of toxoid-bacterin and the non-immunised 
control pig were free from antibody to C.perfringens type A cells 
and alpha toxin prior to immunisation (Table 14). The pigs 
immunised with toxoid and whole culture bacterin had IgG and IGM 
titres of 1:10 against C.perfringens type A cells. No IgA titres 
were detected in the pre-immunisation sera. Only one pig, that 
immunised with whole culture bacterin, had antibody to alpha *toxin 
(titre 1:4) in pre-immunisation serum (Table 15).
All immunised pigs showed production or increase of their 
titres to C.perfringens type A cells and to alpha toxin after the 
first immunisation (Tables 14 and 15). There was a further 
increase of antibody titres after the second immunisation. Slight 
variations in antibody titres among the immunised animals were 
found. The non-immunised pig control developed a low IgM titre to 
C.perfringens type A cells at the last bleeding. The Nagler 
reaction was less sensitive than counterimmunoelectrophoresis for 
the detection of antibodies to alpha-toxin.
3. IMMUNISATION OF PREGNANT SOWS WITH ADJUVANTED TOXOID AND
BACTERIN AND WITH FREEZE-DRIED BACTERIN IN FEED
(a) Experimental design
Ten hybrid sows on Farm 2 were immunised with a subcutaneous 
dose of 5.0 ml of toxoid, bacterin or toxoid-bacterin combined up 
to eight weeks before farrowing, and a second 5.0 ml subcutaneous 
dose three weeks before farrowing (Table 16).
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TABLE 13
Serological response of rabbits and mice immunised with 
adjuvanted toxoid and adjuvanted whole culture bacterin
Species Immunisation Reciprocal of Anti-alpha toxin
IgG titre to C.I.E. Nagler reaction 
C.perfringens 
type A cells
Rabbit (1) 
Rabbit (1)
toxoid
bacterin
Rabbit (1) uninoculated 
control
Mice (6) 
Mice (6) 
Mice (6)
toxoid
bacterin
uninoculated
control
1,000
1,000
1
1,000
1,000
- = absent
+ = present
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TABLE 14
Serological response of pigs immunised with 
adjuvanted toxoid and adjuvanted whole culture bacterin
(a) Reciprocal of antibody titres to C.perfringens type A cells.
Antigen Pre-immunisation 14 days after 14 days after
inoculated first second
immunisation immunisation
IgG IgM IgA IgG IgM IgA IgG IgM IgA
toxoid 1 10 - 10 10 1 100 1,000 1
bacterin 10 10 - 100 1,000 1 100 1,000^ 10
toxoid- - - - 10 100 1 1,000 1,000 1
bacterin
control — — “ “ 10 —
= absent
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TABLE 15
Serological response of pigs immunised with 
adjuvanted toxoid and adjuvanted whole culture bacterin
(b) Antibody titres to alpha toxin (a)
Antigen Pre-immunisation 14 days after 14 days after
inoculated first second
immunisation immunisation
Titre Nagler Titre Nagler Titre Nagler
reaction reaction reaction
toxoid - - 1:4 - 1:16 ±
bacterin 1:4 - 1:16 + 1:32 +
toxoid- — - 1:4 — 1:4 —
bacterin
control
(a) detected by counterimmunoelectrophoresis.
- = absent
+ = positive
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FIG. 15: C.perfringens type A fluorescent cells following
treatment with serum from a mouse immunised with whole culture 
bacterin. Stained using fluorescent rabbit anti-mouse IgG.
(xl200)
p s
FIG. 16: Control preparation for Fig. 15 in which serum from a
non-immunised mouse was used.
Compare the fluorescence in the two preparations.
(xl200)
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*FIG. 17: Nagler reaction on egg yolk agar plate.
Note the absence of the opalescent zone from the half of the plate 
which had been treated previously with the serum of the rabbit 
immunised with C.perfringens type A toxoid (arrow).
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Three of these sows were given freeze-dried bacterial cells 
which were previously mixed at a 10 per cent concentration with 
cornflour, this mixture was administered in the feed in a relation 
of 3.75g per 2,5kg of feed. The sows received this mixture daily 
from eight weeks before farrowing until delivery (Table 16).
Serum samples were taken from the sows before they were 
immunised, before second immunisation and at farrowing time. 
Samples of colostrum were taken from three sows just after
farrowing. Milk samples were taken from eight sows. Colostra and 
milks were cleared of solids by the method described in Chapter 2 
and stored at -20°C until required. Two milks from non-immunised 
sows were used as controls.
(b) Results
Immunisation of pregnant sows with adjuvanted toxoid and
bacterin and with freeze-dried bacterin in feed elicited or 
enhanced an antibody response to C.perfringens type A cells and to 
alpha toxin. Sows 402 and 406 were devoid of antibodies to 
C.perfringens type A cells in their pre-immunisation sera whereas
sows 36 and 93 showed low titres of IgM antibodies; these sows
plus sow 405 were negative for antibodies to alpha toxin in their 
pre-immunisation sera. All other sows presented variable titres of 
antibodies to C.perfringens type A cells and to alpha toxin in 
their pre-immunisation sera. All immunised sows showed a rise in 
their antibody levels after the first immunisation. The second
immunisation increased further the average titre of the immunised 
sows. The milks from two non-immunised sows showed lower titres of 
antibodies to C.perfringens type A cells than those of the 
immunised animals, and were negative to antibodies to alpha toxin.
Results are summarised in Tables 17 and 18.
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TABLE 16
Immunisation of pregnant sows with adjuvanted toxoid and
bacterin and with freeze-dried bacterin in feed
Sow No. Immunisation Days before farrowing
First Second
immunisation immunisation
295 Toxoid 38 23
93 Toxoid 39 24
403 Toxoid 48 33
36 Bacterin 40 25
292 Bacterin 43 28
401 (a) Toxoid-bacterin -
402 Toxoid-bacterin 36 21
406 * Toxoid 57 42
40 * Bacterin 59 44
45 * eToxoid-bacterin 58 43
* Freeze-dried cells administered in feed from first immunisation 
to farrowing
(a) •= Sow immunised but did not farrow.
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TABLE 18
Serological response of sows immunised with adjuvanted toxoid, 
adjuvanted whole culture bacterin and freeze-dried bacterin in feed
b) Antibody titres to alpha toxin (a)
Sow No • Pre­ Before
immunisation second farrowing farrowing In
immunisation in serum in colostrum milk
285 1:4 1:16 1:16 1:32 1:8
93 - 1:8 1:16 1:32 1:8
403 1:8 1:16 1:32 NT 1:8
36 - 1:2 1:4 NT 1:2
292 1:2 1:2 1:8 NT * 1:2
401 1:2 1:8 NT NT NT
402 - 1:4 1:4 1:8 1:2
406 - 1:16 1:16 NT 1:4
40 1:4 1:8 1:16 NT NT
405 - 1:8 1:32 NT 1:4
Control NT NT NT NT -
Control NT NT NT NT —
(a) detected by'counterimmunoelectrophoresis. 
(-) = absent. NT = not tested.
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4. THE PROTECTION OF HYSTERECTOMY-DERIVED, COLOSTRUM-DEPRIVED 
PIGLETS AGAINST INFECTION WITH C.PERFRINGENS TYPE A (EXPERIMENT 
2)
(a) Materials and Methods
(i) Immune products for passive protection
Sera from pigs immunised with alpha toxin toxoid (A) and with 
mixture toxoid-whole culture bacterin (B) described in Section 2, 
and the following pools of milks and colostra from immunised sows 
described in Section 3 were sterilized by gamma irradiation.
Pool C. Milks from sows immunised with toxoid (sows 93, 295, 403).
Pool D. Colostra from sows immunised with toxoid (sows 93, 295).
Pool E. Milks from sows immunised with bacterin (sows 36, 292-).
Pool F. Milk and colostrum from sow immunised with mixture toxoid- 
bacterin (sow 402).
Pool G. Milks from sows which were given freeze-dried cells admin­
istered in feed (sows 405, 406) and toxoid-bacterin 
parenterally.
(ii) Piglets
Twenty-three hysterectomy-derived, colostrum-deprived piglets 
were obtained by the methods described in Chapter 2 and housed in 
the same pen in racks of cages individually or in pairs.
(iii) Experimental design
The piglets were passively immunised two hours after delivery 
by the oral or intraperitoneal routes or both according to the 
schedule given in Table 19.
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TABLE 19
Protection of HDCD piglets against C.perfringens type A 
infection by passive immunisation with colostrum, 
milk or serum from immunised pigs 
Immunisation schedule*
Passive Route and Infection
immunisation quantity
2 - - -
6 - - +
2 A 10 ml i/p 5 ml oral +
2 B 10 ml i/p 5 ml oral +
3 C 10 ml oral +
2 D 10 ml oral +
2 E 10 ml oral +
2 F 10 ml oral +
2 G 10 ml oral +
A = serum from pig immunised with toxoid-bacterin.
B = serum from pig immunised with toxoid.
C = pool of milks from sows immunised with toxoid.
D = pool of colostra from sows immunised with toxoid.
E = pool of milks from sows immunised with bacterin.
F '•= pool of milk and colostrum from sow immunised with toxoid- 
bacterin.
G = pool of milks from sows immunised with freeze-dried bacterin in 
feed and parenteral toxoid-bacterin.
Number of 
piglets
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Two piglets were kept as non-immunised, non-infected controls, 
and 6 piglets as non-immunised, infected controls.
Twenty-two hours after delivery the piglets were challenged 
with the same C.perf ringens type A (isolate 7) used for the 
experiment described in Chapter 3 and grown under the same 
conditions.
Five ml of inoculum containing approximately 1.6 x 10 ^
organisms/ml were given to each piglet after being fasted for 12
hours.
All piglets were examined daily and their appearance, appetite 
and the consistency of their faeces were recorded. Rectal 
temperatures were taken from each piglet daily. Rectal swabs were 
taken daily from all animals and examined for the presence of
C.perfringens type A and other bacteria by the methods described in
*r
Chapter 2.
Blood samples were taken from all piglets at slaughter and the
sera collected and stored at -20°C. These sera were examined for
the presence of antibodies to C.perfringens type A cells and
anti-alpha toxin by the methods described in Chapter 2.
The piglets were sacrificed in the sequence shown in Table 20 
by the methods described in Chapter 2, and post-mortem,
histological and-bacteriological examinations were also carried out 
using the methods described in Chapter 2.
(b) Results
(i) Clinical findings
All piglets were clinically normal and healthy during the 
period prior to infection with the exception of piglets C0+-2 and 
CCH--3 which were weak and underweight. Their faeces were normal 
(Table 20).
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Twelve hours after infection piglet C0+-3 presented diarrhoea 
and was moribund, dying a short time later. No clinical signs were 
seen in the rest of the animals at that time. Twenty-two hours 
after infection all infected, non-immunised control piglets 
developed a profuse diarrhoea, creamy in colour (Table 20). Less 
profuse but similar diarrhoea developed in immunised piglets E-l 
and E-2 and the faeces of piglets A-2 and F-l also became soft and 
yellowish in colour. All other animals, immunised and non-infected 
controls were healthy with normal faeces.
At 36 hours post-infection piglets C0+-2 and C0+-5 were found 
dead. Their hindquarters were soiled with a creamy diarrhoea and 
they were in poor bodily condition.
Forty-eight hours post-infection piglet C0+-4 was found dead 
and piglet C0+-1 was moribund and was sacrificed. Both piglets had 
hollowed flanks. Their coats were hairy, their eyes sunken* and 
they were in poor bodily condition. Their perineums were soiled 
with diarrhoea. The remaining infected, non-immunised piglet C0+-6 
appeared weak and depressed with a profuse diarrhoea. Immunised 
piglets E-l and E-2 were diarrhoeic though not profusely so. 
Piglets F-l and F-2 had soft faeces. All the rest of the animals 
were clinically normal.
Infected, non-immunised piglet C0+-6 presented diarrhoea until 
the fourth day post-infection being weak and depressed then at the 
fifth day post-infection the diarrhoea stopped but the animal 
remained feeble for the remainder of the period of observation. 
The immunised piglets as well as the controls remained healthy and 
passed normal faeces. The changes in the faecal consistency of the 
piglets are summarised in Table 20.
The rectal temperatures of all piglets remained within the 
normal range with the exception of the two non-immunised 
non-infected controls CO-1 and 2 (38°C, day 1) and infected
non-immunised control piglet C0+-6 which had a rectal temperature 
of 38°C until Day 4.
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(ii) Faecal bacteriology
Pre-inoculation faecal swabs were all negative for the presence 
of C.perfringens type A in all animals. The organism was isolated 
in profuse culture from the rectal swabs of all infected, 
non-immunised piglets from the first day post-infection. It was 
also isolated in profuse culture from rectal swabs of piglets A-2, 
E-l and E-2. A few colonies of the organism were isolated from 
piglets B-l, D-2 and F-l. C.perfringens type A was not detected in 
the rectal swabs of the rest of the animals on the first day 
post-inoculation.
On the second day post-infection profuse cultures of
C.perfringens type A could still be isolated from the rectal faeces 
of the infected non-immunised piglets and from immunised piglets 
E-l and E-2. Fewer organisms were isolated from piglet A-2. Few
colonies of C.perfringens type A were isolated from the remaining
piglets shown to be infected in Table 20.
On the third day post-infection all animals including
non-infected controls were infected with the organism (Table 20).
Non-haemolytic E.coli, Clostridium spp., Streptococcus spp. and 
Staphylococcus spp. were isolated from the rectal swabs of most of 
the piglets from the second day of the experiment.
(3-haemolytic’ E.coli was isolated from the rectal swabs of 
piglets B-2, E-2 and F-2 in the tenth day of observation period.
(iii) Pathological findings
At post-mortem examination, infected, non-immunised piglets 
C0+-1, C0+ -2, C0+ -3, C0+ -4 and C0+ -5 were in poor bodily
condition, their hindquarters soiled with diarrhoea, sunken eyes, 
hollowed flanks and hairy coats (Fig. 18). Gross changes were 
confined to the abdominal viscera. The livers of these animals 
were slightly pale and the mesenteric lymph nodes were congested.
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Piglet C0+ -2 had' an extensive necrotising peritonitis. The 
gastrointestinal tract of this piglet was severely congested with 
large areas of haemorrhage.
The stomach of piglets C0+ -1, C0+ -3, C0+ -4 and C0+ -5
appeared normal on their external surfaces though distended with 
milk and gas. Both the spleen and kidneys were normal. The 
jejunum and ileum in all these animals were distended with gas. 
The mesenteric vessels were congested. The large intestine was 
reddened from the serosal surface and distended.
The gastric mucosa of these piglets appeared slightly 
congested, except that of piglet C0+ -2 which was severely
congested with large areas of haemorrhage, a feature that was 
present throughout the gastrointestinal tract in this piglet. The 
duodenal mucosa of piglets C0+ -1, C0+ -3, C0+ -4 and C0+ -5 was 
slightly congested. Necrotic debris was present on the mucosa of
«v
the jejunum and ileum which appeared distended and largely 
congested, with pinpoint haemorrhages in some areas. The jejunal 
and ileal contents were frothy and yellowish in colour (Fig. 19). 
The mucosa of caecum and colon was congested in large areas, the 
contents were brownish in colour with mucoid tags.
Examination of portions of the jejunum under the dissecting 
microscope showed shortened villi. In the case of piglet C0+-2 
they were completely absent.
Infected, non-immunised piglet C0+ -6 was killed on day 9 of 
the observation and had clinical signs of diarrhoea at the time of 
death. The serosal surface of the jejunum, ileum and caecum were 
reddened but all other organs appeared normal. The gastric and 
duodenal mucosa was normal. The jejunal and ileal mucosa were 
congested with normal contents. The mucosa of the colon .was 
slightly congested and the contents were solid. The mesenteric 
lymph nodes were enlarged and pale in appearance.
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FIG. 18: Perineal region of piglet C0+-1, 3 days post-inoculation
with C.perfringens type A.
Note the soiling of the perineum with diarrhoea.
FIG. 19: Gross appearance of the small intestine of piglet C0+-1,
3 days post-inoculation with C.perfringens type A.
Note the distention of the intestine and the frothy contents.
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With the exceptions listed below the rest of the infected,
immunised animals as well as the non-infected controls, were in 
good bodily condition. No pathological changes were seen in the 
organs of these animals. The gastrointestinal tract, mucosa and 
contents were all normal in appearance.
Infected, immunised piglets A-2, E-2 and F-2 were in good
bodily condition when sacrificed. The stomachs of these piglets 
were distended and filled with undigested milk. The duodenums were 
normal in appearance and the jejunums and ileums wete distended and 
pale. The caecum and colon of piglets E-2 and F-2 were dilated and 
filled with fluid contents. The caecum and colon of piglet B-2 
were empty and pale. The mucosal surface of the jejunum and ileum 
of these three piglets was congested and covered with flecks of
undigested milk. The villi were of the normal height. The mucosal 
surface of the caecum and colon was slightly congested.
Piglet E-l when killed at the 6th day of observation had 
slightly hollowed flanks but was otherwise in good bodily 
condition. The serosal surface of jejunum and ileum appeared 
reddened. All other parts of the gastrointestinal tract appeared 
normal. The mesenteric lymph nodes were enlarged and pale in
colour.. The mucosa of the jejunum and ileum was slightly 
congested. The villi were not reduced in height.
Histopathology was carried out on only two of the infected, 
non-immunised piglets, C0+ -1 and C0+ -6. The gastric mucosa of 
both piglets appeared normal. Piglet C0+ -1 had shortened villi 
and marked congestion in the lamina propria of the jejunum. Piglet 
C0+ -6 only had shortened villi at this level. Changes in the 
ileum of both piglets included shortening of the villi; marked 
congestion of the lamina propria, especially that of piglet C0+ -1; 
submucosal lymphoid hyperplasia and both eosinophilic and 
neutrophilic polymorphonuclear leucocytes were prominent in the 
lamina propria, free cells were observed in the lumen (Fig. 20). 
Piglet C0+ -6 had areas of localised oedema at lamina propria 
level.
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The caecum of piglet C0+ -1 was congested at all levels, there 
was presence of oedematous fluid and cells in the lumen, and 
hypereellularity was evident in the lamina propria was evident 
(Fig. 21). Milder changes at this level were seen in piglet C0+ -6
in which congestion and the presence of inflammatory cells in the
lamina propria. No changes were noted in the colon of piglet C0+ 
-6 whereas that of piglet C0+ -1 presented areas of extensive 
oedema, free cells in the lumen and a diffuse hypercellularity at 
mucosal and submucosal levels.
Some histological changes were noted in the gastrointestinal 
tract of piglet E-l. These included congestion of the lamina 
propria of the jejunum and ileum. No changes were seen in the
stomach, caecum and colon. Similarly piglet B-2 had congestion of 
the lamina propria of the jejunum and ileum; inflammatory cells 
were present at this level. In the caecum and colon there was 
fluid in the lumen. Areas of localised oedema were seen in the 
lamina propria.
Histopathological changes were seen in both E-2 and F-2 which 
included a diffuse hypercellularity of the lamina propria of the
jejunum, ileum, caecum and colon. The mucosa and submucosa of both 
caecum and colon were congested and diffuse oedema of the lamina 
propria was seen.
No histological changes were seen in the gastrointestinal tract 
of the other infected, immunised piglets or in the non-infected 
control animals (Fig. 22).
(iv) Bacteriological findings
Gram-stained smears prepared from the jejunal, ileal, caecal 
and colonic mucosa of all pigs contained C.perfringens-like 
bacteria with no spores. The numbers seen varied considerably and 
were least in the non-infected control piglets and greatest in the 
non-immunised, infected control piglets and in immunised piglets 
C-l, E-l, E-2, F-l and F-2.
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FIG. 20: Histological section of the ileal mucosa of piglet
C0+-1, 3 days post-inoculation with C.perfringens type A.
Note the congestion of the lamina propria (arrow) and the presence 
of free cells in the lumen (star).
FIG. 21: Histological section of the caecal mucosa of piglet
C0+-1, 3 days post-inoculation with C.perfringens type A.
Note the hypercellularity in the lamina propria (arrow) and the 
presence of free cells and oedematous fluid in the lumen (star).
(HE x 120)
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FIG. 22: Histological section of the ileal mucosa of immunised
piglet A - l , 4 days post-inoculation with C.perfringens type A. 
Note the normal appearance of the villi and the lamina propria.
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The recovery of C.perfringens type A from tissues sampled at 
post-mortem examination is shown in Table 21. Colonies of 
C.perfringens type A were isolated in large numbers from all the 
organs sampled, of all infected, non-immunised animals. 
C.perfringens type A was isolated from the stomach only in 
immunised piglets E-l and E-2. C.perfringens type A was found in 
all other parts of the gastrointestinal tract regardless of the 
protection given or the length of time for which piglets had been 
infected.
In general, colonies of the organism isolated from immunised 
piglets and from non-infected controls were fewer in numbers than 
from infected, non-immunised animals.
Other bacteria were also isolated from the gastrointestinal 
tract of all piglets. They were non-haemolytic E.coli, 
Streptococcus spp., Staphylococcus spp., Clostridium spp.^ and 
Bacillus spp. 10-haemolytic E .coli was isolated from the 
gastrointestinal tract of piglets D-2, E-2 and F-2.
(v) Serological findings
The serological findings are shown in Table 22. The sera of
all passively immunised piglets contained antibodies to
C.perfringens type A cells. IgG titres ranged from 1:10 in the
serum of piglet E-2 to greater than 1:1000 in the sera of piglets 
A-l, A-2, B-l, B-2, C-3, D-l, D-2, F-l and F-2. The infected, 
non-immunised piglet C0+ -6 showed a titre of 1:10. IgM titres 
ranged from 1:10 to greater than 1:1000 among the immunised 
animals. Piglet C0+-6 presented an IgM titre of 1:10. Titres for 
IgA antibodies varied from 1:1 to. 1:10; no IgA antibodies to 
C.perfringens type A cells were detected in piglets E-2 and F-2 or 
in piglet C0+ -6. Titres of antibodies to alpha toxin ranged from 
1:2 to 1:8 but were not detected in the sera of piglets E-l, E-2, 
F-2 and C0+ -6. Sera from piglet C0+ -1 and piglets non-infected 
controls C0+ -1 and C0+ -2 were negative to the presence of
antibodies to C.perfringens type A cells and to alpha toxin.
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TABLE 21
Sites from which C.perfringens type A was isolated
from HDCD piglets passively immunised , following
infection with pure cultures of the organism
Piglet Passive Infection Stomach Jejunum 
No• immun i s at i on
Ileum Caecum Colon
CO---1 - - — + + + +
CO---2 - - - + + + +
C0+ -1 - + + ++ ++ ++ ++
C0+ -2 - + ++ ++ ++ ++ ++
C0+ -3 - + + ++ ++ ++ +
C0+ -4 - + ++ ++ ++ ++ ++•v
C0+ -5 - + ++ ++ ++ ++ ++
C0+ -6 - + + ++ ++ ++ ++
A-l A + - ++ + + +
A-2 A + - + + + +
B-l B + - + + + +
B-2 B + - + + + +
c-i C + - ++ ++ + +
C-2 C + - + .+ + +
C-3 C + - + ++ ++ ++
D-l D + - + ++ + +
D-2 D + - + ++ ++ ++
E-l E + + ++ -H- + +
E-2 E + + ++ ++ + +
F-l F + - ++ ++ ++ ++
F-2 F + - ++ ++ + +
G-l G + - + + + +
G-2 G + + + + +
- = no colonies of C.perfringens isolated 
+ = between 1 and 8 colonies of C.perfringens isolated 
++ '■ = more than 8 colonies of C.perfringens isolated
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5. DISCUSSION
(a) Potency and safety of the toxoid and bacterins
(i) Toxoid
Previous reports (MacLennan, 1962; Yamamoto etal., 1970) 
mentioned the difficulties of producing an alpha-toxin toxoid. By 
following the method described by Ito (1970) in which 
detoxification was carried out by stringent control of the 
constituents of the medium, formalin concentration, temperature and 
incubation period, a complete detoxification was achieved.
This detoxification was demonstrated by the safety tests in 
mice and by the haemolysis test using sheep red blood cells. 
Antigenicity was still present and was demonstrated by the 
production of serum antibody in mice, rabbits and pigs capable of 
neutralising crude alpha toxin using Nagler reaction. Mice, 
rabbits and pigs immunised with the toxin all produced antibodies 
containing anti-alpha toxin demonstrated by counter-immunoelectro- 
phoresis (Tables 13 and 15). Assay of the sera produced by 
immunisation of these animals using the crude alpha toxin toxoid 
showed that antibody to cells was also present (Tables 13 and 14). 
Pre-inoculation sera were not available from mice and rabbits where 
contemporary control animals were used. No antibody to whole cell 
antigen was demonstrated in the sera of control mice but in both 
rabbit and pig sera low levels of antibody to cells were found 
either pre-inoculation or in uninoculated animals (Tables 13 and 
14). The consistent response to cell antigen following the use of 
toxoid suggests that the toxoid was contaminated with cellular 
antigens.
(ii) Whole culture inactivated bacterin
In the cell culture preparation produced in this study, both 
alpha toxin and whole cell antigenicities mere preserved in spite of 
the problems reported by Yamamoto et al. (1970). Inactivation of 
the bacterin was achieved under different conditions using a higher
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formalin concentration, higher temperature and longer incubation 
period but even so alpha toxin antigenicity was preserved (Tables 
13 and 15). Inactivation was complete using this method and was 
confirmed by the mouse inoculation and the haemolysis test.
Antigenicity of the cells was also preserved. Antibody to 
cells was demonstrated in the sera of immunised mice, rabbits and 
pigs (Tables 13 and 14). Pre-inoculation levels of antibody to 
cells were found in the sera of pigs (Table 14) and in the sera of 
the control rabbit (Table 13) but in the mice and in the pig 
inoculated with whole killed culture there was no evidence for 
previous antibody and high levels of antibody were formed following 
immunisation. In the pigs, the high levels of IgM found suggest 
that this was a primary response.
The ubiquity of C.perfringens type A in the intestines and 
environment of all the animals used to assess antigenicity was a 
complicating factor in this part of the study. It must be assumed 
that animals with no obvious serum antibody response had been 
exposed to the organism at some stage. In the case of the control 
pig (Table 14) IgM antibody to whole cell antigen appeared during 
the period of immunisation of the remainder of the group. This may 
suggest that all the pigs were exposed to infection or 
environmental antigen during immunisation.
The inactivated whole culture bacterin was potent when used at 
1:2 and 1:4 dilutions in mouse protection studies (Table 12). 
Protection was only 80% complete at 1:4, but was complete at 1:2. 
Estimation of potency for the two preparations differed less than 
would be expected on the grounds of their protein concentration 
alone, this may be due to a higher amount of detoxified alpha toxin 
present in the toxoid.
(iii) Combined toxoid-whole culture bacterin
As both toxoid and whole culture bacterin stimulated the 
production of antibody to whole cells and to alpha toxin the mixed
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product also produced similar results. The mixture was assumed to 
be potent and was not tested by mouse immunisation.
(b) The Immunisation of pregnant sows
(i) Pre-immunisation antibody to C.perfringens
The sows were from the same farm as the pigs used to produce 
serum antibody and also had antibody to C.perfringens cells and 
sometimes to alpha toxin in pre-immunisation titres (Tables 17 and 
18). Two sows (402 and 406) were completely free from such 
antibody pre-inoculation.
Low levels of antibody to C.perfringens cells but not to alpha 
toxin were found in the milks of the control animals.
(ii) Serological response to immunisation „
All 3 products induced serum antibody in the sows in exactly 
the same way as in the immunised weaned pigs. In the majority of 
cases, post-immunisation serum antibody levels to whole cells 
increased (Table 17) and in all cases serum antibody levels to 
alpha toxin rose above pre-immunisation levels. IgA levels in 
serum remained low at 1:10 in exactly the same way as in the weaned 
pigs. The addition of the freeze-dried whole cells to the feed of 
sows 406, 40 and 405 appeared to have had no obvious effect on the 
levels of antibody produced. The reason for this is not clear but 
the response may have been masked by the effects of the priming 
injections or the antigen may have been destroyed in the gut.
(iii) The colostral and milk antibody response to 
immunisation
IgG and IgM antibodies to C.perfringens type A cells were found 
to be predominant in the colostra of immunised sows (Table 17). 
Higher titres of IgA antibody were found in milks than in colostra 
and sera being the immunoglobulin class which presented the highest
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titres to the organism in milks. Naturally-occurring C.perfringens 
type A, a predominantly enteric organism, would be expected to 
evoke enhanced production of IgM and IgA, the two classes primarily 
associated with local immunity. Results from this experiment agree 
with the above prediction by demonstrating enhanced IgM and IgA 
titres in sera, colostra and milks, although IgG titres were also 
increased probably due to the systemic immunisation of the sows. 
Anti-alpha toxin titres were lower in milks than in colostra or 
sera probably due to a lower amount of IgG antibodies to alpha 
toxin in milks where the predominant, immunoglobulin is of IgA 
class. No anti-alpha toxin was demonstrated in the control milks, 
thus the anti-alpha toxin demonstrated was probably entirely due to 
immunisation. It is unfortunate that control colostra were not 
available for comparative purposes.
Only slight differences in antibody levels were found between 
groups and once again no obvious benefit from the oral feeding of 
freeze-dried cells was detected.
In all cases, colostra and milks obtained from immunised sows 
contained antibody to both cells and alpha toxoid and so might be 
considered protective. The evidence for this view comes indirectly 
from the work of Djurickovic et al. (1975) who found that
immunising sows with C.perfringens type C toxoid at 4 and 2 weeks
before parturition increased antitoxin titres in sera, colostra and 
milks when compared to non-immunised sows. Pre-farrowing 
immunisation of jsows with toxoid and bacterin in the present study
was also found to increase IgG, IgM and IgA titres in sera,
colostra and milks. They concluded that immunisation of sows and 
allowing passive transfer of immunity to their progeny protected 
piglets against C.perfringens type C enterotoxaemia. Immunisation 
for enhancement of passive transfer should be directed toward 
stimulating maximum antibody production with subsequent elevated 
specific immunoglobulin levels in colostrum and milk. In the 
present experiment, the sows immunised 3-6 weeks prior to farrowing 
showed a significant increase in sera, colostra and milks and it 
was therefore assumed that these colostra, milks and sera would be 
protective.
1 7 0
(c) The efficacy of protection
(i) The validity of the controls
The immune sera, colostra and milks protected the 
hysterectomy-derived, colostrum-deprived piglets of Experiment 2 
against death from C.perfringens type A challenge (Table 20). The 
results have been summarised here in Table 23 where it can be seen 
that the control infected piglets suffered from severe and rapidly 
fatal disease. The uninfected control animals remained healthy 
although they did become colonised by C.perfringens type A later in 
the study, either from the environment or by cross infection from 
the other animals. In ideal circumstances these controls would 
have been separated from the infected animals in another room or in 
an isolator.
The severe disease produced resembled that describe^ by 
Olubunmi (1982) but was more severe than that described by Nabuurs 
et al. (1983) and that described in Experiment 1 (Chapter 3). 
These piglets were younger and more closely resembled those of 
Olubunmi. They therefore provided a perfect positive control and 
demonstrated that the protection shown was real. Unfortunately the 
numbers available did not allow the inclusion of protected control 
groups using serum, milk or colostra from non-immune animals.
(ii) Disease in the infected controls
The severity of the disease in the infected controls differed 
from that seen in Experiment 1 and therefore requires discussion. 
The piglets in this study were younger, the inoculum was, however, 
smaller (8 x 10^  cells versus 1.5 x 10^  cells per piglet) but the 
piglets were also smaller in body size. They had had no 
opportunity to form adequate levels of plasma protein, gastric 
acidity or protective intestinal flora (Tlaskalova et al., 1983) 
and piglets CO+2 and CO+3 were small and weak. The other 3 piglets 
which died were, however, strong animals. As in Experiment 1 the 
diarrhoea was creamy, became pasted over the hindquarters and was
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accompanied by loss- of bodily condition. This loss of condition 
continued in piglet CO+6 which recovered on daiy 4 but it remained 
weak.
C.perfringens type A was isolated from the faeces of all pigs 
of this control group within 24 hours of inoculation. The 
differences between this group and the others and their 
significance are discussed below.
The post-mortem lesions were restricted to the gastrointestinal 
tract in 4 of the piglets which died but peritonitis was seen in 
one (CO+2). As no protected piglets died, direct comparison on an 
age-matched basis is only possible with piglet CO+6 which 
recovered. The early lesions were most severe in piglet CO+2 in 
which all levels of the gastrointestinal tract were congested and 
where large areas of haemorrhages were seen in both small and large 
intestine as in the pigs described by Olubunmi (1982). Piglets, C0+ 
-1, C0+ -3, C0+ -4 and C0+ -5 presented less dramatic pathological 
changes. The jejunums and ileums of these animals were distended 
with gas and slightly congested; the large intestines appeared to 
have large areas of congestion. Piglet C0+ -6 (recovered) had 
congestion of the jejunal and ileal mucosa; the mucosa of the 
large intestine was less congested than that of the other infected, 
non-immunised animals. It is with this animal that the 
pathological changes seen in the protected groups are best 
compared.
Histological changes were observed in infected, non-immunised 
piglets C0+ -1 and C0+ -6. Histology was not carried out in the 
other piglets of this group due to the time that had elapsed from 
death to the necropsy of these animals. No histological changes 
were seen in the stomach. Shortened villi were observed at jejunum 
and ileum level, a marked congestion of lamina propria was evident 
together with diffused hypercellularity. Changes in the large 
intestine included large areas of congestion, the presence of 
inflammatory cells at lamina propria, and, in the case of piglet 
C0+ -1 the presence of shed cells in the lumen with oedematous 
fluid. These changes resemble much more closely those described
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by Olubunmi (1982) than those found in Experiment 1.
C.perfringens type A was present throughout the gastro­
intestinal tracts of all 6 controls (Table 21),
(iii) Changes in the protected animals
Complete protection against challenge was given by Serum A 
(toxoid-immunised pig), Milk C (pooled sow milk; toxoid-immunised), 
Colostrum D (pooled sow colostrum; toxoid-immunised) and Milk G 
(pooled sow milk, toxoid-bacterin and feed immunised).
In these completely protected piglets there was no diarrhoea 
and faecal isolation of C.perfringens type A was delayed until days 
2 (Group D) or 4 (Groups A, C and G). This late colonisation, 
complete absence of clinical signs and pathological changes was 
identical with the uninfected-unprotected controls (Table 23).
ft*
Minor differences in the distribution of C.perfringens in the 
gastrointestinal tract were seen (Table 21). C.perfringens 
appeared to be more profuse in some regions of the gut of the 
infected-protected animals when compared with the uninfected 
controls This finding is only subjective. C.perfringens type A 
was absent from the stomach in all protected animals, unlike the 
situation in the animals of groups C0+ and E in which clinical 
disease occurred.
No deaths occurred in the remaining protected piglets but 
E.coli diarrhoea did occur on the last day of life in piglets B2, 
E2 and F2. This diarrhoea was separated in time from the diarrhoea 
seen in the challenged animals and was not considered to affect the 
results of the study. Clostridial diarrhoea did occur in the 
piglets of Group E (pooled milk, sows bacterin-immunised). In this 
group C.perfringens type A appeared in the faeces within 24 hours 
of infection but the diarrhoea only lasted 2 days (Table 20). 
Groups B and F were protected from clinical clostridial disease. 
The lesions seen in them at post-mortem examination may be
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attributable to the E.coli infection identified in the piglets with 
lesions. This supposition is borne out by the distribution of 
C.perfringens in their gastrointestinal tracts which resembled that 
of the protected animals. In piglets from Group E, the 
distribution of C.perfringens type A found was that of infected 
untreated controls and the lesions in El, killed before any E.coli 
infection could have been due to C.perfringens type A. Those in 
piglet E2 may have been due to E.coli.
(iv) Passive antibody levels in the piglets
As may be expected, the control uninfected animals had no trace 
of antibody either to cells or to alpha toxin (Tables 22 and 23). 
One of the two members of the infected control group, C0+-6, had 
low levels of IgG and IgM which probably resulted from active 
infection. No antibody to alpha toxin was detected.
IgG and IgM antibody to C.perfringens cells was present in all 
protected piglets and levels were in general highest in those 
animals which had received serum or colostrum. IgA was not found 
in the sera of piglets El and F2 and was low in most piglets. 
There is therefore no absolute relationship between levels of 
antibody to C.perfringens type A detected at slaughter and the 
occurrence of C.perfringens diarrhoea. There is, however, a 
stronger correlation between antibody to alpha toxin and 
protection. Neither piglet of Group E (pooled milk, sows bacterin 
immunised) had any and they developed diarrhoea. One of the Group 
F piglets also lacked detectable serum anti-alpha toxin but did not 
develop C.perfringens diarrhoea.
These antibody levels may have been affected in 
orally-protected animals by the retention of secretory IgA and some 
IgM in the gut lumen with consequent neutralisation of any initial 
clostridial products. Some serum antibody, once absorbed may also 
have been lost during challenge but there appears to be little 
relationship between levels of antibody and day of slaughter. This 
also applies to actively produced antibody which was demonstrated
in control piglet C0+ -6 killed on day 9. The beginnings of active 
immunity could, therefore, have contributed to the final levels 
found.
(v) Significance of the protection study
The results of the study reported in this chapter and discussed 
above, provide clear evidence that colostrum, milk and serum from 
animals immunised with toxoid prepared from crude C.perfringens 
alpha toxin and serum and colostrum from pigs immunised with a 
whole culture bacterin alone or in combination can protect piglets 
against challenge with C.perfringens type A of piglet origin. This 
protection included protection against clinical disease, death and 
lesions but not against colonisation which was merely delayed in 
protected piglets.
The actual reasons for this protection were not cleg,r.
Antibody to alpha toxin and to cells was produced by all the
immunogens used and it cannot be said with any certainty which 
antigen gave rise to protective antibody although the poorest 
protection (against death only) was provided by milk from whole 
culture vaccinated sows giving low anti-alpha toxin levels in 
piglet serum. Neither alpha toxin or cell wall antigens may have 
been involved as unsought antigens such as minor toxins, 
hyaluronidase, collagenases or proteinases may have been present in 
the material used. The lack of a normal antibody-free serum, 
colostrum and milk .controls mean that an element of uncertainty 
must remain about the specificity of the protection observed.
Similarly, it is not completely clear which immunoglobulin class is 
responsible for protection, neither is it clear at which site
protection was being provided. Toxins may have been neutralised in 
the gut lumen or systemically.
For this reason it was decided to concentrate on purified 
antigens and alpha toxin was chosen for the first study.
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CHAPTER 5
STUDIES ON THE ALPHA TOXIN OF CLOSTRIDIUM PERFRINGENS TYPE A
1. INTRODUCTION
It appeared from the results of the studies described in 
Chapter 4 that toxoid prepared from crude C.perfringens type A 
alpha toxin would induce protective antibodies against challenge 
infections in hysterectomy-derived, colostrum-deprived piglets. 
The antisera, colostra and milks from pigs immunised with this 
toxoid possessed antibody both to alpha toxin and to cell antigens, 
thus providing no clear evidence for the protective value of anti­
alpha toxin alone. For this reason the studies described here were 
undertaken in order to clarify the role of alpha toxin in 
C.perfringens Type A enteritis in the pig.
Alpha toxin was purified, used to produce specific antisera
and used as an antigen in serological studies. The alpha toxin
production of pig isolates of C.perfringens type A was studied and
the effects of pure alpha toxin on the pig intestine were studied 
in gut loops.
2. THE PURIFICATION OF ALPHA TOXIN AND THE PRODUCTION OF ANTISERA 
TO IT
(a) Purification of alpha toxin 
(i) Methods
The methods used were described in Chapter 2.
(ii) Results
The results of the different stages of purification are
summarised in Table 24.
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50 per cent of ammonium sulphate saturation of the 10 litres 
culture supernatant resulted in 8-fold increase of alpha toxin 
activity/ml. This step gave a 80 per cent recovery of total alpha 
toxin activity. Ultrogel AcA-34 gel chromatography gave a recovery 
of 3.8 per cent from the original alpha toxin activity. The first 
peak after the void volume consisted of the bulk of protein since 
it had a high absorbance at 280nm and little alpha toxin activity. 
The highest haemolytic activity per ml eluted was found in the 
second peak (Fig. 23).
Alpha toxin which produced turbidity of saline extract of egg 
yolk was separated in a narrow peak with an isoelectric point of 
5.6. Low alpha toxin activity was also found between pH 5.4-5.5. 
No alpha toxin activity was detected at other pH ranges (Figs. 24 
and 25). The recovery of alpha toxin activity after isoelectric 
focusing was 0.8 per cent of original activity with a specific 
activity of 64 haemolytic units/ml and a protein concentration of
0.59 mg/ml.
Figure 26 shows the extent of homogeneity at each step as 
determined on polyacrylamide gels. After ammonium sulphate 
precipitation 6-8 bands were revealed. After gel chromatography 3 
bands were identified. A single stained band was revealed after 
the last step of purification.
Purified alpha toxin gave a single line of identity when 
tested against the rabbit anti-crude alpha toxin serum described in 
Chapter 4 by double immudiffusion (Fig. 27). A single line was 
also identified when the purified alpha toxin was tested by 
immunoelectrophoresis (Fig. 28). The purified alpha toxin was 
stored at -20°C until required.
(b) The production of antiserum to pure alpha toxin
(i) Methods
Alpha toxin purified in part (a) above was used to inoculate
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FIG. 23: Separation of alpha toxin by gel filtration
chromatography.
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FIG. 24: Separation of alpha toxin by isoelectric focusing in a
pH gradient 5-8.
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FIG. 25: Isoelectric focusing pattern of the electrophoresed
proteins from peak 2 (Fig. 23).
The alpha toxin activity was contained at pH 5.6.
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FIG. 26: Polyacrylamide gel electrophoresis pattern obtained
after each step of purification of alpha toxin. (a) after 
ammonium sulphate precipitation; (b) after gel chromatography; 
(c) after isoelectric focusing electrophoresis; (d) Reference 
control Phospholipase C XII.
Note the alpha toxin bands at each step of purification (arrow).
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FIG. 27: Double immunodiffusion pattern obtained with purified
alpha toxin (a), crude alpha toxin (b) and rabbit antiserum to 
crude alpha toxin (s).
Note the presence of only one line of identity between alpha toxin 
and antiserum to it (arrow).
FIG. 28: Immunoelectrophoresis pattern obtained with alpha toxin
after gel chromatography (g) and after further purification by 
isoelectric focusing (i). The troughs are filled with rabbit 
antiserum to crude alpha toxin.
Note the single line of precipitation produced by the alpha toxin 
(arrow).
184
two rabbits using the immunisation schedule described in Table 4, 
The antigens consisted of 1ml of pure alpha toxin containing 
590pg protein per ml and an activity of 64 haemolytic units/ml 
emulsified with Freund's adjuvant.
Antibody was detected using counterimmunoelectrophoresis 
using the purified alpha toxin described above as an antigen (Fig. 
29).
(ii) Results
The results are shown in in Table 25.
Preimmunisation sera of the two rabbits were negative p>r 
antibodies to alpha toxin. Titres of 1:4 were produced in the
serum of both animals after the first immunisation. Further 
increases in the titre were obtained with each immunisation. After 
the fifth immunisation a titre of 1:128 was found in serum of 
rabbit 1, whereas serum of rabbit 2 possessed a titre of 1:64 to 
alpha toxin.
Figure 30 shows that only one precipitin line of partial 
identity was produced when the antisera were tested against crude 
alpha toxin by double immunodiffusion. Pure alpha toxin produced a 
single line against both antisera. Both antisera were able to 
neutralise 64 haemolytic units of purified alpha toxin to sheep red 
blood cells, at fhe following dilutions: 1:16 from rabbit 1, and
1:8 serum from rabbit 2, thus giving a specific neutralising 
activity of 1024 and 512 HU units/ml respectively.
3. ALPHA TOXIN PRODUCTION BY C.PERFRINGENS TYPE A ISOLATES FROM 
PIGS
(a) Materials and Methods 
(i) Isolates
The isolates of C.perfringens Type A used in this 
study were those isolated in the surveys described in 
Chapters 3 and 6.
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TABLE 25
Antibody titres* of rabbits immunised with purified alpha toxin
Rabbit Titre 14 days after each immunisation
No. Preimmunisation No. of immunisations
1 2 3 4 5
1 - 1:4 1:16 1:32 1:64 1:128
2 1:4 1:16 1:16 1:64 1:64
* '• = detected by counterimmunoelectrophoresis 
- = absent
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FIG. 29: Detection of antibodies to purified alpha toxin by
counterimmunoelectrophoresis. Double dilutions of serum from 
rabbit 2 immunised with purified alpha toxin: (a) 1:2; (b) 1:4;
(c) 1:8; (d) 1:16; (e) 1:32; (f) 1:64; (g) 1:128; and (h)
1:256.
Note the titre of 1:64.
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FIG. 30: Double immunodiffusion pattern obtained with crude alpha
toxin (a) and antisera to purified alpha toxin from rabbit (1) and 
rabbit 2 (2). Commercial antiserum to C.perfringens type A (b). 
Note the line of partial identity between crude alpha toxin and 
the rabbit antisera to alpha toxin (arrow).
(ii) Procedures
Isolates stored in cooked meat medium were plated on horse 
blood agar plates and then grown in the peptone medium described by 
Takahashi et al. (1981). Samples were treated and tested as
previously described. Isolates 5,6,14,20,21,29 and 34 were tested 
repeatedly.
Haemolysin activity was tested in all isolates, whereas 
turbidity in saline extract of egg yolk, toxicity for mice and
alpha toxin titres detection by counterimmunoelectrophoresis were 
tested only in 22 of the 42 isolates.
(b) Results
The levels of alpha toxin produced by each isolate are shown 
in Table 26. The results for isolates 7, 8, 14, 21, 22, 29, 30 and 
35 were the same on each single occasion and as reported in Table 
26 when 22 of the isolates were tested for alpha toxin production 
by the haemolysis of sheep red blood cells (Fig. 31) the turbidity 
of saline extract of egg yolk, toxicity to mice and counterimmuno­
electrophoresis. Good agreement was found between the results of 
the haemolysis test and the other tests. Alpha toxin levels were 
identical in all cases when tested by the haemolysis of sheep red 
blood cells and turbidity of saline extracts of egg yolk. Toxicity 
to mice proved to be slightly less sensitive as a method of
detecting alpha toxin levels than the other tests as 13 isolates
showed a lower level of toxin than that detected by the other
methods. Counterimmunoelectrophoresis the highest alpha
toxin levels in 13 isolates, whereas in 9 isolates it produced an
identical titre as the one detected by haemolysis of sheep red
blood cells and turbidity of saline extract of egg yolk.
Alpha toxin was produced by 38 of the 42 isolates tested 
(90.4 per cent) 4 isolates (9.6 per cent) did not produce alpha
toxin or did not produce sufficient for detection by the methods 
used. The remainder produced varying amounts of alpha toxin
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TABLE 26
Alpha toxin production by 42 C.perfringens type A 
isolates in peptone medium
Submission Sample Amount of alpha toxin detected
number number (HU/ml)(a) (TU/ml)(b) (MLD/ml)(c) (CIE)(d)
2 5 16 16 16 32
6 64 64 32 64
7 16 16 16 32
8 32 32 16 64
3 14 16 16 8 16
17 16 16 16 32
4 20 16 16 8 32
21 64 64 64 128
22 8 8 4 16
6 29 — _ _ —
30 64 64 32 64
8 34 128 128 64 128
9 35 8 8 4 8
36 16 16 8 32
37 64 64 32 64
12 44 16 16 8 32
45 16 16 16 32
46 16 16 16 32
47 16 16 8 16
15 53 4 4 4 8
54 4 4 4 8
55 4 4 2 4
16 56' 16 NT NT NT
57 16 NT NT NT
58 16 NT NT NT
17 59 8 NT NT NT
60 - NT NT NT
19 62 256 ‘ NT NT NT
21 c 64 8 NT NT NT
65 8 NT NT NT
25 74 8 NT NT NT
75 32 NT NT NT
76 32 NT NT NT
77 16 NT NT NT
78 32 NT NT NT
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•TABLE 26 (Cont'd)
Alpha toxin production by 42 C.perfringens type A 
isolates in peptone medium
Submission Sample Amount of alpha toxin detected
number number (HU/ml)(a) (TU/ml)(b) (MLD/ml)(c) (CIE)(<*)
28 82 64 NT NT NT
29 83 16 NT NT NT
84 16 NT NT NT
31 86 8 NT NT NT
87 8 NT NT NT
32 88 — NT NT NT
89 - NT NT NT
(a) = Reciprocal of highest dilution producing haemolysis of sheep
red blood cells.
(b) = Reciprocal of highest dilution producing turbidity of saline
extract of egg yolk.
(c) = Reciprocal of highest dilution causing death of mice in 24
hours.
(d) = Reciprocal of highest dilution detected by counterimmuno­
electrophoresis.
- = absent 
NT = not tested
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FIG. 31: Haemolysis test. Alpha toxin production by
C.perfringens type A isolates: 22 (1), 35 (2), 29 (3), 7 (4), 21
(5), 14 (6), 8 (7) and 30 (8) producing 8,8,0,16,64,16,32 and 64
haemolytic units respectively. Neutralisation of haemolysis of
undiluted samples achieved with rabbit antiserum to purified alpha
measured in haemolytic units (Table 26). 3 isolates (7.1 per cent)
produced 4HU, 8 isolates (19 per cent) produced 8HU, 16 isolates 
(38 per cent) produced 16HU, 4 isolates (9.5 per cent) produced 
32HU, 5 isolates (11.9 per cent) produced 64 HU, one isolate (2.3 
per cent) produced 128HU and 1 isolate (2.3 per cent) produced 
256HU.
4. ANTIBODY LEVELS TO ALPHA TOXIN IN PIG SERA
(a) Materials and Methods
106 serum samples from 4 Scottish farms were obtained and
divided as previously described in Chapter 2. The sera were 
diluted two-fold with phosphate buffered saline, pH 7.2. The 
anti-alpha toxin titre was determined by counterimmunoelectro-
phoresis using a constant alpha toxin amount of lOpl containing 
1.60 mg of protein/ml.
(b) Results
The results are summarised in Table 27. Of 106 sera examined,
45 (42.4 per cent) were found to possess antibodies to
C.perfringens type A alpha toxin with titres ranging from 1:2 to 
1:16.20 sera presented titres of 1:2; 14 showed a titre of 1:4;
8 sera showed a titre of 1:8, and 3 sera showed a titre of 1:16. 
No obvious differences in serum titres to alpha toxin were found in 
the 4 different pig populations tested.
5. THE EFFECTS OF ALPHA TOXIN IN PIGLET INTESTINAL LOOPS
(a) Materials and Methods
One conventionally born one day-old piglet was used. The 
ligated intestinal loop technique was carried out as described in 
Chapter 2. The animal was killed 12 hours after injection of the 
preparations.
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TABLE 27
Distribution of serum antibody titres to C.perfringens type A 
alpha toxin in adult pigs
Alpha toxin 
CIE titre Farm 1
No. 
Farm 2
of pigs 
Farm 3 Farm 4 Total %
0 24 17 14 6 61 57.5
2 8 6 4 2 20 18.8
4 5 3 3 3 14 13.2
8 3 2 3 0 8 7.5
16 0 2 0 1 3 2.8
Total 40 30 24 12 106 100
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13 intestinal loops were ligated. Three loops were inoculated 
with purified alpha toxin containing 0.60mg of protein per ml and 
an activity of 64 haemolytic units per ml. One loop was injected 
with the same alpha toxin previously incubated for 30 minutes at 
room temperature with 0.25 ml of rabbit anti-alpha toxin serum 
possessing a titre of 1024 anti-alpha toxin units. Two loops were 
inoculated with the filtered culture supernatant of isolate number 
7, grown in peptone medium with meat particles, containing 2.60mg 
of protein per ml and an activity of 16 haemolytic units per ml. 
Another loop was injected with some filtered culture supernatant 
fluid previously incubated with the anti-alpha toxin serum. Two 
loops were inoculated with some culture supernatant concentrated by 
dialysis against polyethylene glycol 20,000 to a protein 
concentration of 11.7mg per ml and an activity of 64 haemolytic 
units per ml. One loop was injected with the same concentrated 
culture supernatant previously incubated with anti-alpha serum. 
Two loops were inoculated with saline solution and one with sterile 
peptone medium as controls. Accumulation of fluid, macroscopic 
congestion of mucosa and histopathological changes were recorded 
for each of the inoculated loops. Segments of the loops were kept 
frozen at -70°C for immunofluorescence studies.
(b) Results
Examination of the stomach of this piglet at post-mortem 
examination showed that it had ingested colostrum in spite of 
assurances from farm staff that it had not done so.
The macroscopic findings are indicated in Table 28. No 
differences were apparent among the inoculated loops. No 
accumulation of fluid, congestion of the mucosa or apparent lesions 
were seen in any of the inoculated loops (Fig. 32). Histological 
changes were observed only in loops 1,2,3,5,9 and 13 inoculated 
with purified alpha toxin and with concentrated culture 
supernatant. The changes consisted only of a mild congestion of 
the lamina propria and localised hypercellularity at lamina propria 
level (Fig. 33). No histological changes were noticed in loops
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FIG. 32: Inoculation of purified alpha toxin into intestinal
loops of conventionally born piglet.
Note the absence of apparent changes among the inoculated loops.
inoculated with alpha toxin and concentrated culture supernatant 
previously incubated with anti-alpha toxin serum. No histological 
changes were seen in loops injected with culture supernatant, 
sterile peptone medium and saline solution (Fig. 34).
No binding of alpha toxin to the intestinal epithelium could 
be demonstrated by indirect immunofluorescence.
6. DISCUSSION
(a) Purification
Alpha toxin was purified in three steps and was found to be 
devoid of contaminating antigens as shown by double 
immunodiffusion? Immunoelectrophoresisand electrophoresis on a 
polyacrylamide gel. This purification was achieved by combination
of the purification methods reported by Takahashi et al., (1981)
"
and Mollby and Wadstrom (1973). The first authors purified the 
toxin by four steps involving affinity chromatography, ion exchange 
chromatography and gel filtration chromatography methods which 
followed an initial precipitation with ammonium sulphate. The 
second authors purified alpha toxin by ion exchange chromatography, 
affinity chromatography and isoelectric focusing following 
freeze-drying of the toxin as first concentration step. The 
purification procedure of Takahashi et al., (1981) yielded very 
active toxin with 1620 haemolytic units/mg of protein, whereas the 
procedure of Mollby and Wadstrom (1973) yielded 371 haemolytic 
units/mg of protein. In the present experiment the yield was of 
108 haemolytic units/mg of protein, this low-yield was possibly due 
to the variations from the methods of purification reported or to 
differences in the strain of C.perfringens type A. Although the 
isolate used for purification of alpha toxin isolate 7 is not a 
high yield alpha toxin producer, it was employed because it was the 
isolate used in the previous experiment described in Chapter 3 and
4.
The first step of purification, 50 per cent saturation with
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ammonium sulphate, produced a considerable increase in alpha toxin 
activity per ml of medium by concentrating the toxin and very 
little total activity was lost at this step, however, after gel 
chromatography 96.2 per cent of the original alpha toxin activity 
was lost. This effect was possibly due to the binding of the toxin 
to other proteins present in the medium or to a denaturation of the 
toxin. A further loss occurred after the isoelectric focusing 
technique when 0.8 per cent of the original alpha toxin activity 
was recovered. Separation of the toxin by this^  method was in 
agreement with Smyth and Arbuthnott (1973) who reported that most 
of the alpha toxin activity was found at pH 5.6 when isoelectric 
focusing was carried out. When the fraction collected from 
isoelectric focusing was examined for lecithinase, haemolytic and 
lethal activities, it was found to possess all three properties 
thus confirming the presence of alpha toxin. The purity of the 
toxin was considered satisfactorily high for immunological and 
biological use. J
(b) Antibody production
Immunisation of rabbits with purified alpha toxin mixed with 
Freund’s adjuvant showed a high immunogenicity of the toxin by 
eliciting and enhancing anti-alpha toxin titres after each 
immunisation. Alpha toxin has been considered to be a poor antigen 
(Oakley, 1970). Ito (1970) reported that detoxified alpha toxin 
was superior in immunogenicity to non detoxified toxin which 
induced a low titre anti-alpha toxin response; no adjuvants were 
used in this work. The good antigenicity of alpha toxin in the 
present study may be attributed to the use of adjuvants. Similar 
effects were obtained in rabbits using the crude toxoid and 
aluminium hydroxide adjuvants (Table 13, Chapter 4). The lower 
titres obtained in that study may have been due to the lower 
concentration of alpha toxin in the toxoid, the adjuvant or to the 
smaller number of injections.
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(c) Alpha toxin production by porcine isolates of C.
perfringens type A
The high percentage of alpha toxin producer isolates found in 
this study (Table 26) confirms the findings of Chapter 3 that most 
of C.perfringens type A strains were alpha toxin producers. The 
selection of colonies which were haemolytic on primary isolation 
plates were discussed at the end of Chapter 3.
Comparison of the alpha toxin levels (Table 26) in 22 
C.perfringens strains demonstrated by the haemolysis test of sheep 
red blood cells and the turbidity test of saline extract of egg 
yolk, indicated that theta toxin was not produced in the peptone 
medium in which the isolates were grown, or if produced, it was in 
quantities that did not enhance the haemolytic activity of alpha 
toxin. This failure to detect the toxin in the supernatant is in 
agreement with Takahashi et al. (1981) who reported that the
*r
peptone medium employed impeded theta toxin production. It 
therefore seemed that the test used for the activity of alpha toxin 
in this study was specific.
It has been reported (Nakamura et al. , 1969) in quantitative 
studies that alpha toxin production by C.perfringens type A is 
dependent upon the strain, the medium, the culture conditions, pH, 
temperature of incubation and the length of incubation. The 
isolates tested in this study were all cultured under the same 
conditions on the same occasion and it was noticed that the amount 
of alpha toxin produced by the isolates was always the same if the 
medium, pH, temperature and length of incubation did not change in 
the isolates when cultured repeatedly. These data indicate that 
alpha toxin production is associated with properties of the 
strains. No attempt was made in this study to measure the numbers 
of organisms inoculated or the optical density or bacterial counts 
achieved in each culture. These factors may introduce an element 
of uncertainty into the results described in Table 26.
The variation in alpha toxin production among isolates was
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marked. Isolates 29,60,88 and 89 produced no detectable alpha 
toxin and isolate 62 produced 256 haemolytic units of alpha toxin 
per ml.
Variations in the alpha toxin production by C.perfringens type 
A isolated from animals with the same submission number
(Submissions 2,4,6,9,17 and 25) were found, indicating that 
different C.perfringens type A strains may be isolated from related 
animals presenting a clinical disease. The possible association of 
these strains and their alpha toxin production with disease is not 
clear from the data obtained in this study. Isolate 7 was a proven 
pathogen (Experiments 1, Chapter 3 and 2, Chapter 4) but was only a 
moderate alpha toxin producer. The best producers of alpha toxin, 
isolates, 62 and 34 were neither of them isolated from cases in 
which they were present as the Sole cause (62) or in large numbers 
(34). The other isolate of known pathogenicity isolate 29,
(Experiment 3, Chapter 6) produced no alpha toxin and also produced 
an entirely different disease suggesting that there might be some 
relationship between disease and alpha toxin production.
(d) Serum antibody to alpha toxin in adult pigs
Of 106 pig sera examined 45 were found to possess antibodies 
to alpha toxin with titres ranging from 1:2 to 1:32. No obvious 
differences in serum titres were found among the pig populations of 
the four tested farms. It was known that all the animals tested 
for anti-alpha toxin antibodies were healthy at the time of being 
sampled. As the age of the animals sampled was not recorded it was
not possible to say whether there was any effect of age or parity
on the levels found.
The presence of anti-alpha toxin antibodies in the tested sera 
could possibly be due to prolonged absorption of alpha toxin in 
symptomless carriers possessing high numbers of C.perfringens type 
A, or, it may suggest that the indigenous intestinal C.perfringens 
flora produces sufficient toxin to elicit an immune response. It 
was unlikely that preformed alpha toxin would be ingested with the
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feed or in the faeces of piglets. Any such ingested toxin would 
probably be destroyed in the stomach by the low pH or by the 
presence of antitoxic factors in feed. Finally there is the 
possibility of subclinical systemic exposure from local lesions, 
for example in the reproductive tract.
The finding that 42.5 per cent of all 106 sows surveyed had 
serum antibody to alpha toxin is of interest. These figures were 
not used in any statistical analysis as the sample was considered 
to be too small and unrepresentative, but the results suggest that 
antibody to C.perfringens alpha toxin is common in sows. Further 
evidence for this view comes from the findings in the pre­
immunisation sera from the sows used in the protection studies 
described in Chapter 4 where 5 out of 10 sows sampled had 
circulating anti-alpha toxin antibody.
(e) The gut loop studies
The most important feature in assessing the significance of 
these studies was the finding that the piglet used had ingested 
colostrum and was therefore of unknown immune status. From the 
discussion in section d above, it is clear that antibody to alpha 
toxin can be demonstrated in the sera of 40 per cent of normal 
sows. Neither the serum antibody titre of the sow to alpha-toxin 
nor the passive antibody titre of the piglet used were determined 
in this study.
No accumulation of fluid or macroscopic lesions were observed 
in intestinal ligated loops receiving purified alpha toxin, culture 
supernatant or concentrated culture supernatant. These results are 
in agreement with Hauschild et al. (1968) and Duncan et al. (1968) 
who failed to produce an intestinal loop response when crude alpha 
toxin injected into loops prepared in lambs and rabbits 
respectively. The first authors, however, observed accumulation of 
fluid in intestinal loops when large amounts of alpha toxin were 
injected. 1000 MLD of alpha toxin per loop produced fluid 
accumulation which amplified several-fold when 8000 MLD were
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inoculated into loops. Such large quantities of alpha toxin 
inducing accumulation of fluid provide no indication of the role of 
the toxin in C.perfringens enteritis because it is unlikely that 
such amount of alpha toxin would be produced in a natural case of 
C.perfringens type A infection. Such high levels of alpha toxin 
were not used in this study.
With the 64 haemolytic units of toxin used in this study, 
there were histological lesions of mild congestion and localised 
hypercellularity in loops injected with pure alpha toxin and 
concentrated culture supernatant (Table 28, Fig. 33). These 
changes were not seen in loops inoculated with unconcentrated 
culture supernatant containing 16 haemolytic units but were present 
when the culture supernatant was concentrated to contain 64 
haemolytic units, the same as in the pure alpha toxin. These 
lesions may be due to the effects of the alpha toxin as they did 
not appear in controls. The changes may have been due to the 
effect of alpha toxin which stimulates histamine release from^mast 
cells to cause inflammation. However, no globular leucocytes were 
seen in the sections and this mechanism may not be important in 
animals of this age.
No binding of alpha toxin to the intestinal epithelium could 
be demonstrated by indirect immunofluorescence. This result may be 
explained due to the enzymatic nature of alpha toxin which results 
in rapid yele&sg of the antigen from surfaces to which it fixes 
initially. The ,alpha toxin may also have been neutralised in the 
lumen by antibody from the milk. Analysis of the gut loop contents 
by the haemolysis test or by counterimmunoelectrophoresis would 
have resolved the question as to whether active alpha toxin or 
inactivated, but still antigenic, alpha toxin was still present. 
The lack of fluid in the loops at 12 hours post-inoculation would 
have made this procedure difficult but it might have been possible 
earlier, for example 3 hours after inoculation.
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(f) Conclusions
The studies described in this chapter produced pure alpha 
toxin and antibody to it. Using these reagents it became clear 
that the majority of C.perfringens isolated from pig enteritis 
produced alpha toxin, although there was some doubt about the 
comparability of the results between isolates because of the lack 
of controls on culture density. The repeated studies suggested 
that there was little variability under the conditions used and 
that real variation in alpha toxin production was present.
Antibody to alpha toxin was widespread in adult pig sera 
(42.5 per cent of all pigs surveyed) and confirmed that exposure of 
animals to C.perfringens type A was common. These studies and 
those reported so far did not lead to any unequivocal association 
between alpha toxin production and pathogenicity. There is no 
doubt that isolates 7 and 29 were pathogenic but the diseases 
produced differed. It may be that the changes reported in Chapters 
3 and 4 (Experiments 1 and 2) were largely due to alpha toxin, as 
isolate 29 was not an alpha toxin producer. One of these changes, 
congestion of the mucosa was reproduced in the piglet of the 
intestinal loop study reported here but, as already discussed, the 
ingestion of colostrum by this piglet rendered these results 
inconclusive. It seemed, therefore that although alpha toxin might 
be involved in piglet enteritis, it was not the only component and 
enterotoxin was selected for study in Chapter 6.
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CHAPTER 6
STUDIES ON ENTEROTOXIN PRODUCTION BY PORCINE CLOSTRIDIUM 
PERFRINGENS TYPE A AND ITS ASSOCIATION WITH ENTERIC DISEASE
IN THE PIG
1. INTRODUCTION
The studies described in this chapter were intended to assess 
the effects of enterotoxin in porcine enteric disease and fall into 
7 parts. In the first part, pig faeces and intestinal contents 
were studied to determine whether or not sporulating C.perfringens 
were present. The C.perfringens isolates obtained were combined 
with those isolated earlier and all were tested for their ability 
to sporulate and produce enterotoxin. In the second part 
enterotoxin was purified from one of these isolates and antiserum 
to it was produced. These reagents were then used to stud^ the
incidence of serum antibody to enterotoxin in adult pigs in the
third part and the presence of enterotoxin in pig faeces in the
fourth part. The numbers of sporulating and vegetative cells
present were also determined. The effects of enterotoxin on the 
piglet intestine were then assessed by gut loop studies in part 5, 
by intraluminal injection in part 6 and by infection and protection 
studies in piglets in part 7.
2. SPORULATION AND ENTEROTOXIN PRODUCTION BY PORCINE ISOLATES OF
C.PERFRINGENS TYPE A
(a) Materials and Methods
(i) Isolates of C.perfringens type A used
42 isolates of C.perfringens type A were used. They comprised 
27 isolates obtained in the survey described in Chapter 3 and 15 
isolates obtained in a second survey carried out at Norwich 
Veterinary Investigation Centre and described in detail in section 
5 of this chapter. They were the same as those used in Chapter 5 
for studies on alpha toxin production.
(ii) Methods
The media and methods used to assess the ability of the 
organisms to sporulate have been described in Chapter 2. All three 
sporulation media (Duncan and Strong, Ellner and Tsai media) were 
used for each of the 42 isolates. The production of spores was 
recorded and enterotoxin production was determined by counter- 
immunoelectrophoresis using the antiserum to enterotoxin produced 
in part 2 of this chapter and confirmed by Vero cell assay.
(b) Results
The percentage of sporulation and the numbers of enterotoxin 
producing isolates are shown in Table 29. Enterotoxin was produced 
by 11 of the 42 (26.1 per cent) C.perfringens type A isolates. 13 
isolates (30.9 per cent) produced spores at a frequency of 10 per 
cent or more. Spore production was recorded in 24 (57.1 per cent) 
of the isolates. The titres of enterotoxin produced ranged** from 
1:2 to 1:64. Of the 11 enterotoxin producing isolates 3 were non 
alpha toxin producers of which one produced the highest percentage 
of spores and the largest amount of enterotoxin giving a titre of 
1:64. Among the 9 alpha toxin producing isolates only 2 produced a 
frequency of sporulation of 50 per cent or more and titres of 1:8 
and 1:16 for enterotoxin; relatively low levels of sporulation and 
enterotoxin production were detected in the other 7 alpha toxin 
producing isolates. No enterotoxin was detected in 4 isolates 
which had a percentage of sporulation between 5 to 15 per cent, 
these isolates were also negative using Vero cell assay. One non 
alpha toxin producing isolate failed to sporulate or to produce 
enterotoxin.
The degree of sporulation and enterotoxin production differed 
in the three media used. Duncan and Strong medium was best with 
23 isolates sporulating in this medium, followed by Tsai medium (19 
isolates) and lastly Ellner’s with 17 isolates. The variation in 
spore production in the three media is given in Table 29.
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'3. THE PRODUCTION OF ENTEROTOXIN AND THE PRODUCTION OF ANTISERUM
TO IT
(a) Materials and Methods
(i) Organisms
Isolate number 29 which produced 95 per cent of spores in 
Duncan and Strong medium (Fig. 35) but no alpha toxin (Table 29) 
was used as a source of enterotoxin.
(ii) The production and purification of enterotoxin
The methods used in production and purification are described 
in Chapter 2.
(iii) The production of specific antiserum
Specific antiserum was produced in rabbits using the adjuvants 
described in Chapter 2 and the schedule described in Table 4.
Antibody levels to enterotoxin were assessed by counterimmuno-
electrophoresis as were those to alpha toxin. The protective 
properties of the antiserum were assessed by the mouse protection 
test and in Vero cells. The antiserum was examined for its
activity against enterotoxin produced by the reference strain of 
C.perfringens type A.
(b) Results
(i) The purification of enterotoxin
High yields of enterotoxin activity were obtained when the
percentage of sporulated cells was higher than 90 per cent of the 
total cellular count. The result on the different stages of 
purification are summarised in Table 30.
The three-step purification procedure gave a homogeneous 
protein with a recovery of 25 per cent of the initial enterotoxin 
activity. The results from the gel filtration chromatography are
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?L
FIG. 35: Smear of C.perfringens type A isolate 29.
culture in Duncan and Strong medium.
Note the sporulated organisms (arrow).
(Gram >
8 hour
1200)
214
given in Figure 36. The first peak after the void volume consisted 
mainly of nucleic acids since it had a much higher absorbance at 
260nm than at 280nm. All the enterotoxin activity was found in the 
second peak of elution.
Figure 37 shows the extent of homogeneity at each step as 
determined on polyacrylamide gels. After the second ammonium 
sulphate precipitation the enterotoxin appeared nearly 
homogeneous. This figure also shows the results of electrophoresis 
of a 0-40 per cent ammonium sulphate precipitate of a cell sonicate 
of a culture with 40 per cent of sporulated cells. A weak band 
with the electrophoretic mobility of enterotoxin was detected by 
comparing it with purified enterotoxin from a culture with a higher 
percentage of sporulation.
The purified enterotoxin had a biological activity of 64 
MLD/ml when injected intraperitoneally to mice, and 256 TU/itrl on 
Vero cells.
(ii) Antiserum production
The titres of antibodies to enterotoxin, in immunised pigs and 
rabbits, detected by counterimmunoelectrophoresis using a constant 
purified enterotoxin concentration of 500yg/ml are shown in Table 
31.
Preimmunisation sera of the two pigs showed titres to 
enterotoxin of 1:4 and 1:2 respectively, whereas both 
pre-immunisation sera from rabbits were negative to the presence of 
antibodies to enterotoxin. Titres were increased or produced after 
a first immunisation and a further increase was seen after a second 
immunisation (Fig. 38).
Figure 39 shows that only one precipitation line of identity 
appeared with the antisera produced and purified enterotoxin when 
tested by double immunodiffusion. Lines of identity appeared when 
supernatants from the reference strain were tested.
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FIG. 36: Separation of enterotoxin by gel filtration
chromatography.
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d a b
FIG. 37: Polyacrylamide gel electrophoresis pattern obtained
after each step of purification of enterotoxin. (a) after 0-40 per 
cent ammonium sulphate precipitation; (b) after 0-13 per cent 
ammonium sulphate precipitation; (c) after gel chromatography; 
(d) reference control enterotoxin.
Note the enterotoxin bands at each step of purification (arrow).
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TABLE 31
Antibody titres* of pigs and rabbits
immunised with purified enterotoxin
Animal Preimmunisation 21 days after first 21 days after second
immunisation immunisation
Pig 1 1:4 1:16 1:32
Pig 2 1:2 1:8 1:16
Rabbit 1 - 1:4 1:8
Rabbit 2 - 1:4 1:16
* = detected by counterimmunoelectrophoresis 
- = absent
218
FIG. 38: Detection of antibodies to purified enterotoxin by
counterimmunoelectrophoresis. Double dilutions of serum from 
rabbit 2 immunised with purified enterotoxin: (a) 1:2; (b) 1:4,
(c) 1:8; (d) 1:16; (e) 1:32 and (f) 1:64.
Note the titre of 1:16.
FIG. 39: Double immunodiffusion pattern obtained with purified
enterotoxin (E) and antisera to enterotoxin from pig 1 (W), pig 2 
(X), rabbit 1 (Y) and rabbit 2 (Z).
Note the presence of only one line of precipitation between 
purified enterotoxin and the antisera to it.
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The antisera produced were able to neutralize 8 MLD of 
purified enterotoxin when injected intraperitoneally into mice, 
at the following dilutions: 1:8 (pig 1) 1:4 (pig 2), 1:2 (rabbit
1) and 1:4 (rabbit 2), thus giving a specific activity of 64, 32, 
16 and 32 neutralising MLD units/ml respectively.
The sera neutralised the toxicity of 32 TU of purified 
enterotoxin to Vero cells at the following dilutions: 1:4 (pig 1)
1:2 (pig 2), 1:1 (rabbit 1) and 1:2 (rabbit 2) giving a specific 
activity of 128, 64, 32 and 64 neutralising TU/ml respectively.
4. SURVEY OF ANTIBODY TO ENTEROTOXIN IN ADULT PIG SERA
(a) Materials and Methods
106 serum samples from sows on 4 Scottish farms were used in 
this study as described in Chapter 2. They were the same as .those 
used in Chapter 5 for the study of antibody to alpha toxin. Prior 
to testing the sera were diluted two fold in phosphate buffered 
saline pH 7.2. The level of antibody to enterotoxin was determined 
by counterimmunoelectrophoresis using a constant volume of 10pl of 
enterotoxin containing 5.7mg protein per ml.
(b) Results
Results are summarised in Table 32. Of 106 sera examined, 98 
were found to possess serum antibodies to C.perfringens type A 
enterotoxin with titres ranging from 1:2 to 1:64. No obvious 
differences in serum titres were found in the pig population of the 
four farms tested.
5. LEVELS OF VEGETATIVE C.PERFRINGENS TYPE A CELLS,.SPORES AND THE 
PRESENCE OF ENTEROTOXIN IN PIG FAECES
(a) Materials and Methods
(i) Origin of the faecal samples
A total of 33 faecal samples was examined. 29 samples were
oon
TABLE 32
Distribution of serum titres to C.perfringens type A
Enterotoxin 
CIE * titre Farm 1
enterotoxin in adult pigs 
Farm 2 Farm 3 Farm 4 Total percentage
0 3 2 3 0 8 7.5
2 5 8 6 1 20 18.8
4 9 7 8 4 28 26.4
8 17 8 5 2 32 30.1
16 4 3 0 2 9 8.4
32 2 1 2 3 8 7.5
64 0 1 0 0 1 0.9
Total 40 30 24 12 106 100
* CIE = Counterimmunoelectrophoresis
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obtained at Norwich V.I. Centre and 4 were part of the diagnostic 
material submitted to Glasgow University Veterinary School (Chapter
2). 23 of the samples were from diarrhoeic pigs and 10 were from
non diarrhoeic animals.
(ii) Examinations carried out
The numbers of vegetative cells and spores of C.perfringens 
were determined using tryptone sulphite agar medium (Fig. 40) as 
described in Chapter 2. The presence of enterotoxin was determined 
using Vero cell assay (Figs. 41, 42 and 43), the specificity of 
which was confirmed using neutralisation of toxicity by anti-
enterotoxin and by indirect immunofluorescence on Vero cells 
(Figs. 44 and 45). The other bacteria and enteric pathogens
present were studied using the methods outlined in Chapter 2 and 
the results recorded. C.perfringens type A colonies isolated from 
these samples were stored for use in the alpha toxin determination 
described in Chapter 5 and the sporulation and enterotoxin studies
described in section 2 of this chapter.
(b) Results
The results are shown in detail in Table 33.
C. perfringens type A colonies were detected in horse blood 
agar plates in 15 samples from diarrhoeic animals; colonies were 
not detected in samples from non-diarrhoeic animals, but some 
diarrhoeic samples failed to yield C.perfringens type A on 
horse blood agar.
C.perfringens vegetative cells were, however, detected in all 
the samples with viable counts ranging from 2.5x10  ^cells per gram 
of intestinal material to 3x10^ cells per gram of faeces, on 
tryptone sulphite agar.
C.perfringens spores were detected in 25 out of the total of 
33 samples with ranges from 2x10  ^ cells per gram of intestinal 
material to 5x10^ cells per gram of faeces. Higher viable counts 
of spores than vegetative cells were present in samples 64,65,82,86
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FIG. 40: C.perfringens type A spore counts. Heat-shocked
dilution showing colonies of the organism. 24 hour culture on 
tryptone-sulphite agar.
Note the colour and morphology of the colonies (arrow).
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FIG. 41: Demonstration of enterotoxin by its effects on Vero 
cells. Vero cells after 60 minutes exposure to a sample 
containing 0.25MLD/ml of enterotoxin.
Note the spherical morphology of the cells.
(Transmitted light x 40)
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FIG. 42: Demonstration of enterotoxin by its effects on Vero 
cells. Vero cells after 60 minutes exposure to a sample 
containing 1 MLD/ml of enterotoxin.
Note the detachment of the cells.
(Transmitted light x 40)
FIG. 43: Negative sample to enterotoxin on Vero cells.
Note the typical Vero cell morphology.
(Transmitted light x 40)
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FIG. 44: Demonstration of enterotoxin adsorbed onto Vero cells by
indirect immunofluorescence. Sample positive for enterotoxin.
Note the fluorescence concentrated in the peripheral cytoplasm of 
the cells.
(x 1200)
FIG. 45: Sample negative for enterotoxin.
Note the absence of fluorescence and the integrity of the cell 
sheet.
(Fluorescent antibody x 1200)
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and 87. These same samples were the only ones in which 
enterotoxin could be detected. These samples were from the 
submissions, 21,28 and 31. The clinical signs associated with 
these samples are given below.
Submission 21 consisted of carcases from 2 seven day old 
piglets from a herd with 20 per cent losses from birth to weaning 
at 3-10 days of age. The diarrhoea and death occurred only in gilt 
litters. Gilts were housed separately from sows. The carcases 
were in poor condition with a yellowish creamy diarrhoea. The 
small intestines were mildly congested and empty and the large 
intestines were filled with creamy or pasty yellowish contents. No 
gross lesions were seen in other organs. C.perfringens was 
isolated in profuse culture on horse blood agar from the duodenum, 
jejunum, ileum and large intestine. Submission 28 consisted of 
diarrhoeic faeces from a 3 week old piglet submitted with no 
history. The p-haemolytic E.coli isolated was untypable. 
Submission 31 consisted of 2 diarrhoeic faeces samples from 12*»week 
old pigs with mucoid diarrhoea in a pen of 8 pigs none of which had 
died. Swine dysentery was absent.
6. THE EFFECTS OF ENTEROTOXIN ON PIGLET INTESTINAL LOOPS
(a) Materials and Methods
(i) Animals
Two hysterectomy-derived, colostrum-deprived piglets and one 
conventionally born, colostrum-deprived piglet were used.
(ii) Methods
The ligated intestinal loop technique was performed as 
previously described in Chapter 2. The animals were killed 12 
hours after injection of the preparations.
Eleven intestinal loops were prepared in the conventionally 
born, colostrum-deprived piglet as shown in Table 34. Two loops 
were inoculated with purified enterotoxin containing 1.68mg of
protein per ml with an activity of 512 toxic units to Vero cells
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per ml. One loop was injected with the same enterotoxin after 
incubation for 30 minutes at room temperature with 0.25ml of rabbit 
anti-enterotoxin serum containing 16 units of antibody to 
enterotoxin when tested by counterimmunoelectrophoresis. Two loops 
were inoculated with the culture supernatant of isolate number 34 
grown in Duncan and Strong medium, centrifuged and filtered through 
a filter of APD 0.22pm. Another loop consisted of the same culture 
supernatant fluid previously incubated with anti-enterotoxin serum 
for 30 minutes at room temperature. Two loops were injected with 
the culture supernatant fluid of isolate 29. One loop was 
inoculated with this culture supernatant incubated with 
anti-enterotoxin serum. Two control loops received sterile Duncan 
and Strong medium. Accumulation of fluid, macroscopic congestion 
of mucosa, and histo-pathological changes were recorded for each of 
the inoculated loops.
Ten intestinal loops were utilised in hysterectomy-derived, 
colostrum-deprived piglet according to the schedule in Table. 35. 
Five loops were injected with dilutions of purified enterotoxin 
ranging from a concentration of protein per loop of 0.04mg to 
1.14mg. The activity of the inoculated dilutions of enterotoxin 
ranged from 4 to 256 toxic units per ml. Two loops were inoculated 
with dilutions of purified enterotoxin containing 16 and 64 toxic 
units per ml, respectively which were previously incubated with 
0.25ml of pig anti-enterotoxin serum possessing a titre of 32 anti- 
enterotoxin units when tested by counterimmunoelectrophoresis. One 
loop was injected with the whole culture of isolate 29 grown in 
Duncan and Strong medium, and contained 95 per cent of sporulated 
cells (total number of 3x10® cells per ml). One control loop was 
injected with saline solution. Accumulation of fluid and 
macroscopic congestion of the mucosa were recorded for each 
segment. Histopathological and immunofluorescence studies were 
carried out on the mucosa of the loops.
Eleven intestinal loops were utilised in hysterectomy-derived 
colostrum deprived piglet 2 inoculated at the same time as piglet 
1 with a complementary series of C.perfringens products. Loops 
were inoculated as follows: five loops were injected with
dilutions of purified enterotoxin ranging from a concentration of
232
1protein per loop of 0.04mg to 1.14mg. One loop received a dilution 
of purified enterotoxin containing 32 toxic units per ml which was 
previously incubated with 0.25ml of pig anti-enterotoxin serum 
described above. One loop was inoculated with whole culture of 
isolate 29 grown in cooked meat medium. Another loop received 
vegetative cells (isolate 29) grown in the same cooked meat medium 
and washed by centrifugation in saline solution. Two loop controls 
were incubated with saline solution and one loop control received 
sterile cooked meat medium.
(b) Results
(i) Conventionally born, colostrum-deprived piglet
Ligated intestinal loops prepared in the conventionally born, 
colostrum deprived piglet showed accumulation of fluid when 
purified enterotoxin was injected, (Table 34, Fig. 46) one of these 
loops (loop 9) was found to have burst when post-mortem examination 
was carried out and congestion of the mucosa was evident. The 
effect of the enterotoxin was neutralised by the rabbit 
anti-enterotoxin serum preventing accumulation of fluid and 
congestion of the mucosa in the inoculated intestinal loop (loop 
5). No evidence of accumulation of fluid was noted in loops 
injected with culture supernatant alone, although congestion of the 
mucosa was present in the 4 loops (loops 2,3,10 and 11) inoculated 
with these preparations. Loops inoculated with culture
supernatants previously incubated with rabbit anti-enterotoxin 
serum did not show evidence of congestion of the mucosa (loops 6 
and 7). Loops injected with sterile Duncan and Strong medium did 
not show fluid accumulation or congestion of the mucosa (Table 34).
Intestinal loops inoculated with enterotoxin showed marked 
histological changes consisting of massive destruction of the 
villous architecture (Fig. 47). Necrosis and inflammation of the 
mucosa was evident. Large quantities of cell debris were present 
in the lumen. Congestion of the mucosa and lamina propria was 
observed. The loop inoculated with enterotoxin mixed with anti- 
enterotoxin serum presented an increased hypercellularity in lamina 
propria but no other histological changes were denoted in this
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FIG. 46: Inoculation of purified enterotoxin and C.perfringens
type A culture supernatant fluids into intestinal loops of 
conventionally-born, colostrum-deprived piglet. Loops 1,9 and 5 
were inoculated with concentrated purified enterotoxin. Loop 1 is 
distended with fluid, loop 9 has burst and in loop 5 the toxin was 
neutralised by rabbit antiserum.
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FIG. 47: Histological section of the ileal mucosa in loop 1 of
conventionally born, colostrum-deprived piglet, inoculated with 
purified enterotoxin.
Note the destruction of the villous architecture, the cell debris 
in the lumen (a), and areas of congestion of the lamina propria.
FIG. 48: Histological section of the ileal mucosa of control loop
4 of conventionally born, colostrum-deprived piglet, inoculated 
with sterile Duncan and Strong medium.
Note the normal appearance of the villi and the lamina propria.
(HE x 120)
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loop. Loops inoculated with culture supernatants had congestion of 
the mucosa and lamina propria but no desquamation of villous 
epithelium was observed in these loops. Loops injected with 
culture supernatants mixed with anti-enterotoxin serum and control 
loops inoculated with sterile Duncan and Strong medium did not show 
any histopathological changes (Fig. 48).
No immunofluorescence studies were carried out on this animal,
(ii) Hysterectomy-derived, colostrum-deprived piglet
Ligated intestinal loops prepared in the hysterectomy-derived, 
colostrum-deprived piglet showed accumulation of fluid when doses 
of 1.14 (loop 1), 0.85 (loop 10) and 0.35mg (loop 4) of protein 
were injected (Table 35, Fig. 49). The degree of fluid 
accumulation was correlated with the amount of enterotoxin 
inoculated, the highest dose produced a larger accumulation of 
fluid. Enterotoxin doses of 0.08 and 0.04mg of protein did not 
induce accumulation of fluid in the injected loops 8 and 9. 
Accumulation of fluid was not noted in loops inoculated with 0.71 
and 0.17mg of enterotoxin mixed with pig anti-enterotoxin serum 
(loops 3 and 7). Accumulation of fluid was absent in loops 
inoculated with sporulated cells, saline solution and sterile 
Duncan and Strong medium. Macroscopic congestion of the mucosa was 
evident in loops 1,10 and 4 inoculated with enterotoxin doses of 
1.14, 0.85 and 0.35mg, as well as in loop 3 inoculated with 0.71mg 
of enterotoxin mixed with pig anti-enterotoxin serum.
Intestinal loops inoculated with doses of enterotoxin of 1.14, 
0.85 and 0.35mg presented a massive destruction of the intestinal 
epithelium. Necrosis and inflammation of the mucosa were evident. 
Cell debris was present in the lumen. Large haemorrhages were seen 
in loops with doses of enterotoxin of 1.14 and'0.85mg (Fig. 50). 
Congestion of the mucosa and lamina propria was present in loops 
inoculated with 1.14, 0.85 and 0.35mg of enterotoxin as well as in 
loop inoculated with 0.71mg of enterotoxin mixed with pig 
anti-enterotoxin serum. Loop inoculated with sporulated cells had 
shortened villi and areas of haemorrhage at lamina propria level. 
Loops inoculated with doses of enterotoxin of 0.08 and 0.04mg
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FIG. 49: Inoculation of purified enterotoxin and C.perfringens
type A sporulated cells into intestinal loop of hysterectomy- 
derived, colostrum-deprived piglet 1.
Note the accumulation of fluid in loops 1 (E), 4 (E 1/8) and 10 (E 
1/2) which were inoculated with dilutions of purified 
enterotoxin. The other loops did not show accumulation of fluid. 
The enterotoxin effect was neutralised by rabbit antiserum in loop
FIG. 50: Histological section of the ileal mucosa of loop 10 of
hysterectomy-derived, colostrum-deprived piglet 1, inoculated with 
purified enterotoxin.
Note the destruction of the villous architecture, the cell debris 
in the lumen (a) and the haemorrhages in the lamina propria 
(arrow).
3 (Ab E 1/4).
a
(HE x 120)
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showed a mild congestion in the lamina propria. Loops injected 
with saline solution and sterile Duncan and Strong medium did not 
show histological changes.
Tracing of enterotoxin with its specific antiserum by indirect 
immunofluorescence in frozen sections of intestinal loops revealed 
its presence at the surface of the villous epithelium. Doses of 
1.14 and 0.85mg of enterotoxin produced an almost solid fluorescent 
outline on the epithelium (Fig.51) and complete bright fluorescence 
of individual epithelial cells. Strongly-fluorescent desquamated 
epithelial cells were found in the lumen (Fig.52). Enterotoxin 
could be detected in the epithelium of loops inoculated with doses 
of 0.08 and 0.04mg but the fluorescence seen was weaker than with 
higher levels of enterotoxin (Fig. 53) and to be concentrated in 
the peripheral cytoplasm of the cells.
Fluorescence could be demonstrated also in the epithelium of
the loop inoculated with sporulated cells and loop 3 inoculated
with enterotoxin and antiserum, fluorescence in these segments was 
similar to that found with low doses of enterotoxin in intestinal 
loops.
Fluorescence could not be demonstrated in the epithelium of 
loops inoculated with saline solution and sterile Duncan and Strong 
medium (Fig. 54).
Piglet 2 died 2 hours after operation and there were no 
obvious changes in the loops (Table 36). No further examination 
was carried out on this animal.
7. THE INTESTINAL RESPONSE TO THE INTRALUMINAL INJECTION OF
C.PERFRINGENS ENTEROTOXIN
(a) Materials and Methods
Two hysterectomy-derived, colostrum-deprived piglets were
used. The operative procedure for the intraluminal injection of 
enterotoxin was carried out as previously described in Chapter 2. 
The animals were injected with a 2ml dose of purified enterotoxin
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FIG. 51: Demonstration of enterotoxin by indirect immuno­
fluorescence on the mucosal epithelium of loop 10 of hysterectomy- 
derived, colostrum-deprived piglet 1 inoculated with purified 
enterotoxin.
Note the solid fluorescent outline of the epithelium (arrow).
(x 300)
FIG. 52: Demonstration of enterotoxin by indirect immuno­
fluorescence on desquamated epithelial cells in the ileal lumen of
loop 10 of hysterectomy-derived, colostrum-deprived piglet 1
inoculated with purified enterotoxin.
Note the bright fluorescence of individual epithelial cells
(arrow).
(x 400)
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FIG. 53: Demonstration of enterotoxin by indirect immuno­
fluorescence on the mucosal epithelium of loop 9 of hysterectomy- 
derived, colostrum-deprived piglet 1 inoculated with purified 
enterotoxin.
tm
Note the weaker fluorescence (arrow) than in loops inoculated with 
higher levels of enterotoxin (Figs. 51 and 52).
(x 400)
FIG. 54: Control loop 5 of hysterectomy-derived, colostrum-
deprived piglet 1 inoculated with sterile Duncan and Strong 
medium.
Note the absence of fluorescence.
(Fluorescent antibody x 400)
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containing 5.7mg of protein per ml and an activity of 256 toxic 
units per ml to Vero cells into what was intended to be the 
j ej unum.
The injection site was marked with dye in one piglet and by a 
suture in the other. After laparotomy, the animals were observed 
at intervals for the occurrence of diarrhoea and killed 12 hours 
after the enterotoxin injection. The whole intestine of the 
piglets was extended and observed for the presence of fluid 
accumulation and macroscopic lesions. Segments of duodenum, 
jejunum, ileum, caecum and colon were taken for histology and 
immunofluorescence studies and processed by the methods described 
in Chapter 2.
(b) Results
(i) Clinical „
A watery-mucoid diarrhoea which stained the perineum developed 
in both piglets within one hour post-inoculation (Fig. 55) followed 
by return to an apparently normal state at 6 to 8 hours.
(ii) Pathological
At post-mortem examination the site of injection could not be 
identified unequivocally in the animal marked with dye but was 
thought to be 30cm anterior to the caecocolic junction. In the 
sutured animal it was found to be in the mid-ileum 30cm anterior to 
the ileocaecocolic junction.
The duodenum, and jejunum of both animals appeared normal with 
no excess of fluid. From the site of enterotoxin injection, at 
mid-ileum, to the terminal ileum, a mild congestion of the mucosa 
was noticed in both piglets. The colon of one of the piglets was 
filled with a watery mucoid fluid, in the other animal fluid was 
also present although in smaller quantities. The colonic mucosa of 
both piglets was mildly congested.
FIG. 55 Hysterectomy-derived, colostrum-deprived piglet 1 with 
diarrhoea, one hour post-intraluminal inoculation of purified 
enterotoxin.
Note the watery mucoid diarrhoea (arrow).
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Histologically, the duodenum and jejunum of both animals did 
not show pathological changes. The upper ileum, anterior to the 
site of injection appeared to have areas of congestion in the 
lamina propria in both animals. The epithelial cells were normal 
at this level. The caudal region of the ileum, posterior to the 
site of injection showed a shortening of the villi to about 
two-thirds from the normal length in both piglets. At this level 
one of the animals had areas of congestion in submucosa, muscular 
layer and serosa; the lamina propria between the crypts and in the 
cores of the villi contained inflammatory cells mainly mononuclear 
cells, and haemorrhages were present at lamina propria level. 
Desquamated epithelial cells were observed in the lumen (Fig. 56). 
Less severe lesions were observed in the second piglet at this 
level of the ileum where a mild congestion of lamina propria was 
observed; areas of localised oedema were also noted at lamina 
propria level in this animal. The caecal and colonic lesions of 
both animals were identical.
Areas of haemorrhage were seen in the lamina propria. 
Inflammatory cells were present in large numbers mainly in the 
submucosa. The surface epithelium was uneven and covered with 
oedematous fluid. Desquamated epithelial cells were found in the 
lumen. There was local cytoplasmic irregularity of the lumenal 
epithelium of caecum and colon (Fig. 57).
Enterotoxin was demonstrated by indirect immunofluorescence 
in the intestinal sections of first piglet from the terminal 
jejunum where a weak fluorescence was observed to the colon. 
Intestinal sections of the second piglet showed fluorescence from 
the mid-ileum to the colon. Sections of upper duodenum, lower 
duodenum and mid-jejunum were negative for enterotoxin as well as 
section of terminal jejunum of the second piglet (Table 37). 
Enterotoxin could be demonstrated in the epithelial cells of the 
intestinal sections and when desquamated epithelial cells were 
present in the lumen of terminal ileum, caecum and colon, 
fluorescence was demonstrated on them (Fig. 58).
247
FIG. 56: Histological section of the ileal mucosa of
hysterectomy-derived, colostrum-deprived piglet 1 intraluminally 
inoculated with purified enterotoxin.
Note the shortening of the villi and the cell debris in the lumen
a
t,
FIG. 57: Histological section of the colonic mucosa of
hysterectomy-derived, colostrum-deprived piglet 1 intraluminally 
inoculated with purified enterotoxin.
Note the cell debris in the lumen (a) and the haemorrhages at 
lamina propria level (arrow).
(HE x 120)
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FIG. 58: Demonstration of enterotoxin by indirect immuno­
fluorescence on desquamated epithelial cells in the ileal lumen of 
hysterectomy-derived, colostrum-deprived piglet 1 intraluminally 
inoculated with purified enterotoxin.
Note the bright fluorescence of individual epithelial cells 
(arrow).
(x 400)
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8 .  EXPERIMENTAL INFECTION OF PIGLETS WITH AN ENTEROTOXIN
PRODUCING ISOLATE OF C.PERFRINGENS TYPE A AND PROTECTION
AGAINST IT (EXPERIMENT 3)
(a) Materials and Methods
(i) Animals
Ten hysterectomy-derived, colostrum—deprived piglets were 
produced by the methods described in Chapter 2, and housed in the 
accomodation used in the earlier experiments. Two of the piglets 
were found to have atresia ani after allocation to groups and 
inoculation had been carried out.
(ii) Procedures
The animals were divided into pairs forming 5 groups (Table 
38). The first group was formed of non—infected, non—immunised 
controls. The second group comprised non—immunised animals 
infected with sporulated cells of C.perfringens type A. The third 
group consisted of passively immunised animals infected with 
sporulated cells. A fourth group was formed of non—immunised 
piglets infected with vegetative cells of C.perfringens type A. 
The fifth group consisted of passively immunised animals infected 
with vegetative cells.
Anti-enterofcoxin serum from pig 1 described in Part 3 above 
containing 128 neutralising TU/ml was absorbed with washed 
C.perfringens type A cells (isolate 29) and filtered through a 
membrane filter of APD 0.22pm. Passive immunisation was carried 
out by giving 5ml orally and 5ml intraperitoneally of this 
anti—enterotoxin serum to each of the piglets described above one 
hour after delivery.
Two hours after delivery the piglets were challenged with 
C.perf ringens type A (Isolate 29, Chapter 3, and part 2 above) 
which was an enterotoxin producer but which did not produce alpha 
toxin.
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5ml of inoculum containing approximately 3x10® C.perfringens 
type A sporulated cells/ml were given to four piglets, whereas 
other four animals received 5ml of inoculum containing 
approximately 4x10^ C.perfringens type A vegetative cells/ml (Table 
38).
All piglets were examined daily and their appearance, 
appetite and the consistency of their faeces were recorded. Rectal 
swabs were taken daily from all animals and examined for the 
presence of C.perfringens type A and other bacteria by the methods 
described in Chapter 2.
Viable counts of C.perfringens type A vegetative cells and 
spores were determined on tryptone sulphite agar medium as 
previously described. The viable counts were determined in faecal 
samples taken 36 hours after infection and in intestinal fluids 
collected from the piglets at post-mortem. The presence of 
enterotoxin in these samples was detected using Vero cell assay and 
confirmed using anti-enterotoxin serum by the methods described in 
Chapter 2.
The piglets were sacrificed in the sequence shown in Table 37 
and post-mortem examination was carried out as previously described 
in Chapter 3.
Mucosal samples from jejunum, ileum and colon of each piglet 
were examined for the presence of C.perf ringens type A and other 
bacteria by the methods previously described. The percentages of 
spores seen in intestinal smears were recorded. Histological, 
immunofluorescence and bacteriological examinations were all 
carried out on sections of intestine. Blood samples were taken 
from all piglets at slaughter and the sera collected and stored at 
-20°C. These sera were examined for the presence of antibodies to 
enterotoxin by counterimmunoelectrophoresis.
(b) Results
(i) Clinical findings
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All piglets were clinically normal and healthy during the 
period prior to infection with the exception of piglets 1 and 5 
which had atresia ani, this condition was noticed after the groups 
had been formed.
The clinical effects of infection are shown in Table 38. 24
hours after infection piglets 3,4,7 and 9 presented a profuse milky 
diarrhoea. No clinical signs were noted in the rest of the animals 
at that time.
At 36 hours post infection piglets 6,8 and 10 developed the
same kind of diarrhoea, thus, all infected piglets presented 
diarrhoea at that time. Piglet control 2 was healthy, passing 
normal faeces.
48 hours after infection diarrhoea stopped in all infected
piglets except in piglet 7 which presented a mild creamy
diarrhoea. 6 hours later diarrhoea stopped in this piglet. At
that time piglets 8 and 10 presented soft faeces. The rest of the 
animals were clinically normal.
At 60 hours post-infection all piglets were clinically normal 
and passing normal faeces.
96 hours post-infection piglet 3 developed a mild creamy 
diarrhoea which lasted until slaughter on the fifth day of 
observation.
All the rest of the piglets remained healthy and had normal 
faeces. The changes in the faecal consistency of the piglets are 
summarised in Table 38.
(ii) Cultural findings from faecal swabs
Pre-infection faecal swabs were all negative for the presence 
of C.perfringens type A in all infected piglets. The organism was 
isolated in pure culture from the rectal swabs of all infected
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TABLE 38
Changes in faecal consistency in HDCD piglets following infection
with pure cultures of C.perfringens type A enterotoxin-•producer
Piglet
No.
strain and isolation of the organism from faecal swabs
6
Passively Infection 
immunised 0 1
Day of 
2
:Experiment 
3 4 5
1 - * * *
K
2 - N N N N N N NK
- - - - +2 +2 +2
3 A N D N N D DK
- +1 +1 +1.2 +2 +2
4 - A N D N N N NK
- +1 +1 +1,2 +2 +2
5 + A * * *
K
6 + A N D N N N NK
- +1 +1 +1,2 +2 +2
7 B N D D N N N NK
- +1 +1 +1 +1;2 +2 > ^ +2
8 B N D S N NK
- +1 +1 +1 +1:2>
9 + B N D N N N N NK
- + 1 +1 +1 +2 +2 +2
10 + B N D S N NK
- +1 +1 +1 +2
A = 5ml inoculum containing 3xl0®/ml C.perfringens sporulated cells 
B = 5ml inoculum containing 4x10^/ml C.perfringens vegetative cells 
* Piglets with atresia ani 
N = normal faeces D = diarrhoea
S = soft faeces K = killed
+ = 1 - C.perfringens non-haemolytic isolated from faecal swabs 
2 - C.perfringens haemolytic isolated from faecal swabs 
- = C.perfringens not isolated from faecal swabs
254
animals on the first day post-inoculation (Table 38), The isolated 
C.perfringens type A corresponded in all cases to the non- 
haemolytic strain used for the infection. Control piglet 2 did not 
show presence of any bacteria at this time.
On the second day of experiment profuse cultures of the same 
non-haemolytic C.perfringens type A were obtained from faecal swabs 
of all infected piglets, although, only in piglets 9 and 10 did it 
appear as a pure culture. Staphylococcus spp. was isolated from 
faecal swabs of the rest of the animals including control 2 which 
remained negative for C.perfringens type A. On. the third day 
post-inoculation faecal swabs from piglets 3,4 and 6 contained 
mixed colonies of haemolytic and non-haemolytic C.perfringens type 
A. Plates from faecal swabs of piglets 7,8,9 and 10 showed only 
the presence of non-haemolytic colonies of the organism. Control 
piglet 2 remained negative to the presence of the organism.
On the fourth day of the experiment, faecal swabs from piglets 
3,4,6,9 and 10 revealed only the presence of haemolytic 
C.perfringens type A, whereas infected animals 7 and 8 still had 
mixed colonies of haemolytic and non haemolytic C.perfringens type 
A. Control piglet 2 had C.perfringens type A haemolytic colonies 
only. Other bacteria identified in the faecal swabs of all animals 
on this day were non-haemolytic E.coli, Streptococcus spp. and 
Staphylococcus spp.
On the fifth day post-infection, only haemolytic C.perfringens 
type A colonies were detected in faecal samples of piglets 
2,3,4,6,7 and 9.
On the sixth day of the experiment the remaining animals 7,9 
and control 2 presented colonies of C.perf ringens type A haemolytic 
apart from colonies of other bacteria which included non-haemolytic 
E.coli, Clostridium spp. Staphylococcus spp. and Streptococcus spp.
In all cases, when haemolytic C. perfringens type A was 
isolated, was not present in profuse culture, and, generally few 
colonies of the organism were detected in each case.
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(iii) Viable counts of C.perfringens type A cells and 
enterotoxin detection
The results of the viable counts carried out on faeces are 
shown in Table 39. At 36 hours post-infection sporulating cells 
were present at levels of up to 4.5x10^ per gram. None were found 
in the faeces of the uninoculated controls. Higher levels of 
sporulating cells were identified than of vegetative cells.
Enterotoxin was present at levels of 1:4 to 1:32 in the faeces 
of all inoculated piglets (Table 39). None was detected in the 
faeces of control piglet 2.
(iv) Post-mortem findings
The results of the post-mortem examinations are described 
below:
*
Piglets 1 and 2, uninfected controls killed on days 2 and 6 
Piglet 1 had atresia ani but the findings in both piglets were 
essentially similar. Both piglets had grossly normal
gastrointestinal tracts with normal contents which in the case of 
piglet 1 consisted of meconium in the colon. No histological 
abnormalities were detected and no enterotoxin was found (Table 40) 
in immunofluorescence studies.
C.perfringens cells were seen in mucosal smears from both 
piglets (Table 41) but no spores were seen. C.perfringens type A 
of the haemolytic colony type was isolated in small numbers from 
both piglets from the sites shown in Table 42. The small numbers 
seen were confirmed by the counts of vegetative cells and spores 
shown in Table 43. No spores were detected and low levels of 
vegetative cells (lO^-lO^/gram) were present. No enterotoxin was 
identified and no antibody to enterotoxin was found in their sera 
(Table 43).
Piglets 3 and 4, infected with sporulated cells but non­
immunised and killed on day 5. Piglet 3 was found to have 
congestion of the jejunum and ileum with oedema of the large
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intestinal wall and pinpoint haemorrhages of the mucosa. The 
contents were fluid but no mucus, blood or necrotic material was 
seen in them. Piglet 4 was grossly normal. The major feature of 
the histological findings were congestion of the lamina propria 
with no apparent abnormalities of the villous structure or 
epithelium. Cellular accumulations consisting largely of
lymphocytes and neutrophils were seen in the lamina propria of the 
ileum. Haemorrhages, inflammatory cell infiltrates and oedema were 
present in the lamina propria of the colon (Fig. 59). Mild 
congestion of the jejunal mucosa and inflammatory cell infiltration 
of the lamina propria were the only changes seen in the gastro­
intestinal tract of piglet 4.
Enterotoxin was only demonstrated in sections of the colon of 
piglet 3 (Table 40) and was located in the epithelium. Both 
vegetative and sporulating cells of C.perfringens were seen in 
direct smears of the mucosa of both pigs (Table 41). Appreciable 
numbers of sporulating cells (5 to 10 per cent) were seen only in 
the colon. C.perfringens type A was isolated from both piglets and 
from the sites shown in Table 42. Non-haemolytic C.perfringens 
type A was only detected in the colonic contents of piglet 3. 
Sporulating cells were, however, present in the intestinal contents 
of both piglets at levels of 10  ^organisms per ml (Table 43) but no 
enterotoxin was demonstrated in these contents. No antibody to 
enterotoxin was demonstrated in the sera of either piglet (Table 
44).
Piglets 5 and 6, infected with sporulated cells, passively 
immunised and killed on days 2 and 5. Piglet 5 had atresia ani, 
the intestines were dilated with fluid contents and the walls of 
the intestine were thin. The gastrointestinal tract of piglet 6 
was normal. The only histological abnormality seen in piglet 5 was 
accumulation of lymphocytes and neutrophils in the lamina propria 
of the jejunum. In piglet 6, however, shortening of the ileal 
villi and accumulations of inflammatory cells in the lamina prorpia 
were seen but no other microscopic changes were detected. 
Enterotoxin was detected in the epithelium of the jejunum, ileum 
and colon (Table 40) but none was seen in the gut of piglet 6.
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C.perfringens was seen in direct smears of the mucosa of both 
piglets (Table 41) but was present in greatest numbers and with 30 
per cent of spores in piglet 5 (Fig. 60). These findings were 
confirmed by culture (Table 42) and all of the C.perfringens type A 
isolated from piglet 5 were found to be non-haemolytic. In 
contrast those from piglet 6 were all haemolytic. The viable 
counts (Table 43) also confirmed the results of the smears and 
showed that high levels of both vegetative cells (4x10® per gram) 
and spores (6.5x10^ per gram) were present in the intestinal 
contents of piglet 5. Enterotoxin was also present in these 
contents. Antibody to enterotoxin was present in the sera of both 
piglets (Table 44).
Piglets 7 and 8, infected with vegetative cells but not 
passively immunised and killed on days 6 and 4. There was mild 
congestion of the jejunal and ileal serosa and mucosa of both 
piglets and patchy congestion of the colonic mucosa of piglet 8. 
The contents were normal in both piglets. Histological changes 
included oedema and congestion of the lamina propria of the jejunum 
and ileum of piglet 8. The apparent congestion seen in the 
intestines of piglet 7 could not be identified in histological
sections. Enterotoxin was detected by immunofluorescence in the 
colons of both animals and in the ileum of piglet 7 (Table 40).
Vegetative C.perfringens cells were seen in all regions of the 
gut in gram stained smears (Table 41) and large percentages of 
spores (10 per cent-piglet 7; 25 per cent-piglet 8) were present in 
the colonic mucosa of both piglets. The presence of C.perfringens 
type A was confirmed by culture (Table 42) when a mixture of both 
haemolytic and non-haemolytic C.perfringens type A was isolated
from the colons of both piglets and from the jejunum and ileum of 
piglet 7. Few non-haemolytic colonies were isolated from these 
sites. The colony counts confirmed that both sporulating and 
vegetative cells were present (Table 43) but no enterotoxin was
detected in the gut contents of either piglet. No antibody to
enterotoxin was present in their sera (Table 44).
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TABLE 40
Demonstration of enterotoxin antigen by indirect immunofluorescence 
on intestinal sections of HDCD piglets following infection with 
pure cultures of C.perfringens type A enterotoxin-producer strain
Piglet Passively Infection Intestinal section
No.______ immunised_____________ Jejunum____ Ileum____ Colon
1 - - - - -
Z
3 — A — — ++
4 - A - - -
5 + A ++ +++ ++
6 + A - — -
7 - B - + + •»
8 - B - - +
9 + B - - -
10 + B — — —
Results graded + to +++ on amount of fluorescence observed 
- = negative
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TABLE 41
mucosal. smears from HDCD piglets following infection with pure
cultures of C.perfringens type A enterotoxin-producer strain
Piglet
No.
Passively
immunised
Infection Mucosal smear 
Jejunum Ileum Colon
1 +
2 - - +(0) +(0) +(0)
3 - A ++«]1) ++«1) ++(5)
4 - A ++(0) ++« 1) ++(10)
5 + A +++(30) +++(30) +++(30)
6 + A +(0) ++« 1) ++« 1)
7 - B ++(<1) ++(<U ) ++(10)
8 - B ++(<11) ++« 1) ++(25J
9 + B ++«1) ++(0) ++«H)
10 + B ++(0) ++(<11) ++(«!)
+
++
+++
«)
= no C.perfringens detected in smear
= few of the bacteria observed corresponding to C.perfringens 
= most of the bacteria observed corresponding to C.perfringens 
= only C.perfringens observed in smear
= percentage of spores from total number of C.perfringens cells 
= less than
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TABLE 42
Sites from which C.perfringens type A was isolated from HDCD
piglets following infection with pure cultures of
C.perfringens type A enterotoxin-producer strain
Piglet Passively Infection Jejunum Ileum 
No. immunised
Colon
1
2 - - + + -
3 - A ++ + +*
4 - A ++ + +
5 + A ++* ++* ++*
6 + A + + -
7 - B ++* ++* ++*
8 - B -H- ++ ++*
9 + B ++ ++ +
10 + B ++ ++ +*
- = no colonies of C.perfringens isolated
+ = between 1 and 8 colonies of C.perfringens isolated
++ = more than 8 colonies of C.perfringens isolated 
* = Non-haemolytic colonies of C.perfringens detected
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TABLE 44
Antibody titres to enterotoxin in sera of HDCD piglets 
passively immunised, following infection with pure cultures 
of C.perfringens type A enterotoxin-producer strain
Piglet Passively Infection Collection of CIE titres to
No. immunised samples (days after enterotoxin
____________________________immunisation)_______  . __
1 - — 2 -
2 - - 6 -
3 - A 5 -
4 - A 5 -
5 + A 2 1:32
6 + A 5 1:16
7 - B 6 -
8 - B 4 -
9 + B 6 1:16
10 + B 4 1:32
- = absent
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FIG. 59: Histological section of the colonic mucosa of
hysterectomy-derived, colostrum-deprived piglet 3, 5 days post­
inoculation with C.perfringens type A enterotoxin-producer isolate 
29.
Note the haemorrhages at the lamina propria level (arrow).
(HE x 400)
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FIG. 60: Smear of the colonic mucosa of hysterectomy-derived,
colostrum-deprived piglet 5, 3 days post-inoculation with
C.perfringens type A enterotoxin-producer isolate 29.
Note the sporulated C.perfringens type A organisms (yellow arrow) 
and the free spores (black arrow).
(Gram x 1200)
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Piglets 9 and 10, infected with vegetative cells, passively 
immunised and killed on days 6 and 4. Piglet 4 was normal apart
from mild congestion of the jejunum, ileum and colon. In
contrast, piglet 10 was moribund when killed and had marked 
distension of the small intestine with gas, mild congestion of the 
jejunum and ileum and marked oedema of the meso-colon. The 
contents of the large intestine were normal. In histological 
sections of piglet 9 there was congestion of the jejunal lamina 
propria, congestion and inflammatory cell infiltrates were present 
in the wall of the ileum and epithelial cell shedding but no 
villous atrophy was seen. The colonic mucosa appeared to be 
normal. Piglet 10 appeared to be histologically normal apart from 
the presence of colonic oedema. No enterotoxin was detected by 
immunofluorescence in either piglet (Table 40).
Vegetative cells of C.perfringens with few spores were seen in
direct smears from the mucosa of all levels of the intestine (Table 
41) and this was confirmed by isolation (Table 42). A few non- 
haemolytic C.perfringens cells were isolated from the colon of 
piglet 10. Spores were only present in low levels (10  ^ per gram; 
Table 43) and vegetative cells were present in greater numbers (10^ 
per gram). No enterotoxin was detected in the contents but serum 
antibody to it was found in both piglets in sera taken at slaughter 
(Table 44).
9. DISCUSSION
(a) Sporulation and enterotoxin production by porcine isolates 
of C.perfringens
The studies on the ability to sporulate and produce 
enterotoxin by 42 C.perfringens type A isolates revealed that 24 
were able to sporulate to a lesser or greater degree as shown in 
table 29. In general, all isolates sporulated better in Duncan and 
Strong medium than in Ellner or Tsai media, this result differs 
slightly from Tsai et al. (1974) who reported that from a total of 
65 strains, a better sporulation was produced in the medium 
developed by them than in Duncan and Strong and Ellner media. 
However, two isolates from the same submission (64 and 65) produced
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a larger number of spores in Tsai medium than in the others.
The difficulty of getting C.perfringens to sporulate in most 
laboratory media is widely reported (Sacks and Thompson, 1978; 
Labbe, 1981), A number of sporulation media and techniques have 
been developed to sporulate C.perfringens but production of a 
significant number of spores has been a continuing problem in many 
strains.
High levels of spores were produced by 3 isolates in Duncan 
and Strong medium. The best was isolate 29 (95 per cent
sporulation) while isolate 59 produced 50 per cent of spores and 
isolate 82, 85 per cent of spores. Isolates such as 35, 36, 37, 
53, 54 and 55 produced no spores and it is of interest that these 
were all from individual submissions. In other submissions such as 
submission 12 both sporulating and non-sporulating isolates were 
found. The significance of this finding is not clear but pigs from 
a common background are likely to be infected with similar 
organisms. This difference of sporulation percentage is* not 
associated with selection for spores at isolation as all these 
isolates were taken from horse blood agar plates. The occurrence 
of sporulation in strains selected from spores might be much
higher.
The ability of C.perfringens type A to produce enterotoxin has
been shown to be directly related to the ability of the organism to
sporulate, thus, non-sporulating strains are non-enterotoxin 
producers. The .results shown in table 29 are in agreement with 
this statement, thus, all enterotoxin producing isolates were found 
to produce spores and in all cases the percentages of spores 
obtained were 10 per cent or higher. However, 2 isolates (56 and 
62) formed a relatively high percentage of spores but were found to 
be non-enterotoxin producers. Sporulating strains of C.perfringens 
type A have been found to be non-enterotoxin producers possibly 
because of a mutation of the gene that codifies enterotoxin 
production (Ando et al, 1985).
A total of 11 of the 42 C.perfringens type A isolates tested 
(26 per cent) was capable of producing enterotoxin under the
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conditions used in this study. This result suggests that 
enterotoxin-producing isolates are relatively common in enteric 
disease in pigs. The selection of isolates from heat-treated 
cultures (Table 33) would probably reveal an even higher percentage 
of enterotoxin producers. Three of the eleven enterotoxin 
producer-isolates (29,88,89) were found to be non-alpha toxin 
producers. Tsai et al (1974) reported that a higher proportion of 
enterotoxigenic strains were non-alpha toxin producers; however, 
as 8 of the enterotoxin-producer isolates produced alpha toxin in 
different amounts, it is not possible to relate enterotoxin 
production to alpha toxin production.
(b) The purification of enterotoxin
On the purification of enterotoxin, a 3-step purification 
procedure gave a homogeneous protein with a recovery of 25 per cent 
of the initial activity (Table 30). The 0-15 per cent ammonium 
sulphate precipitate obtained appeared nearly homogeneous, on 
polyacrylamide gel electrophoresis (Fig. 37). This result agrees 
with that of Bartholomew and Stringer (1983) who described the 
purification of enterotoxin by the same method. The chromatography 
on Sephadex G-200 did not significantly increase the yield based on 
protein content. The enterotoxin produced appeared to have all the 
properties of enterotoxin produced from reference strains of 
C.perfringens type A and this was confirmed by immunodiffusion 
studies using the antiserum and enterotoxin from the reference 
strain.
(c) Production of antibody to enterotoxin
Preimmunisation samples of pig serum (Table 31) contained 
antibody to enterotoxin but none was found in the rabbit sera. The 
greater increase in antibody levels in the pig sera when compared 
with those from the rabbits was probably due to the previous 
exposure of the pigs. The initial levels present in the pig sera 
suggested that the animals used had been previously exposed to 
enterotoxin, possibly from an enteric infection. The absence of 
such antibody from the rabbits used may reflect a species 
difference or a difference in the quality of housing.
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The low levels of antibody obtained (maximum 1:32 in pigs and 
1:16 in rabbits) agree with those produced in rabbits immunised 
with purified enterotoxin by Bartholomew and Stringer (1983) who 
pointed out some of the difficulties for the o b t a . i ° f  high 
titres of antibodies to purified enterotoxin.
The specificity of the antiserum produced was confirmed by the 
results of the double immunodiffusion tests (Fig. 39) and the 
neutralisation tests. The use of a reference strain confirmed its 
relationship to enterotoxin produced by human food poisoning 
strains.
(d) Antibody to enterotoxin in adult pig sera
98 of the 106 adult pig sera examined were found to possess 
antibody to enterotoxin with titres ranging from 1:2 to 1:64 (Table
32). This finding suggests that antibody to enterotoxin is common 
in adult pig sera in Scotland and therefore its presence in/ the 
sera of the two pigs hyperimmunised for antibody production was not 
unusual.
The high prevalence of antibodies to enterotoxin in these pig 
sera may suggest that the exposure to C.perfringens 
enterotoxin-producer strains is common and that this organism 
sporulates and produces enterotoxin in the intestinal tract of 
pigs. The antibody production might be induced during an 
enterotoxaemia of C.perfringens type A enterotoxin-producer, but 
could possibly also be due to a prolonged absorption of enterotoxin 
in symptomless carriers who harbor C.perfringens enterotoxin- ' 
producnr^  strains. The occurrence of disease in these sows was not 
known and their previous exposure to enterotoxin was therefore 
unknown. It is of interest to note that only 45 of the same sera 
were positive for antibody to alpha toxin (Table 27, Chapter 5) 
suggesting that enterotoxin exposure may be more common or that 
enterotoxin binds more closely to the gut or is absorbed more 
readily than alpha toxin. The ready inactivation of alpha toxin by 
gut contents may also contribute to this difference in exposure.
(e) The survey of pig faeces for vegetative and sporulating 
C.perfringens type A and enterotoxin
C.perfringens (Table 33) type A vegetative cells were detected 
in all 33 samples when inoculated onto tryptone sulphite agar 
containing D-Cycloserine. The viable counts ranged from 2.5x10^ 
cells per gram of intestinal material to 3x10^ cells per gram of 
faeces. C.perfringens type A colonies in horse blood agar plates 
were detected in only 15 of the 33 samples indicating the effect 
discussed in Chapter 3, in which the isolation of C.perfringens may 
be masked by the presence of other organisms when non-selective 
media such as horse blood agar are used. The presence of 
C.perfringens type A vegetative cells in all the samples counted 
confirms the statement that C.perfringens type A is always present 
in the intestine of all animals as part of the normal intestinal 
microflora (McDonel 1980). The reasons for the failure to isolate 
C.perfringens type A on horse blood agar when they are clearly 
present in large numbers in the sample is not obvious. Sample 93 
contained 5x10^ cells of C.perfringens type A in total and 5x10^ 
spores yet the organism was not detected on horse blood agar. It 
may be that inhibitory substances such as antibody or antibiotic 
are not sufficiently or uniformly diluted out when streaked on 
plates. In the Miles and Misra technique this would always occur. 
The lowest level of detection of vegetative cells by streaking on 
horse blood agar was in sample 74 which contained only 2x1 (P 
vegetative cells per gram.
Vegetative cell levels could not be related to diarrhoea in 
this survey in contrast to the situation found in Chapter 3 when 
much of the material was from neonatal pigs.
C.perfringens spores were detected in 25 out of the 33 samples 
(Table 33) with ranges from 2x10^ cells per gram of intestinal 
material to 5x10^ cells per gram of faeces.
Higher viable counts of spores than vegetative cells were 
present in samples 64,65,82,86 and 87; this effect has been 
reported (Sutton et al., 1971) in cases of human food poisoning in 
which higher counts of spores than vegetative cells are observed
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when heat-shock is carried out. Samples from cases other than 
C.perfringens type A food poisoning do not show the activation of 
spores and vegetative cell counts are always higher than spore cell 
counts. The ability of C.perfringens to sporulate in faecal
samples is not known but it is not considered likely.
In the study spores were present in only 5 of the 10 normal 
faeces samples at levels varying from 3xl03 to 2x10^ (mean count 
4.8xl03 spores per gram). In contrast spores were found in 20 of 
the 23 diarrhoeic samples at levels varying between 2x10^ to 5x10^ 
spores per gram (mean count 6.5xl03 per gram). This association 
of spores with diarrhoea took no account of the presence of other 
infectious agents. In three of the animals with diarrhoea and no 
faecal spores other agents were present (Epidemic diarrhoea, 67 and 
68; Campylobacter, 92).
Spores were present in the faeces of pigs of all ages examined 
(2 days - 16 weeks).
Enterotoxin was identified in 5 samples of pig faeces. All 
were from diarrhoeic pigs and in all samples more spores were 
counted than vegetative cells. The levels of enterotoxin present 
were not determined in this study. Samples in which enterotoxin 
was demonstrated were related to the history and to the other 
bacteria present (Table 33). Enterotoxin was present in piglets of 
seven days of age, 3 weeks of age (with enteropathogenic E.coli) 
and in mucoid diarrhoea from 12 week old pigs. There was no common 
feature of the. submissions other than the association with 
C.perfringens spores. It is possible that C.perfringens
sporulating strains and enterotoxin could be associated with the 
three distinct syndromes seen here: creamy diarrhoea at 7 days of
age, post-weaning diarrhoea at weaning and mucoid diarrhoea in 
slightly older pigs.
It was clear from the studies discussed above that 
C.perfringens type A strains in pigs could sporulate and produce 
enterotoxin in vitro and in vivo and that enteritis might be 
associated with sporulating organisms in vivo. The actual 
relationship between the clinical and pathological signs seen in
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the few field cases were studied in the experiments . described in 
sections 6,7 and 8.
(f) Enterotoxin from C.perfringens type A in porcine
intestinal loops
This study demonstrated that C.perfringens type A enterotoxin 
of porcine origin (from isolate 29) could cause intestinal lesions 
in gut loops in contrast to the Usance op evidence found for alpha 
toxin and discussed in Chapter 5.
Doses of purified enterotoxin of 32 to 512 TU/ml (Table 34 and
35) produced accumulation of fluid in the inoculated loops. Lower
doses of purified enterotoxin (4 to 16 TU/ml) failed to produce a 
detectable response in the hysterectomy-derived, colostrum-deprived 
piglet 1 (Table 35). Culture supernatants 1 and 2 of unknown toxic 
activity failed to produce fluid accumulation in the conventionally 
born, colostrum-deprived piglet (Table 34) but, congestion of the 
mucosa was observed in the loops inoculated with these 
preparations, possibly indicating a mild enterotoxic activity.
In loops which contained fluid, the mucosa was disrupted and
the villous architecture destroyed (Fig. 47). When immuno­
fluorescence was carried out (hysterectomy-derived piglet 1) 
enterotoxin was present in large amounts on the epithelium (Fig. 
51). The changes found resembled those seen grossly in piglets 
which had died from natural C.perfringens type A associated 
diarrhoea (Survey 1, Chapter 3) or experimental infections (Chapter 
4) but were more severe than those seen microscopically in moribund 
animals, the only ones to be examined histologically in these 
chapters.
The lesions appeared to be dose dependent, as described above 
but enterotoxin was detectable in the epithelium of loops 
inoculated with all levels of enterotoxin tested. It was also 
present to some extent in loop 3 piglet 1 in which enterotoxin had 
been neutralised by antiserum and in loop 6 inoculated with 
sporulated cells. The congestion of the mucosa seen in these loops 
(Table 35) may, therefore have been caused by enterotoxin but is
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unlikely to have been due to levels of enterotoxin similar to those 
seen in loops 7 and 9 in which weak fluorescence but no congestion 
were seen. The changes may therefore have been due to incomplete 
neutralisation of the enterotoxin or to dissociation of the toxin- 
antibody complexes in the gut. A similar quantity of antiserum had 
been found to protect Vero cell against damage (Section 2b above). 
Similar changes were seen and enterotoxin was demonstrable when 
sporulated cells were inoculated into loop 6. It is possible that 
more than 8 toxic units but less than 32 toxic units of enterotoxin 
was produced by this culture or was present in it at inoculation. 
The loss of piglet 2, intended to provide a full control for this 
point is to be regretted. Duncan and Strong medium alone caused no 
such lesions (loop 5). No counts, cultural studies or enterotoxin 
determinations were carried out on the contents of this loop. Had 
they been done the possibility of multiplication of C.perfringens, 
sporulation and enterotoxin production in vivo in the loop might 
have been determined. Duncan et al.(1968) considered that 
enterotoxin was not present in washed cells but could be produced 
when these were suspended in a milk substrate not used here. **
The loss of piglet 2 meant the loss not only of the 16 toxic 
unit enterotoxin loop but also the vegetative cell control intended 
to resolve this point.
The only information to be gained from piglet 2 was that fluid 
accumulation took more than 2 hours to become apparent in loops.
(g) The intraluminal inoculation of piglet intestine
This study was largely successful. It was clear that 
intestinal marking with dye was unsuccessful but the point of 
inoculation could be determined in both cases, by immuno­
fluorescence in piglet 2 (Table 37) and, by inference the injection 
site was the terminal jejunum. Enterotoxin was only found attached 
to the epithelium distal to the point of injection.
The effects of the enterotoxin were both clinical and 
histopathological. Clinical signs consisting of a transient watery 
mucoid diarrhoea lasting 6-8 hours resulted from the inoculation of
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enterotoxin. Lesions consisting of villous shortening, mild 
congestion and the presence of inflammatory cells were seen at 
sites where enterotoxin was identified. The absence of a saline 
inoculated control may reduce the value of these results but the 
relatively distal portion of the ileum inoculated in piglet 2 
provides a histological control for the jejunum and ileum of piglet
I
1.
It was clear from this study that clinical signs could result 
from enterotoxin administration to piglets and that histological 
changes resulted, thus confirming the results of the gut loop 
studies.
(h) The experimental infection of piglets with sporulating 
isolate 29 of C.perfringens type A and protection using 
anti-enterotoxin serum
The results of this study were marred to some extent by the 
presence of two piglets with atresia ani. Both piglets did, 
however, provide valuable information. A transient diarrhoea 
resulted from the inoculation of the two piglets given washed 
sporulated cells. It was creamy, contained no blood or mucus and 
did not occur until 36 hours after inoculation. The reason for the 
later diarrhoea seen in piglet 3 (Table 38) was not clear. No 
diarrhoea occurred in the controls. A similar but slightly longer 
lasting diarrhoea occurred in the two piglets inoculated with 
vegetative cells and it must be assumed that this diarrhoea was 
associated with the inoculation of C.perfringens type A isolate 29.
Colonies with the characters of this organism were isolated 
from all infected piglets on days 1-3 but another organism with 
different haemolysis characters appeared on that day and was 
present in all piglets by day 4. The changes seen on day 4 and 
subsequently could have been affected by the organism. In the 
control animal (piglet 2) neither clinical nor pathological changes 
were seen and the haemolytic organism remained at low levels in 
faeces and in the gut. These findings provide additional evidence 
for the view that the early changes seen were associated with 
isolate 29.
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The studies of the faeces shown in Table 39 confirmed the
presence of vegetative cells at 4x10^ to 6x10^ in the faeces of all 
inoculated piglets and the presence of larger numbers of spores in 
most cases. Enterotoxin was present in the faeces at levels of 
4TU/ml - 32TU/ml (piglet 7). It must be assumed that both spores 
and toxin found in the faeces were produced in the intestine as no 
ready-formed enterotoxin should have been present in either
inoculum and no spores were present in inoculum B (vegetative
cells).
Passive protection by a combination of oral and parenteral 
serum containing antibody capable of neutralising 128TU of 
enterotoxin per ml was unsuccessful. Neither group immunised
remained unaffected to challenge and the diarrhoea which resulted 
was of similar duration and intensity to that in unprotected
controls. Serum antibody to enterotoxin was still present at 
slaughter (Table 44) and little if any of the antibody given could 
have been lost in spite of exposure to enterotoxin which was
present in gut during the disease. It seems from this study that
the failure of anti-enterotoxin to neutralise completely the
effects of enterotoxin in the gut loop studies also occurred here. 
The failure was presumably also associated with the type of 
antibody given - largely IgG and IgM with little or no secretory 
IgA antibody.
No gross or microscopic lesions were found in either control 
animal. The lesions found at post-mortem examination in the 
infected animals may, therefore, have been associated with isolate 
29 infection and almost certainly were in the case of piglet 5 
killed with atresia ani. The presence of haemolytic C.perfringens 
type A and the time which elapsed between the end of the diarrhoea 
and post-mortem examination could have affected the changes seen. 
In all piglets there was some congestion of the intestinal mucosa 
and in piglet 6 there was shortening of the villi. Oedema of the 
mesocolon was seen in piglet 10. A variety of changes including 
some accumulations of inflammatory cells and congestion of the 
lamina propria were seen but these could not be associated with 
passive protection or with inoculation with vegetative or 
sporulated cells.
More marked changes associated with C.perfringens type A of 
the inocular type were seen in piglet 5 with atresia ani. 
Enterotoxin was demonstrated in its jejunum, ileum and colon (Table 
40) and 30 per cent of the C.perfringens seen in smears were 
sporulated (Table 41 Chicrdfek\Y\ CouIq
eeudy sjwfikberim °£Tke pklct M d  or bHte- °F~£te
Ti m  "the fesfe. aw AvulHridn or~tt\£ ten i^yndr. Q
This piglet had dilated intestines with fluid contents and 
the presence of inflammatory cells. No villous atrophy or cell 
shedding was seen unlike the situation in gut loop studies where 
fluid had accumulated. The only other piece of small intestine in
which enterotoxin was demonstrated was the ileum of piglet 7 in
which there was mild congestion. This region of the gut contained 
many non-haemolytic C.perfringens type A (Table 42) but few spores 
(Table 41).
More sporulating organisms, enterotoxin and non-haemolytic 
organisms were found in the colons (Tables 41,42 and 43) but of the 
piglets 3,5,7 and 8 in which enterotoxin was demonstrated, the most 
severe changes were seen in piglets 3 and 5 which had high levels 
of enterotoxin attached to the wall. Changes were also seen in
piglet 8 which had 25 per cent spores and enterotoxin in the 
colonic mucosa but none were seen in that of piglet 7 with 10 per 
cent spores and enterotoxin. The absence of enterotoxin from the 
intestinal contents suggests that any enterotoxin present was fixed 
and not free and that the absence of enterotoxin in the faeces does 
not exclude the presence of fixed enterotoxin and enterotoxin- 
related changes, at least in the large intestine.
(i) Conclusions
The studies described in this chapter and discussed above 
suggest that sporulating C.perfringens type A occurs in the pig and 
that enterotoxin can be produced by porcine isolates of the 
organism both in vivo and in vitro. Both enterotoxin produced from 
one of these isolates and the organism itself were capable of 
producing lesions in gut loops and clinical signs in experimental 
pigs. The significance of these findings is discussed further in 
relation to the literature in Chapter 7.
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CHAPTER 7
GENERAL DISCUSSION
1. INTRODUCTION
In this chapter, the results of Chapters 3, 4, 5 and 6 are 
discussed in the context of C.perfringens type A in porcine enteric 
disease and in enteric disease in general. The results of the 
individual studies and their validity have already been discussed 
in the appropriate chapters and, as the work falls into 2 main 
parts, this discussion has been organised in a similar manner.
In the first section (Section 2), the results of the survey 
and the role of C.perfringens type A in porcine enteric disease in 
the field are discussed with relation to the literature reviewed in 
Chapter 1 and material which is considered relevant in view of 
those findings.
In the second section (Section 3), the experimental studies 
are discussed under four subheadings. The results obtained from 
animal experiments are discussed. The roles of alpha toxin and 
enterotoxin in clostridial enteric disease are examined in terms of 
the results presented above and with relation to the general 
literature. Lastly the role of immunity in revealing the 
pathogenesis of C.perfringens type A infections and in protection 
from them is discussed.
The whole is put into context by a brief conclusion.
2. C.PERFRINGENS TYPE A IN FIELD CASES OF PORCINE ENTERIC DISEASE
(a) Bacteriological results from survey material
The examination of field cases in the surveys described in
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Chapters 3 and 6 showed that a wide variety of bacteria (which 
included C.perfringens type A) could be isolated from the rectal 
swabs, faecal material and carcases submitted. Other agents such 
as T.G.E. and Porcine Epidemic Diarrhoea were demonstrated and 
agents such as rotavirus, coccidia and Cryptosporidia may have been 
present in some samples but were not recorded owing to the 
limitations in technique and sample quality discussed in Chapters 3 
and 6.
More than one species of bacterium was always found in the 
samples. In some cases, the bacteria isolated are known to cause 
enteric lesions in pigs e.g. U-haemolytic E.coli, C.perfringens 
type C, Salmonella typhimurium and Campylobacter coli, but others 
have been considered to be normal inhabitants of the alimentary 
tract e.g. non-haemolytic E.coli, Streptococcus spp., Clostridium 
spp., Fusobacterium spp., and Bacteroides spp. (Ducluzeau, 1983). 
In general, bacteria which have been reported to be present in the 
intestinal tract of the pig as part of the normal intestinal irlora 
were isolated in the surveys. C.perfringens type A has been 
generally considered to be a normal inhabitant of the gastroenteric 
tract of the pig (Ducluzeau, 1983) and of other species of animal 
(Niilo, 1980). The evidence obtained from the surveys suggested 
that it was involved in enteric disease and this view was supported 
by a growing body of observations from other workers (Olubunmi, 
1982; Nabuurs et al., 1983; Secasiu, 1984 and Jestin et al., 1985).
The evidence that suggests C.perfringens type A was involved 
in gastrointestinal disease was presented in Tables 7 (Chapter 3) 
and 33 (Chapter 6). C.perfringens type A was isolated in profuse 
culture from the jejunum, ileum and caecum of 16 diarrhoeic piglets 
(Table 7) and from 2 diarrhoeic piglets in the second study (Table
33).
The organism was less commonly isolated from the gastric, 
duodenal and colonic mucosa. These results differ slightly from 
the findings reported by Olubunmi (1982) who recovered the organism 
in profuse cultures from the mucosa of the duodenum, jejunum and 
ileum and less frequently from the mucosa of the stomach, caecum
279
and colon. C.perfringens type A was isolated from the stomach of 
four piglets and from the duodenum of nine animals (Table 8) and 
from both duodenums in the second study. In humans, except under 
disease conditions, C.perfringens type A is not found in the 
stomach and duodenum, while it is commonly isolated from the ileum 
(Vince et al., 1972). C.perfringens type A is normally absent from 
the stomach and duodenum of the healthy piglet (Ducluzeau, 1985). 
Thus, the presence of the organism at these levels in the sampled 
piglets may indicate the involvement of C.perfringens type A in the 
diarrhoeic syndrome observed in the animals.
Additional evidence for the involvement of C.perfringens type 
A in piglet diarrhoea came from its identification from the faeces 
of 14 animals in study 1 (Table 7, Chapter 3). This result
conflicts with the statement that C.perfringens type A is normally
present in the intestinal tract of healthy animals (Niilo, 1980). 
However in this survey, non-selective media were used and this may 
have led to the masking of C.perfringens type A by other organisms 
present in larger numbers. When a selective medium,
tryptone-sulphite-cycloserine agar, was used in the studies 
described in Chapter 6, C.perfringens type A was identified in 
every sample examined thus, an agreement with the above mentioned 
statement was found. However, as already discussed in Chapters 3 
and 6, a relationship may exist between the numbers of 
C.perfringens type A present in the gastrointestinal tract and the 
number of colonies found in non-selective media. The results of 
the second survey described in Chapter 6 and discussed there 
suggest that, although there is a general relationship between
numbers of C.perfringens present and detection on blood agar, this 
relationship is not absolute. The results in the two surveys tend 
to confirm those of Secasiu (1984) who associated an increase in 
the number of C.perfringens type A in the intestines of diseased 
animals with clostridial disease.
The diarrhoeic animals in both surveys on which post-mortem 
examination was carried out and from which C.perfringens type A was 
isolated in the absence of any other known pathogens, showed
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pathological lesions similar to those reported by Nabuurs et al. 
(1983) who described a diarrhoeic syndrome produced experimentally 
in piglets one to three weeks old with C.perfringens type A. At 
post-mortem the jejunum and ileum of these animals were distended 
with abundant gas. Histologically the villi were slightly reduced 
in length, and infiltration of inflammatory cells was found in the 
lamina propria. Olubunmi (1982) reported similar lesions in field 
and experimental cases of neonatal diarrhoea associated with 
C.perfringens type A, although some of the animals described by 
this author showed more severe lesions than those found in the 
surveys in Chapters 3 and 6; large haemorrhages and sloughing of 
the villi were described.
The results discussed above link findings concerning 
vegetative cells with diarrhoea and enteritis but there are no 
accounts of any link between sporulating organisms and diarrhoea in 
the pig or even the presence of C.perfringens type A spores in pig 
faeces. The results of the spore counts described in Chapter 6 
(Table 33) provide completely new information for the pig. In the 
pig and in other species studies which describe the presence of 
enterotoxin or enterotoxigenic C.perfringens type A infer the 
presence of sporulating organisms. Spore counts and the 
association of sporulating C.perfringens type A with diarrhoea are 
best documented in man (Sutton et al., 1971) where food-borne
intoxication and the ingestion of both spores and preformed 
enterotoxin is most commonly considered to be the source. However, 
the 7-day old piglets (submission 21, Table 33) with high faecal 
spore counts could not have ingested preformed toxin or large 
numbers of spores as piglets of this age ingest milk direct from 
the sow. This finding suggests that sporulation is taking place in 
the gut of the diarrhoeic pig. The survey described in Chapter 6 
(Table 33), suggested that spores were present in the faeces of 
pigs of all ages, that few or low numbers of spores were present in 
normal faeces (range 3 x 10  ^- 2 x 10^  per g) and that high numbers 
were present in diarrhoeic faeces (2 x 10^  - 5 x 106 per g). As 
spores form an indication of the possible presence of enterotoxin, 
the relationship between diarrhoea and the presence of spores is 
discussed under that heading below.
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(b) Serological studies
Antibody to alpha toxin and enterotoxin was sought in the sera 
of sows and the results described in Chapters 5 and 6 and discussed 
there, suggested that a high proportion (42.3 per cent) contained 
antibody to alpha toxin and to enterotoxin (92.4 per cent). The 
significance of these results is discussed below with the 
discussion of the individual toxins and their role in 
pathogenici ty•
3. EXPERIMENTAL STUDIES WITH C.PERFRINGENS TYPE A
(a) Introduction
As C.perfringens type A was present in mixed culture in most 
of the samples examined and as post-mortem changes and treatment 
had affected the animals submitted for examination, it was decided 
to use animal and in vitro experiments to study the disease 
further. An isolate of C.perfringens type A (isolate 7) was 
considered typical of vegetative cells and was selected for study 
of the disease. Experimental infections with this isolate are 
described in Experiments 1 and 2, Chapters 3 and 4. Another 
isolate (isolate 29) considered typical of enterotoxin-producing 
sporulating cells was also used in Experiment 3 (Chapter 6).
The remainder of these studies involved the study of alpha 
toxin, enterotoxin and immunity to them in the pathogenesis of the 
disease. The results of each type of study provided new 
information about C.perfringens type A disease in the pig and the 
significance of these results is discussed below in the context of 
the existing literature.
(b) Animal experiments
Both isolate 7 (vegetative cells) and isolate 29 (sporulating, 
enterotoxin producer) of C.perfringens type A produced clinical 
disease in hysterectomy-derived, colostrum-deprived piglets. Both
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types of organism produced diarrhoea in the inoculated piglets and 
colonised the gastrointestinal tract. The results in each 
experiment were different and differed also to some extent from 
previously described experimental infections in similar piglets
(Olubunmi, 1982 and Nabuurs et al., 1983). The infection of 8 
day-old HDCD piglets with isolate 7 in Experiment 1 produced a 
clinical disease less severe than that produced in 1 day-old HDCD 
piglets where most of the infected animals died within 48 hours 
post-infection (Experiment 2). The 8 day-old HDCD piglets 
developed a profuse creamy diarrhoea after infection which lasted 
throughout the period of observation (Table 9). The infection was 
not fatal for these animals although a marked loss of bodily
condition was observed. On the other hand, when non-immune one 
day-old HDCD piglets were infected, the infection appeared to be 
fatal for most animals. The difference in the severity of the
infection for these two groups of piglets may be due to the
establishment of the microbial flora in the 8 day-old piglets which 
could have competed with C. perfringens type A lessening its 
pathogenic effects (Tlaskalova et al., 1983). Increasing maturity 
of the gastro-intestinal tract, increased ability to control fluids 
and electrolytes and possibly the beginnings of an immune response 
to natural C. perfringens type A contaminants may also have been 
involved. The results of Experiment 1 resembled most closely those 
of Nabuurs et al. (1983) who used slightly older piglets and those 
of Experiment 2 resembled most closely those of Olubunmi (1982) who 
infected neonates as was the case here.
The main site of the infection was at jejunal and ileal level 
and inflammatory and necrotic changes appeared to result from the 
infection of piglets. In the 8 day-old HDCD piglets, fluid 
intestinal contents and congestion appeared to be the most 
consistent findings. In the one-day old HDCD piglets, the 
distention of the small intestine at jejunal and ileal levels with 
the presence of gas and frothy contents and congestion of the 
mucosa were marked features. The lesions seen in natural cases 
described in the survey resembled those seen in the experimental 
infections and confirmed that the disease produced was similar to
283
that seen in the field. The lesions resembled those found by 
Nabuurs et al. (1983) but were less severe than those described by 
Olubumni (1982).
The experiment described in Chapter 6 in which one day-old 
HDCD piglets were infected with a non-haemolytic, 
enterotoxin-producer strain (isolate 29) showed that another 
different diarrhoeic syndrome was produced from those described 
above. This study, which will be discussed in the section d of 
this chapter, appears to represent the first account of the 
isolation of C.perfringens type A enterotoxin-producer from a case 
of diarrhoea in pigs and its relation to a specific diarrhoeic 
syndrome in infected piglets by experimental reproduction. Other 
reports of disease associated with enterotoxin-production in pigs 
(Popoff and Jestin, 1985; Jestin et al., 1985) did not consider the 
isolation of the organism or the reproduction of the disease. The 
disease produced by isolate 29 was milder, of shorter duration and 
was non-fatal in neonatal piglets. Few lesions were seen in the 
intestinal tract (Chapter 6).
The clinical signs and lesions observed in the piglets 
infected with C.perfringens type A did not resemble those of 
C.perfringens type C. The massive haemorrhage reported in that 
disease was absent. In C.perfringens type C infections, bloody 
diarrhoea, haemorrhagic intestines and advancing zone of necrosis 
are reported to occur (Bergeland, 1981) involving the mucosa, 
submucosa and the tunica muscularis. When necrotic lesions were 
observed in C.perfringens type A (Experiment 2) they were limited 
to the mucosal layer. It is clear from the studies described in 
Chapters 3, 4 and 6 that the mode of action of C.perfringens type A 
in causing enteric disease in pigs appears to be very different 
from that of C.perfringens type C.
The observations discussed above indicate that C.perfringens 
type A may be isolated in large numbers in cases of diarrhoea in 
piglets and is capable of producing a diarrhoeic syndrome and 
pathological changes when given orally to hysterectomy-derived,
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colostrum-deprived piglets. The syndrome resembles that produced 
by other workers and is distinct from that produced by 
C.perfringens type C. The way in which C.perfringens type A 
produces the changes seen is discussed below.
(c) The role of alpha toxin in porcine enteric disease
C.perfringens type A alpha toxin has been incriminated in 
gastro-intestinal disease in several animal species. Necrotic 
enteritis of chickens has been reported (Al-Sheikhly and Truscott, 
1977) to be caused largely by alpha toxin, and also, it has been 
found (Niilo, 1978) that C.perfringens type A strains associated 
with necrotic enteritis in chickens were strong alpha toxin 
producers. In this thesis, the high percentage of alpha toxin 
producer isolates (Table 26) confirmed the fact that most of 
C.perfringens type A strains isolated from enteric disease in pigs 
are alpha toxin producers, and the isolation of strong alpha toxin- 
producer strains (haemolytic units of 16 or more) may indicate a 
relationship with the enteritis observed in the animals from which 
these C.perfringens type A strains were isolated.
Skjelkvale et al. (1979) reported that from cases of food 
poisoning in humans, only 55 per cent of C.perfringens type A 
isolated were alpha toxin producers, indicating that the 
distribution of alpha toxin producers and non-producer strains may 
vary according to the environment or syndrome from which 
C.perfringens type A strains are isolated.
It was not possible to correlate the porcine diarrhoeic 
syndromes studied in the surveys in this thesis with the alpha 
toxin production of the C.perfringens type A isolated. The role of 
alpha toxin production by C.perfringens type A strains in gastro­
intestinal disease remains unclear and requires further 
investigations. However, there were differences in the syndromes 
produced in Experiments 2 and 3 in neonatal piglets. It may be 
that these reflect the fact that isolate 7 was a moderate alpha 
toxin producer and produced obvious haemolysis while isolate 29
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produced no observable changes on blood agar and no alpha toxin 
(Table 26). It produced less severe disease and this reduced 
severity might be associated with the absence of haemolytic 
products especially alpha toxin.
When the effect of alpha toxin was tested in intestinal 
ligated loops (Table 28), no accumulation of fluid or macroscopic 
lesions were observed in intestinal loops receiving purified alpha 
toxin, culture supernatant or concentrated culture supernatant. 
These results are in agreement with those of Hauschild et al. 
(1968) and Duncan et al. (1968) who failed to produce an intestinal 
loop response when crude alpha toxin was injected into loops 
prepared in lambs and rabbits respectively. The first authors, 
however, observed accumulation of fluid in intestinal loops when 
large amounts of alpha toxin were injected. 1000 MLD of alpha 
toxin per loop produced fluid accumulation which was amplified 
several-fold when 8000 MLD were inoculated into loops. Such large 
quantities of alpha toxin inducing accumulation of fluid provide no 
indication of the role of the toxin in C.perfringens type A 
enteritis because it is unlikely that such amount of alpha toxin 
would be produced in a natural case of C.perfringens type A 
infection.
Microscopically, the intestinal loops injected with purified 
alpha toxin and with concentrated culture supernatant showed a mild 
congestion and localised hypercellularity at lamina propria 
(Chapter 5). These lesions may be due to the effect of alpha toxin 
which stimulates histamine release from platelets causing an 
increased cellularity (Ohsaka et al., 1978). These changes were 
also reported by Hauschild et al. (1968) in his lamb studies. This 
represents the first report of this type of change in the pig.
The specificity of these changes was confirmed by the 
neutralisation studies performed in the gut loops using rabbit 
antiserum to pure alpha toxin. Similar protection was also found 
to the effects of crude culture supernate. This protection was 
also found in vivo in Experiment 2 when colostrum and milk from
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hyperimmunised sows was used to protect against challenge with 
isolate 7. The milk from sows immunised with bacterin alone was 
least protective and had the lowest titres against alpha toxin 
(Table 18). Unfortunately the presence of other antibodies
(Discussion Chapter 4) meant that the protection observed could not 
be attributed exclusively to anti-alpha toxin.
It may be suggested that with the multiplication of 
C.perfringens type A in the intestine, the organism produces 
specific enzymes which could play a role in the pathogenesis by
altering the permeability of the intestinal mucosa to alpha toxin 
and the enhancement of its effects. In this particular role, some 
of the minor toxins with activities of hyaluronidases, collagenases 
and proteinases produced by C.perfringens type A could be of
significance in the pathogenesis by giving the opportunity to other 
toxins, such as alpha toxin, to act at intestinal level. Nothing 
is known about the activity at intestinal level of most of the
C.perfringens type A toxins and this requires further study.
It is also possible that close attachment to the epithelium 
might also enhance the effects of alpha toxin. Attachment is known 
to occur early in C.perfringens type C infections both in pigs 
(Arbuckle, 1972) and in man (Walker, 1985). Comparable studies of 
early infections have not been carried out in the pig with 
C.perfringens type A.
(d) The role* of enterotoxin in porcine enteric disease
C.perfringens type A enterotoxin has been identified as the 
factor responsible for diarrhoea experimentally induced in several 
animal species, and for cases of human food-poisoning.
Enterotoxin production differs from strain to strain, most 
C.perfringens type A strains isolated from faecal samples obtained 
from cases of food-poisoning in humans produce enterotoxin, but few 
strains from other sources are enterotoxigenic. In this thesis, 26 
per cent of the C.perfringens type A isolates were found to produce
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detectable levels of enterotoxin (Table 29). Higher numbers of 
enterotoxin-producer strains were isolated by Yasukawa et al. 
(1975) who reported enterotoxin production by 51 (77 per cent) of 
66 strains associated, with outbreaks of human food-poisoning. 
However, the same authors found that the percentage frequency of 
enterotoxin-producer strains from healthy individuals was low (less 
than 1 per cent). Similar results were obtained by Skjelkvale et 
al. (1979) who found that enterotoxin was produced by 56 of 65 (86 
per cent) of food-poisoning strains, but that 94 strains isolated 
from other sources were negative for enterotoxin. The isolation of 
enterotoxin-producing C.perfringens type A strains (Table 29) 
indicates the presence of such strains in pig populations. The 
diarrhoeic syndrome present in the animals from which 
enterotoxin-producer strains were isolated may have been produced 
by the action of enterotoxin at intestinal level, producing a 
syndrome resembling human food-poisoning, and in some cases,
this syndrome might have been exacerbated by the presence of other 
pathogens.
A correlation between alpha toxin and enterotoxin has been 
reported (Harmon and Kautter, 1976) suggesting that enterotoxin 
levels produced by a strain could be estimated by measuring its 
alpha toxin production. The results indicated in Table 29 do not 
show this correlation. Some of the enterotoxin-producer isolates 
were weak alpha toxin producers, and three of the isolates did not 
produce alpha toxin. These results are in agreement with those of 
Skjelkvale et al. (1979) who reported that some strains of alpha 
toxin negative C.perfringens type A strains can produce large 
amounts of enterotoxin.
Enterotoxin was detected in five faecal samples in which 
increased spore counts in relation to vegetative cells were 
demonstrated (Table 33). These findings resemble cases of human 
food-poisoning in which increased counts can be demonstrated before 
and after heating the faeces: faeces from healthy individuals
do not show increased C.perfringens counts after heating (Sutton et^  
al., 1971). The detection of enterotoxin in faeces has been proved 
to be a diagnostic test of C.perfringens type A human food-
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poisoning. Faecal isolates from cases of food-poisoning reveal the 
presence of enterotoxin, whereas faeces of healthy individuals do 
not show presence of enterotoxin (Itoh et al., 1979). In pigs, 
Jestin et al. (1985) demonstrated the presence of enterotoxin in 
the faeces of diarrhoeic pigs in which no other pathogen could be
demonstrated, and enterotoxin was not detected in the faeces of
healthy pigs. In the studies described in Chapter 6, the increased
spore counts, the enterotoxin detection and the absence of other
pathogens, excepting sample 82 (Table 33) from which 3-haemolytic 
E.coli was isolated, provide strong evidence that the diarrhoeic 
syndrome in the pigs was provoked by the action of the enterotoxin 
at intestinal level.
No previous reports of the presence of enterotoxin in 
diarrhoeic piglet faeces have been' published. Those of Jestin et 
al. (1985) refer only to weaned animals. Enterotoxin was 
demonstrated in the faeces of both weaned and sucking piglets in
4»
this study.
Purified enterotoxin was prepared from isolate 29 and 
inoculated into intestinal ligated loops (Tables 34, 35 and 36) 
where it induced the accumulation of fluid and pathological changes 
which were shown to be enterotoxin dose-dependent, thus, doses of 
enterotoxin from 32 to 512 TU/ml produced increasing amounts of 
accumulation of fluid and respectively more severe lesions which 
ranged from slight congestion of the mucosa to complete 
desquamation of ~the epithelium with severe oedema, haemorrhage and 
infiltration of inflammatory cells (Figs. 47 and 50). The results 
are in agreement with studies on the effect of enterotoxin in 
intestinal loops in other animal species (Duncan and Strong, 1969; 
Hauschild et al. , 1970; McDonel, 197,4; Yamamoto et al. , 1979). By 
immunofluorescence, enterotoxin was found to be bound to the 
epithelial cells of the intestine (Figs. 51 and 52). It was 
observed that a stronger . fluorescence was correlated with higher 
enterotoxin doses. This finding indicates that binding of the 
enterotoxin is essential for its biological activity. McDonel 
(1980) reported the binding of the enterotoxin molecule in the
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rabbit intestine and that this binding was not reversible, thus, 
the enterotoxin molecule binds to a single cell and consequently 
the effects produced by the enterotoxin at intestinal level are 
dose dependent. The specificity of the effects was confirmed by 
the neutralisation of the effects using anti-enterotoxin.
The injection of purified enterotoxin into the intestinal 
lumen of HDCD piglets indicated that good correlation exists 
between the ability of the enterotoxin to produce accumulation of 
fluid in intestinal loops and production of diarrhoea after 
inoculation into the ileum of the piglets. The time of onset and 
duration of diarrhoea in the piglets was comparable to 
experimentally induced diarrhoea by intraluminal inoculation of 
enterotoxin in rats (McDonel, 1974) and rabbits (McDonel and 
Demers, 1982). The watery transient diarrhoea produced in these 
unfed, colostrum-deprived pigs did not resemble that seen in 
field cases of C.perfringens type A diarrhoea.
The enterotoxin was found to be bound to the epithelial cells 
of the intestine from the site of inoculation to the colon, with 
the strongest fluorescence at the level of the terminal ileum 
(Table 37). This finding is in agreement with the results reported 
by Hauschild et al. (1973) who found that enterotoxin is most 
active in the ileum, mildly active in the jejunum, and nearly 
inactive in the duodenum. As in this thesis, the inoculations of 
the enterotoxin were carried out in the terminal jejunum in piglet 
1, and in the ileum in piglet 2, further studies are required to 
evaluate the activity of the enterotoxin in the duodenum and 
jejunum of the pig.
The infection of HDCD piglets with vegetative and sporulated 
cells induced a diarrhoea which was similar in its onset and 
duration to experimentally produced diarrhoea with C.perfringens 
type A enterotoxin-producer strains in lambs (Niilo, 1971), calves 
(Niilo, 1973a), chickens (Niilo, 1974), monkeys (Hauschild et al. , 
1971) and humans (Strong et al., 1971).
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Enterotoxin was detected in the diarrhoeic faeces of all 
infected animals, and the faeces showed increased spore counts in 
relation to vegetative cells (Table 39). These findings indicate 
that C.perfringens type A sporulated in the intestine of the 
piglets releasing enterotoxin. Enterotoxin was detected only in 
the intestinal contents of piglet number 5 which was sacrificed two 
days after infection (Table 39). This result indicates that 
enterotoxin can be detected only for a short period after infection 
and is in agreement with Dowell et al. (1975) who reported that 
enterotoxin can not be detected in the faeces collected from 
individuals after the disappearance of the symptoms provoked by a 
C.perfringens food poisoning outbreak. These authors observed that 
enterotoxin could only be detected in the faeces of individuals 
with active diarrhoea. It is clear, however, that fixed 
enterotoxin can be detected on cells of the ileum and colon in pigs 
which still have moderate or high counts of C.perfringens type A 
spores (Table 40). This evidence for the continued production and 
fixation of enterotoxin in the gut is of interest. It suggests 
that the assay method used here (Vero cell assay) may not be 
sufficiently sensitive to detect all faecal enterotoxin and that it 
might have been detected using ELISA tests (Table 3). The 
intestines of piglets naturally affected with C.perfringens 
diarrhoea have not been tested in this way and it is not known how 
widespread this phenomenon of fixed enterotoxin may be. The rate 
at which fixed toxin is lost was not determined in these studies. 
McDonel (1980) showed that enterotoxin is not released from cells 
to which it binds and the persistence of toxin-bearing colonic 
cells may reflect the slower turnover of colonic epithelium when 
compared with other regions of the gut rather than continued 
production of toxin.
Fixation of enterotoxin to the colonic cells may be of little 
importance in diarrhoeal disease as McDonel and Demers (1982) 
showed that it had no effect on colonic function in the rabbit. 
Fixation in the ileum was more important and it may be that the 
presence of fixed toxin in the ileum in this study did cause fluid 
production but that colonic compensation prevented diarrhoea. The
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numbers of enterotoxin-producing cells necessary in the ileum for 
diarrhoea to be produced has not been determined for any species. 
The studies described in Chapter 6 indicate that C.perfringens type 
A entero-toxin-producer strains can be isolated from naturally 
occurring diarrhoeas in the pig and that C.perfringens type A 
enterotoxin induces an experimental diarrhoeic response in the pig 
similar to the one reported in other animal species. Further 
investigations are required to know the incidence of the disease 
and its effect on productivity in pig populations.
(e) Immunity to C.pefringens type A cells and toxins
Studies on the immunity to C.perfringens cells and toxins are 
the basis of the investigations described in Chapter 4 and some 
information was obtained from results described in Chapters 5 and 
6 .
The studies carried out in Chapter 4 demonstrated that a 
toxoid and a bacterin prepared from cultures of C.perfringens type 
A could be completely detoxified and inactivated respectively. 
Both preparations were found to elicit antibodies to alpha toxin 
and to C.perfringens type A cells in parenterally immunised animals 
as discussed in Chapter 4.
Few reports exist in the literature about the production of 
toxoids and bacterins involving C.perfringens type A cells or alpha 
toxin. This situation may be due to the fact that alpha toxin had 
been considered until a recent past, to be a poor antigen (Oakley, 
1970) and also, it was reported (MacLennan, 1962) that it was 
impossible to convert C.perfringens alpha toxin to a toxoid. Also, 
the lack of literature related to the subject may be due to the 
decreasing importance of gas gangrene as a cause of disease with 
the widespread use of antibiotics in the prophylaxis and treatment 
of the disease, particularly in human beings. Also, as 
C.perfringens type A has been considered to be part of the normal 
intestinal flora and studies are still being carried out to 
elucidate its role in enteric disease, few attempts to produce
bacterins from the organism have been described, Bousicaux et al. 
(1974) immunised sheep with a multi-component bacterin containing 
whole cultures of C.perfringens types A, B, C and D and, antibodies 
to alpha, beta and epsilon toxins were demonstrated in the 
immunised animals and the presence of these antibodies were 
considered to be protective in field trials. However, it is not 
possible to evaluate from this study the role played by
C.perfringens type A cells and toxins in the protection achieved 
because other types of C.perfringens were also present in the 
bacterin.
In this thesis, the immunisation of sows with crude
C.perfringens type A toxoid and bacterins and the demonstration of 
antibodies to alpha toxin and C.perfringens type A cells with the 
subsequent passive protection offered by these antibodies against 
challenge, appears to be the first account in the literature. The 
use of C.perfringens type C toxoids to immunise sows and to provide 
passive protection for their litters has been known for some years 
(Djurickovic et al. , 1975). Antibodies to beta toxin have been 
detected in their milk and colostrum and the transfer of these
antibodies to the progeny protects against the disease. The 
mechanism of sow vacination with clostridial products for the 
protection of the litter against clostridial disease is, therefore, 
well established. What was new, however, was the attempt to 
protect against C.perfringens type A disease.
Examination’ of the antibodies present in the colostrum and 
milk from immunised sows showed that neither the toxoid nor the 
bacterin had stimulated the production of antibodies to alpha toxin 
or to cells alone (Experiment 2, Chapter 4). In contrast, the
protection experiment carried out with antibody to enterotoxin 
(Experiment 3) used relatively specific porcine antiserum to 
enterotoxin (Chapter 6). The results of the two protection studies 
differed markedly and have been compared below.
The antibodies from sows immunised with toxoid and bacterin, 
when passively transferred to hysterectomy-derived, colostrum-
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deprived piglets, were able to protect the animals against 
challenge with C. perfringens type A isolate number 7.
In contrast, protection against disease was not observed when 
hysterectomy-derived, colostrum-deprived piglets were passively 
immunised with anti-enterotoxin serum and then challenged with 
C.perfringens type A isolate 29 (Experiment 3, Chapter 6). In this 
experiment there was no difference between passively immunised 
piglets and non-immunised, infected animals. There was no 
difference either in the recovery rate of C.perfringens type A and 
the post-mortem bacteriological findings in the gastrointestinal 
tract were identical in both immunised and non-immunised piglets. 
On the other hand, in Experiment 2, the recovery of C.perfringens 
type A from rectal swabs of immunised piglets was less profuse than 
from infected, non-immunised controls, and this difference in 
recovery rate was present not merely in the initial stages but 
throughout the infection period as observed in the case of piglet 
C+6. At post-mortem there was also a considerable decrease in 
recovery of C. perfringens type A from the gastrointestinal tract 
of immunised piglets when compared with infected, non-immunised 
controls (Table 21).
The macroscopic and microscopic findings also showed 
differences in the two experiments. In Experiment 3, the 
pathological changes in both immunised and non-immunised animals 
were similar. In contrast, the pathological changes in the 
gastrointestinal’ tract of immunised piglets in Experiment 2 were 
much less severe when compared to those found in non-immunised, 
infected animals; in particular the marked congestion so 
characteristic of the disease seen in infected, non-immunised 
controls was not evident in the immunised piglets.
In Experiment 2, passively immunised piglets were completely 
protected against challenge with isolate 7 by serum, colostrum or 
milk containing antibody to alpha toxin and somatic antigens. The 
exact component giving this protection was not clear. Antibody to 
pure alpha toxin was able to prevent the slight changes noted in
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the gut loops inoculated with alpha toxin in Chapter 5 and it is 
possible that this antibody alone was completely protective. 
Protection studies with pure porcine antibody to alpha toxin were 
not carried out. The reasons for the failure of anti-enterotoxin 
to protect in Experiment 3 are not entirely clear. The antiserum 
was administered both parenterally and orally as with the sera in 
Experiment 2 but failed to protect. Antibody levels in the piglets 
were similar to those in the serum given and transfer of anti- 
enterotoxin was successful. These findings are not unexpected. 
Niilo et al. (1971) used a bacterin prepared from sporulating 
cultures of an enteropathogenic strain of C.perfringens type A and 
produced serum antibody to enterotoxin. No protection occurred 
when the lambs were subsequently challenged with the C.perfringens 
by the intraduodenal route. Similar results have been recorded in 
man by Skjelkvale and Uemura (1977) who showed that volunteers with 
serum antibody to enterotoxin were susceptible to oral challenge.
Since the antibody used neutralised the effects of enterotoxin 
in gut loops (Chapter 6) it appears that systemic antibody to 
enterotoxin can not neutralise the enterotoxin in the gut. As the 
organism and enterotoxin are restricted to the gut lumen it may be 
that local immunity, especially IgA, is important in preventing 
infection. No studies have been carried out on the neutraliation
of enterotoxin by IgA antibody and local immunity in the gut has 
never been reported. The presence of antibody to enterotoxin in 
the colostrum or milk has not been reported in any species.
The examination of pig sera for the presence of antibodies to 
alpha toxin (Table 27) and to enterotoxin (Table 32) revealed that 
42.3 per cent of the sera possessed antibodies to alpha toxin with 
titres ranging from 1:2 to 1:16, and these same sera, 92.4 per cent 
possessed antibodies to enterotoxin with titres ranging from 1:2 to 
1:64. The prevalence of antibodies to these toxins indicates that 
pig populations are commonly exposed to these toxins. The higher 
percentage of animals with antibody titres to enterotoxin than to 
alpha toxin may indicate a better immunogenicity of enterotoxin 
than alpha toxin at intestinal level, possibly due to the
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resistance of enterotoxin to degradation by the intestinal 
contents. The demonstration of antibodies to alpha toxin in pig 
populations does not appear to be reported in the literature. 
The results of studies on the presence of antibodies to enterotoxin 
differed markedly from those reported by Niilo and Bainborough 
(1980) who found that of 620 pig sera, only 10 possessed antibody 
titres to enterotoxin. The same authors reported that of 345 
cattle sera, 53 possessed antibodies to enterotoxin; of 768 horse 
sera, 89 were positive for antibodies to enterotoxin, and of 244 
human sera, 101 possessed antibody titres to enterotoxin. On the 
other hand, Brant et al. (1978) reported that from 141 human sera 
and 151 cattle sera, all were positive to antibodies to 
enterotoxin. Ochoa and Velandia (1978) reported also that of 150 
horse sera, all were positive for antibodies to enterotoxin. These 
differences in antibody titres may indicate variations of 
C.perfringens type A enterotoxin-producer strains among 
populations, or they may be due to variations on the techniques 
used for the detection of antibodies to enterotoxin. Whether or 
not the presence of antibodies to C.perfringens type A cells, alpha 
toxin and enterotoxin in sows have an effect on protection and 
productivity when passively transferred to their progeny in field 
conditions remains to be investigated. The results obtained here 
suggest that exposure to C.perfringens type A and its toxins is 
widespread in the pig population and that infection may be 
important.
CONCLUSIONS
In conclusion, the studies carried out in this thesis have 
shown that C.perfringens type A may be isolated from cases of 
diarrhoea, particularly in young piglets and the disease may be 
reproduced experimentally by infection of hysterectomy-derived, 
colostrum-deprived piglets.
Two different diarrhoeic syndromes were observed to be 
produced by C.perfringens type A, one that might involve alpha
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toxin in its pathogenesis and the other that clearly involves 
enterotoxin.
The first diarrhoeic syndrome was characterised by a long 
lasting diarrhoea in 8 day-old HDCD infected piglets and by 
diarrhoea and death when one day-old HDCD piglets were infected 
with the organism. The disease could be prevented in these last 
animals by passive immunisation with sera, colostra or milks from 
immunised animals with C.perfringens type A bacterin or toxoid. 
Further investigations are required to elucidate the pathogenesis 
and mechanisms of protection of this syndrome. Protection studies 
with specific antibody to pure alpha toxin should be included.
The second diarrhoeic syndrome was characterised by a short 
lasting diarrhoea in one day-old HDCD infected piglets.
C.perfringens type A was found to sporulate and to produce 
enterotoxin at intestinal level; the disease produced may be 
entirely attributed to the enterotoxin. The disease could not be 
prevented by passive immunisation with serum from an animal 
immunised with purified enterotoxin. This syndrome resembles
closely the syndrome of food-poisoning in humans and the diarrhoeas
produced experimentally in other animal species. This study
appears to represent the first account of the isolation of 
enterotoxin producing C.perfringens type A from diarrhoea in pigs
and its relation to a specific diarrhoeic syndrome in infected
piglets by experimental infection. The relationship of this 
infection to effects on productivity requires further study and
experimental infections in weaned pigs should also be carried out.
The relationship between both types of C. perfringens type A
infections and other bacteria, viruses and parasites in the gut
also requires further investigation.
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